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ABSTRACT 
 
 Omega-3 fatty acids, specifically alpha-linolenic acid (ALA), eicosapentaenoic acid 
(EPA), and docosahexaenoic acid (DHA) are known for possessing anti-inflammatory and 
bone modulating properties in murine and in vitro models. Health conscious consumers have 
created market demand for value-added omega-3 fatty acid enriched food, as demonstrated 
by the fact that specialty eggs make up 26.4% of the shell egg market. This has led producers 
to supplement poultry diets to create enriched eggs and meats and satisfy consumer demand. 
Thus far, omega-3 fatty acid research has primarily focused on creating value-added foods 
for the consumer with little attention paid to the effects of supplementation on the animals. 
The overarching goal of this dissertation research was to investigate the potential positive 
effects related to poultry health of dietary omega-3 fatty acid supplementation as a secondary 
benefit for producers. Two models were used to pursue the overarching goal: aged hens with 
mature immune systems at risk of osteoporosis and growing broilers with naïve immune 
systems prone to leg bone pathology. The experimental objectives of this dissertation were as 
follows: 1) Evaluate how dietary ALA sources affect the fatty acid transfer rate from laying 
hen diet to the egg yolk; 2) Determine if dietary supplementation of ALA or the combination 
of EPA and DHA improves performance and bone health of aged laying hens and whether 
protective anti-inflammatory effects would be exerted during acute inflammation; 3) 
Investigate if dietary supplementation of ALA or EPA and DHA impact bone health and 
performance in growing broilers, and 4) Examine the protective anti-inflammatory and bone 
modulating effects of ALA or EPA and DHA on broiler performance and health during a 
period of repeated inflammation. 
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To evaluate dietary ALA sources and their fatty acid transfer rate to egg yolk 
(Objective 1, Experiment 1), diets supplemented with flaxseed oil or ground flaxseed were 
fed to Hy-Line W-36 laying hens near peak production for 8 wk. Egg yolk fatty acid profiles 
were measured to determine the transfer rates for the ALA sources. To determine if ALA or 
EPA and DHA affect bone health and inflammatory status of aged hens (Objective 2, 
Experiment 2), near end-of-second-cycle laying hens (122 to 134 wk of age) were fed diets 
supplemented with flaxseed oil or fish oil for 12 wk, followed by an acute lipopolysaccharide 
(LPS) inflammatory challenge. During the 12 wk dietary supplementation period, feed intake 
(FI), egg production, and egg weight were measured; and eggs and tibia were measured for 
strength prior to the inflammatory challenge. Liver inflammatory gene expression was 
measured 12 h post-LPS challenge.  
To investigate if ALA or EPA and DHA affect the bone health and performance of 
growing Ross 308 broilers (Objective 3, Experiment 3), diets supplemented with flaxseed oil 
or fish oil were fed for 28 consecutive d. FI, body weight (BW), breast yield, lameness, and 
bone mineral content (BMC) and density (BMD) were evaluated. Finally, to examine the 
protective anti-inflammatory effects of ALA or EPA and DHA on broiler performance and 
health (Objective 4, Experiment 4), the broilers from Experiment 3 were subjected to a 7 d 
repeated LPS inflammatory challenge, with the LPS dosage continually increasing by 20% 
every 48 h. Broiler BW and FI were measured from 35 to 42 d of age. Liver, muscle, and 
bone were measured for gene expression and composition. 
Results of the first experiment showed that the laying hens deposited ALA into egg 
yolk at a rate of 1.9 times more when fed flaxseed oil compared to ground flaxseed and total 
omega-3 fatty acids (ALA, EPA, and DHA) at a rate of 2.0 times more at the same dietary 
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flaxseed oil concentrations, demonstrating the use of an extruded oil as a more efficient 
omega-3 fatty acid supplement than a ground seed (P ≤ 0.01). It was also observed that it 
might take up to six wk for transfer efficiency to stabilize and plateau in laying hens. The 
results from Experiment 1 were used for predicting omega-3 fatty acid transfer to egg yolk in 
Experiment 2 and as the basis for using oil as an ingredient source and selecting timeframes 
for diet acclimation for the experiments. The second experiment revealed that feeding aged 
hens EPA and DHA reduced average daily FI by 0.8 ± 0.19 g/hen and egg weight by 2.39 ± 
0.556 g compared to control hens (P ≤ 0.01). Feeding hens ALA supplemented diets resulted 
in increased average daily FI by 1.2 ± 0.19 g/hen g compared to control hens (P ≤ 0.01). 
Feeding dietary ALA or EPA and DHA did not affect keel bone conformation score, tibia 
bone ash, tibia breaking strength, or eggshell breaking strength in aged hens (P ≥ 0.13). 
However, in response to the acute inflammatory challenge, feeding hens ALA or EPA and 
DHA resulted in intermediate gene expression levels of liver pro-inflammatory cytokines 
interleukin 1 beta (IL-1β), IL-6, and IL-18, and the adipogenic mediator peroxisome 
proliferator factor gamma as compared to the control hens (P ≤ 0.05), demonstrating anti-
inflammatory protection. Further testing was conducted using a broiler model with growing 
bones and developing immune system to determine if administration of ALA or EPA and 
DHA at an earlier age would result in health and performance benefits. 
Results of the third experiment demonstrated that feeding broilers diets supplemented 
with ALA or EPA and DHA did not improve BMC (P = 0.21) or BMD (P > 0.05) compared 
to the control. However, ALA supplementation increased broiler BMD by 10% compared to 
EPA and DHA supplementation (P ≤ 0.05), while control was intermediate. Feeding EPA 
and DHA decreased 34 d broiler breast muscle yield by 1.301 ± 0.3553% compared to the 
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control. Moreover, the broilers fed EPA and DHA decreased 34 d BW by 9% and increased 
feed conversion by 11% compared to the control and ALA supplement (P ≤ 0.05). Results of 
the fourth experiment demonstrated that the repeated LPS challenge in broilers reduced 42 d 
BW by 4% and FI by 6% compared to saline injections (P ≤ 0.01). Feeding EPA and DHA 
resulted in increased total lean tissue body composition in broilers by > 4% compared to the 
control and ALA supplemented diet (P ≤ 0.01). A protective effect was observed in broilers 
fed EPA and DHA, resulting in reduced liver gene expression of pro-inflammatory cytokines 
IL-1β, IL-6, IL-18, and IFNγ by 0.38, 0.21, 0.62, and 0.62-fold, respectively, compared to the 
control (P ≤ 0.05). Broilers fed EPA and DHA also experienced reduced liver gene 
expression of anti-inflammatory cytokine IL-10 by 0.41-fold compared to the control (P ≤ 
0.01). Feeding broilers ALA or EPA and DHA supplemented diets increased total BMC by ≥ 
0.2 ± 0.03 g and BMC accretion by ≥ 3.625 ± 0.9263% compared to the control (P ≤ 0.01). 
Collectively, omega-3 fatty acid supplementation did not improve or mitigate 
performance losses during periods of inflammation regardless of poultry model. The only 
instance where supplementation demonstrated a benefit to bone health was at therapeutic 
levels (4.1% ALA or EPA and DHA) during repeated inflammation in growing broilers. 
However, therapeutic levels of oil (14% oil used in Experiments 3 and 4) may not be 
practical to use in commercial broiler diets due to the limitations of feed manufacturing. 
Anti-inflammatory effects were achieved in the aged laying hen and naïve broiler models, but 
actively suppressing the immune system may not necessarily equate to a benefit to animal 
health. Anti-inflammatory effects in poultry housed in research or clean environments with 
low bacterial loads would allow a shift in metabolic activity from the immune system to 
productive activity. Commercial poultry live in microbial laden environments and immune 
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suppression may allow opportunistic infections to occur, such as with Gram-positive bacteria 
or viruses; therefore anti-inflammatory effects would not be a benefit in these scenarios. 
Based on the experiments in this thesis, omega-3 fatty acid supplementation in poultry diets 
would not provide a practical secondary benefit for producers.  
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CHAPTER 1. LITERATURE REVIEW 
 
1.1 Introduction 
Consumers concerned about personal health have created demand for value-added 
omega-3 fatty acid enriched eggs and meats, with the US egg market consisting of 26.4% 
specialty eggs (USDA, 2017b). The omega-3 fatty acids alpha-linolenic acid (ALA), 
eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) possess anti-inflammatory 
properties and modulate bone mineralization in vitro and in murine models (Kruger et al., 
2010; Kajarabille et al., 2013; Longo and Ward, 2016). Supplementing poultry diets with 
functional ingredients, such as omega-3 fatty acids, generates value-added eggs and meats for 
these health conscious consumers (Fraeye et al., 2012; Ribeiro et al., 2013). Thus far, omega-
3 fatty acid research has primarily focused on creating value-added foods for the consumer 
(Fraeye et al., 2012; Goyal et al., 2014); however; dietary omega-3 fatty acid 
supplementation in poultry diets may be serving an overlooked second purpose.  
Physical stress and bacterial challenges in commercial environments may 
compromise the immune system and overall health of laying hens (Lay et al., 2011; Zhao et 
al., 2016). Furthermore, laying hens have been genetically selected over the past 50 years for 
improved egg production and quality, which has contributed to increased risk of keel bone 
fractures and osteoporosis in commercial environments (Wilkins et al., 2011; Stratmann et 
al., 2016). Broilers have a naïve immune system due to their young age and are vulnerable to 
opportunistic infections during their short and demanding production cycle (Saif et al., 2008; 
Siegel, 2014). Broiler chickens have been genetically selected for rapid growth and muscle 
accretion, which has contributed to lameness and leg bone pathology commonly observed in 
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commercial flocks (Knowles et al., 2008; Grupioni et al., 2015). Therefore, two models were 
used to investigate dietary omega-3 fatty acid supplementation health effects on poultry in 
this dissertation research: aged hens with mature immune systems at risk of osteoporosis and 
growing broilers with naïve immune systems prone to leg bone pathology. Omega-3 fatty 
acid supplementation in poultry diets, used by producers to make value-added products, may 
be providing beneficial health effects to aged laying hens and growing broilers under 
production stress. 
 
1.2 Omega-3 Fatty Acids 
 Polyunsaturated fatty acids are composed of a carboxyl group, the alpha terminus, 
attached to a carbon chain with a methyl end, identified as the omega terminus. Omega-3 
fatty acids are part of the long chain polyunsaturated fatty acid family, characterized by the 
presence of more than two double bonds in an 18 to 22 carbon length tail. Omega-3 fatty 
acids contain an unsaturated double bond between the carbon 3 and 4 from the omega 
terminus (Scorletti and Byrne, 2013). Alpha-linolenic acid (ALA) is an essential omega-3 
fatty acid, 18 carbons in length containing 3 double bonds, that cannot be synthesized 
endogenously by mammals and birds and must be consumed in order to maintain biological 
homeostasis because they lack the Δ-15 desaturase enzyme, which converts omega-6 fatty 
acid linoleic acid to omega-3 fatty acid ALA (Scorletti and Byrne, 2013). Omega-3 fatty 
acids are required for normal brain development, neural and immunologic cell signaling, 
cardiovascular regulation, and bone mineral deposition and resorption (Goyal et al., 2014; 
Hou et al., 2015; Kim et al., 2017). 
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 Alpha-linolenic acid can be converted to longer chain omega-3 fatty acids EPA (20 
carbon chain containing 5 double bonds) and DHA (22 carbon chain containing 6 double 
bonds) via liver hepatocytes (Figure 1.1), although the conversion rate is limited in mammal 
and avian species due to ALA oversaturation of the desaturase and elongase enzymes 
(Zivkovic et al., 2011). On average, mammal and avian species convert 5% of dietary ALA 
to EPA and < 1% of dietary ALA to DHA (Burdge and Calder, 2006; Zivkovic et al., 2011). 
In a murine model, tissue deposition of DHA remained relatively constant when fed EPA or 
DHA included at ≤ 0.25% of the diet (Sierra et al., 2008). Due to the limited endogenous 
conversion of ALA to EPA and DHA, the two longer chain omega-3 fatty acids are 
considered conditionally essential because normal cognitive functions require DHA along 
with fetal neurologic development (Horrocks and Yeo, 1999). Although recognized as 
essential or conditionally essential, no dietary requirements have been established for ALA, 
Figure 1.1. Fatty acid cellular metabolism of omega-3 alpha-linolenic acid and omega-6 linoleic acid by rate 
limiting enzymes to modulate respective anti- and pro-inflammatory pathways. 
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EPA, or DHA for laying hens or broilers (Tinoco, 1982; NRC, 1994; Ross, 2007; Hy-Line, 
2012).  
Cell membranes throughout the body contain EPA and DHA, which influence 
membrane receptor organization within microdomains known as lipid rafts composed of 
glycolipoproteins and cell signaling molecules (Hou et al., 2015). Membrane EPA and DHA 
content influences membrane fluidity, which impacts cell signaling, activation, and 
differentiation of immune B and T cells (Hou et al., 2015). A diet containing 10.5% ALA, 
3% EPA, and 2% DHA fed to mice resulted in disruption of B cell lipid raft clustering and 
size by 40% compared to control-fed mice (P ≤ 0.01), demonstrating omega-3 fatty acid 
influence on distribution of membrane receptors located within the lipid raft microdomains 
(Rockett et al., 2011). It is possible that reduced lipid raft clustering and size could prevent 
protein recruitment into lipid rafts from non-raft regions, such as Toll-like receptor (TLR) 
dimerization, due to increased lipid raft spatial distribution across the membrane resulting in 
reduced inflammatory signaling (Rockett et al., 2011).  
Membrane incorporated EPA and DHA also function as precursors for lipid-mediated 
anti-inflammatory signaling eicosanoids metabolized by cyclooxygenase and lipoxygenase 
which include prostaglandins, prostacyclins, thromboxanes, and leukotrienes (Scorletti and 
Byrne, 2013; Longo and Ward, 2016). Eicosanoid metabolites that resolve inflammation 
could not be synthesized without EPA and DHA found in the cell membrane. 
Omega-3 fatty acids EPA and DHA may modulate immune system function in 
various ways. For example, it has been suggested that they serve an anti-inflammatory role 
by displacing pro-inflammatory omega-6 fatty acid arachidonic acid, which is responsible for 
producing pro-inflammatory cytokines including interleukin-1 (IL-1) and tumor necrosis 
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factor (de Pablo et al., 2002). The omega-3 fatty acids EPA and DHA are also thought to 
modulate inflammation through lipid peroxide production where reactive oxygen species are 
neutralized by oxidizing the unsaturated bonds or by inhibiting translocation of transcription 
factors such as nuclear factor kappa B (NF-!B) reducing pro-inflammatory stimulation 
(Figure 1.2; de Pablo et al., 2002; Hichami et al., 2016).  
The anti-inflammatory functional properties of EPA and DHA contribute to consumer 
demand for niche market omega-3 fatty acid enriched poultry products (Fraeye et al., 2012; 
Ribeiro et al., 2013). Human epidemiological studies and randomized clinical trials 
associated EPA and DHA consumption with reduced risk of coronary heart disease and 
sudden cardiac death (Mozaffarian and Wu, 2011). Dietary recommendations from USDA 
and US Department of Health and Human Services (2010) suggests ≥ 250 mg consumption 
of EPA and DHA per day. Other human studies indicate that dietary EPA and DHA are 
linked to increased bone formation, peak bone mass, and reduced bone loss with the 
Figure 1.2. Lipopolysaccharide (LPS) ligand complex stimulation of cell membrane Toll-like Receptor 4 
(TLR4) and Nuclear Factor kappa B (NF-!B) activation by removal of Inhibiting NF-!B Binding Protein 
(I!BP), which allows NF-!B translocation from the cell cytoplasm into the nucleus for pro-inflammatory 
cytokine transcription and translation of interleukin 1β (IL-1β), IL-6 and acute phase protein serum amyloid A 
(SAA).  
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mechanisms connected to the receptor activator of NF-!B which controls osteoclast 
formation (Kajarabille et al., 2013). Attenuation of inflammation through omega-3 fatty acid 
dietary manipulation (ALA, EPA, and DHA) may benefit human and animal well-being, 
warranting further investigation into digestion, transfer, metabolic, and immunologic effects. 
 
1.3 Dietary Omega-3 Fatty Acid Sources 
Alpha-linolenic acid is naturally produced by terrestrial plants, such as flax, that are 
used as ALA sources for enriching human and animal diets (Goyal et al., 2014). Terrestrial 
plants do not produce or only accumulate trace amounts of EPA and DHA (Fraeye et al., 
2012). Conversely, fish meal and marine oils contain primarily EPA and DHA with trace 
amounts of ALA (Fraeye et al., 2012; Lemahieu et al., 2013). This is because EPA and DHA 
are produced by marine and heterotrophic microalgae and accumulate in the tissue of fish 
that consume prey that feed on algae (Table 1.1; Fraeye et al., 2012).  
The choice of omega-3 fatty acid source and how that ingredient source has been 
processed directly affects the fatty acid profile and may potentially affect the bioavailability 
of the fatty acids used for dietary supplementation (Gunstone, 2006; Fraeye et al., 2012). 
Plant sources containing ALA can be ground or milled into a meal and used as an ingredient 
for supplementing poultry diets. Alternatively, the concentrated oil from seeds and other 
plant components can be mechanically extracted by pressing and filtering to create cold 
pressed oil. Solvents can also be used to separate the oil from plant components, or a 
combination of mechanical and solvent extraction techniques can be applied to maximize oil 
yield (Gunstone, 2006).  
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Marine heterotrophic microalgae containing DHA can be fed relatively unaltered as a 
meal ingredient, whereas marine fish sources containing differing concentrations of EPA and 
DHA are processed to make oils (Gunstone, 2006; Fraeye et al., 2012). Marine fish are 
processed in a steam cooker at 100°C where the co-product of water, oil, and fine solids are 
diverted into a decanter which removes the solid particles (Gunstone, 2006). The water and 
oil mixture is centrifuged to separate the water fraction from the remaining oil (Gunstone, 
2006). Ground meal and oil ingredients containing omega-3 fatty acids are available for 
poultry diet supplementation (Table 1.1; Fraeye et al., 2012; Lemahieu et al., 2013). Omega-
3 fatty acid ingredients may differ in ALA, EPA, and DHA compositions based on the raw 
starting material and whether centrifugation or ingredient blending was involved during 
processing (Fraeye et al., 2012; Lemahieu et al., 2013). 
 
Table 1.1. Ingredient omega-3 fatty acid composition.1 
Ingredient ALA % EPA % DHA % 
Palm oil 0.2 0.0 0.0 
Soybean oil2 6.5 0.0 0.0 
Canola oil 9.1 0.0 0.0 
Flaxseed oil3 53.4 0.0 0.0 
Flaxseed meal 22.8 0.0 0.0 
Menhaden fish oil 1.5 13.2 8.6 
Menhaden fish meal4 0.1 1.1 0.7 
1Adapted from USDA (2017a) Food Composition Databases, National Agricultural Library 
on an as-fed basis. ALA = alpha-linolenic acid; EPA = eicosapentaenoic acid; DHA = 
docosahexaenoic acid. 
2Non-hydrogenated. 
3Cold pressed. 
4Containing 8% fat.  
 
Milling processes may also affect energy availability of poultry diets containing 
omega-3 fatty acid ingredients. Flaxseed supplemented diets with inclusions of 0, 5, 10, 15, 
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and 20% ground flaxseed fed to 79 week old roosters resulted in increased nitrogen corrected 
apparent metabolizable energy (AMEn) when processed in pelleted (4,578 kcal/kg) or 
crumbled (4,277 kcal/kg) forms when compared to mash (3,659 kcal/kg) diets (P ≤ 0.01; 
Gonzalez-Esquerra and Leeson, 2000b). In addition, the heat and pressure from processing 
may have released trapped oil within the flaxseed cellular matrix and degraded some of the 
anti-nutrients that flaxseed contain (Calet, 1965; Gonzalez-Esquerra and Leeson, 2000b). 
Omega-3 fatty acid source and processing techniques are important factors of consideration 
when using omega-3 fatty acid supplementation in poultry diets. 
 
1.3.1 Flaxseed Supplementation 
Flaxseed, also known as linseed, is used by producers in the US as a functional feed 
ingredient for supplementing poultry diets with ALA. Whole flaxseed, commonly added to 
diets in a ground meal form, contains up to 45% fat, with 60% of the fat composition 
consisting of ALA and 15% omega-6 linoleic acid (Kratzer and Vohra, 1996; USDA, 2017a). 
Poultry eggs and meat can be enriched with ALA by supplementing ground flaxseed meal 
into the diets (Fraeye et al., 2012; Lopes et al., 2013).  
Different sources of dietary ALA supplementation yield varying total omega-3 fatty 
acid incorporation into egg yolk. Without ALA supplementation in laying hen diets, a sample 
of 48 eggs obtained from retail outlets contained an average of 68 mg (combined ALA and 
DHA) per 50 g egg from conventionally managed laying hens (Samman et al., 2009). In a 
study investigating ALA sources fed to laying hens for 24 weeks, use of 15% dietary canola 
seed yielded 173 mg total omega-3 fatty acids (93 mg ALA) per 50 g egg while 15% dietary 
flaxseed-pea mixtures (1:1 wt/wt, ground-extruded) resulted in increased ALA deposition 
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averaging 355 mg total omega-3 fatty acids (254 mg ALA) per 50 g egg (P ≤ 0.01; Jia et al., 
2008). Dietary inclusion of 15% flaxseed resulted in 468 mg total omega-3 fatty acids (358 
mg ALA) per 50 g egg, demonstrating the increased ALA enrichment potential of dietary 
flaxseed compared to the alternative supplement ingredients (P ≤ 0.01; Jia et al., 2008). 
However, hens fed canola seed diets consumed 6% less feed and produced 5% more eggs, 
resulting in 10% improvement in feed conversion compared to hens fed flaxseed diets (P ≤ 
0.01), suggesting that diets containing 15% flaxseed may significantly reduce performance 
(Jia et al., 2008).  
Flaxseed varieties may differ in their anti-nutrient content of cyanogenic glycosides, 
phytic acid, trypsin inhibitor, and gel-forming non-starch polysaccharides (Feng et al., 2003; 
Jia and Slominski, 2010; Goyal et al., 2014). Flaxseed supplementation may reduce the 
palatability of poultry diets and the presence of anti-nutrients suggests a biological limit for 
ration incorporation to prevent negative effects on performance and feed efficiency. One 
anti-nutrient factor is hydrogen cyanide, which non-competitively inhibits cellular respiration 
and is generated as a metabolic product from cyanogenic glycosides, which includes 
linustatin, neolinustatin, and linmarin (Oomah et al., 1992; Feng et al., 2003). Phytic acid is 
another anti-nutrient that acts as chelator, forming complexes from ions and molecules 
bonding to metal ions such as calcium, iron, or zinc in the digesta interfering with mineral 
absorption, reducing bioavailability (Erdman, 1979). Trypsin inhibitors, common in 
soybeans, reduce feed digestibility and are less concerning in flaxseed because they are only 
found in trace amounts (Bhatty, 1993; Feng et al., 2003). Mucilage is a water-soluble non-
starch polysaccharide common in flaxseeds and causes increased viscosity of chicken 
intestinal content (Rodriguez et al., 2001; Alzueta et al., 2003). When intestinal viscosity is 
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increased, nutrient digestion and absorption may become impaired, thereby reducing nutrient 
utilization (Rodriguez et al., 2001; Alzueta et al., 2003). Although ground flaxseed may be 
used as an ALA supplement to produce value-added eggs and meat, it may have limitations 
as a functional ingredient depending on anti-nutrient content. 
Dietary inclusion of flaxseed at ≤ 15%, ground or whole, did not affect hen-day egg 
production (HDEP) in 43 week old laying hens. However, hen body weight and egg weight 
were reduced in the flaxseed treatments when contrasted to the control (P ≤ 0.05; Scheideler 
and Froning, 1996). The conclusions of this study regarding performance were only based on 
4 experimental units, consisting of 3 hens each, fed for 8 weeks, which might have been too 
short in duration to detect the treatment effect on HDEP, plus the relatively low number of 
replicates (Scheideler and Froning, 1996). 
In a 48 week experiment, feeding diets containing 20% ground flaxseed to laying 
hens resulted in reduced egg production by 5% and increased feed consumption by 7% 
compared to feeding diets containing 0 and 10% flaxseed (P ≤ 0.01; Leeson et al., 2000). 
Even with increased feed consumption, the hens fed 20% flaxseed diets weighed 10% less 
than hens fed diets containing 0 and 10% flaxseed (P ≤ 0.01), which might be due to anti-
nutrients contained in the flaxseeds (Leeson et al., 2000). 
Consumer preference also needs to be taken into consideration when evaluating 
dietary flaxseed supplementation and poultry performance. Sensory panels from multiple 
experiments detected unacceptable “fishy” flavors of value-added eggs from hens fed diets 
containing > 10% ground flaxseed (Leeson et al., 1998; Fraeye et al., 2012; Goyal et al., 
2014). Thus, from the standpoints of performance and consumer acceptability, laying hen 
diets should not include > 10% ground flaxseed.  
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Age and breed are factors that affect how well poultry are able to digest flaxseed 
when included at > 10% in diets. It was observed that 81 week old, single comb white 
leghorn roosters fed 10% ground flaxseed diets did not have adverse reactions to dietary 
flaxseed inclusion (Gonzalez-Esquerra and Leeson, 2000b). In the same experiment, 9 day 
old broiler chicks were fed diets supplemented with 5, 10, 15, and 20% ground flaxseed and 
experienced diarrhea, demonstrating sensitivity to increased dietary flaxseed inclusion due to 
gastrointestinal immaturity and limited digestive capacity (Gonzalez-Esquerra and Leeson, 
2000b). It appears that ground flaxseed can be included up to 10% in laying hen diets without 
performance losses; however, broilers appear sensitive to ground flaxseed even at levels 
below 10% of the diet (Gonzalez-Esquerra and Leeson, 2000b).  
Extracted oils may be an efficient alternative to ground meal products for ALA 
supplementation because they do not possess anti-nutrients yet contain concentrated amounts 
of desired fatty acids. Compared to soybean and corn oils, flaxseed oil contains 7 times more 
ALA content with 3 times less linoleic acid content (NRC, 1994; Goyal et al., 2014). Seed 
cell wall matrix, structural components within flaxseed, remains after processing and trap 
portions of the lipid fraction as observed with other seed types, such as almonds (Ellis et al., 
2004; Mandalari et al., 2008). Portions of oil contained within seed cell compartments, even 
after mastication or mechanical grinding, are not entirely liberated and pass through the 
gastrointestinal tract undigested preventing the oil from being absorbed and used for fatty 
acid transfer to tissue or egg yolk (Cassady et al., 2009). Theoretically, fatty acid transfer rate 
efficiency would improve if unimpeded by cellular compartmentalization. 
Dietary ALA supplementation in laying hen diets yields omega-3 fatty acid (ALA, 
EPA, and DHA) enriched egg yolks (Scheideler and Froning, 1996; Samman et al., 2009). 
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However, fatty acid transfer from diet to egg yolk depends on source and dietary inclusion 
level. Laying hens fed 16% flaxseed diets produced eggs containing 1.4 times higher relative 
egg yolk total omega-3 fatty acid content compared with egg yolk from hens fed 8% flaxseed 
and 6.6 times higher compared to unsupplemented control hens (P ≤ 0.05; Cherian and Sim, 
1991). In another experiment, laying hens were fed 0, 7.5, and 15% ALA supplemented diets 
(50% extruded flaxseed and 50% alfalfa-pea carrier) for 18 d; and the dietary total omega-3 
fatty acid (ALA, EPA, and DHA) transfer efficiency to egg yolk was shown to reduce by 
33% when comparing the 15% treatment to control (P ≤ 0.01; Nain et al., 2012). Broken 
stick analysis was used to determine dietary omega-3 fatty acid transfer efficiency to egg 
yolk, a linear pattern was observed prior to reaching saturation (Nain et al., 2012). The 
reduced transfer efficiency of the 15% treatment (22.2% transfer efficiency) compared to 
control (55.6% transfer efficiency) demonstrated that as dietary ALA inclusion increases, 
then total omega-3 fatty acid transfer efficiency to egg yolk decreases due to down regulation 
of enzymatic activity (P ≤ 0.01; Nain et al., 2012). Eggs from the 15% treatment reached a 
plateau of total omega-3 fatty acid content within 6.2 days, achieved the target threshold of 
300 mg total omega-3 fatty acid egg yolk content within 5 days, and attained blood plasma 
saturation within 7.2 days (P ≤ 0.01; Nain et al., 2012). It appeared that peak transfer 
efficiency for laying hens required a week of diet acclimation when feeding ALA 
supplemented diets using ground-extruded flaxseed and pea meal. Further characterization 
regarding omega-3 fatty acid transfer rate in relation to oil inclusion level would be 
warranted for future industry practical and research applications. 
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1.3.2 Fish Supplementation 
Ground fish meal and fish oils can be included in poultry diets to enhance the 
concentrations of EPA and DHA found in poultry eggs and meat (Hargis et al., 1991; Nash et 
al., 1996; Gonzalez-Esquerra and Leeson, 2000a). Fish meal contains 5 to 10% fat and 60 to 
70% protein depending on the type of fish used in processing (Koning, 2005). Similar to 
flaxseed meal, the omega-3 fatty acids reside in the fat fraction of fish meal. Unlike ground 
flaxseed meal, fish meal does not contain the anti-nutrients of concern that may impair 
digestion, absorption, and utilization of a diet (Kumar et al., 2012). As described earlier, 
flaxseed-based ingredients contain ALA with trace amounts of EPA and DHA (Fraeye et al., 
2012; Goyal et al., 2014). Fish oil differs from flaxseed oil because it contains up to 35% 
EPA and DHA with little to no ALA in its fatty acid profile (Fraeye et al., 2012; Goyal et al., 
2014). Manufacturers distribute a wide range of fish oils containing < 4% ALA, 18% EPA, 
and 12% DHA, while a variety of custom concentrated or blended fish oils may contain > 
70% DHA (Koning, 2005; Gunstone, 2006).  
Plant derived ALA can be converted into EPA and DHA through rate limiting 
elongation, desaturation, and beta-oxidative reactions by most mammals and birds (Figure 
1.1), but direct supplementation forgoes the post-absorptive modifications (Harris et al., 
2008; Gregory et al., 2011; Gregory et al., 2013). Broiler chickens are able to endogenously 
elongate and desaturate ALA to the longer chain EPA and DHA forms in a quadratic 
curvilinear manner (Kartikasari et al., 2012). It was observed that broiler breast muscle tissue 
became saturated with EPA and DHA as dietary flaxseed oil supplementation approached 8% 
(P < 0.01; Kartikasari et al., 2012). However, direct dietary EPA and DHA supplementation, 
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rather than ALA supplementation, is the most efficient method to enrich muscle tissue with 
EPA and DHA (Ribeiro et al., 2013).  
Ingredient fatty acid composition has a direct effect on fat deposition and utilization 
by poultry. Monogastric species limit fatty acid structural alteration post-absorptively, unlike 
ruminants that modify lipids via ruminal microbial enzymatic activity (Hurtaud et al., 2013; 
Haug et al., 2014). During post-absorptive metabolism, ALA is stored in adipocyte lipid 
droplets added to triglycerides for long-term energy storage (Cherian and Sim, 1991). Longer 
chain omega-3 fatty acids EPA and DHA, found in fish oils, are almost exclusively deposited 
for storage in phospholipid form, particularly phosphatidylethanolamine in egg yolk (Jiang et 
al., 1991). Dietary supplementation of EPA and DHA sources into laying hen rations 
generate value-added eggs in a similar manner as ALA supplementation. 
Dietary fish oil supplementation in laying hen diets is a practical way to deposit 
omega-3 fatty acids into egg yolks. Dietary fish oil inclusion of 3.0% has been shown to 
increase egg yolk total omega-3 fatty acid content by 400% when compared to egg yolk from 
unsupplemented hens (Van Elswyk, 1997). In the experiment, Single Comb White Leghorn 
laying hens, 27 hens per treatment, were fed diets containing 0, 0.5, 1.0, 1.5, 2.0, 2.5, or 3.0% 
fish oil for 4 weeks and egg yolk (10 yolks per treatment) from each treatment was analyzed 
for total omega-3 fatty acid content weekly (Van Elswyk, 1997). Egg yolks from the 3.0% 
fish oil treatment reached omega-3 fatty acid saturation after 3 weeks of supplementation, 
containing 234 mg of total omega-3 fatty acids compared to control egg yolk which 
contained 45 mg total omega-3 fatty acids (Van Elswyk, 1997). However, EPA and DHA 
content and omega-3 fatty acid regression analysis were not reported. The study verified that 
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dietary fish oil supplementation was able to increase egg yolk total omega-3 fatty acid 
content. 
Broiler meat can be directly enriched with EPA and DHA through dietary fish oil 
supplementation. It has been demonstrated that feeding 8% fish oil supplementation in 
broiler diets resulted in 450% increase in broiler breast tissue EPA and DHA content 
compared to unsupplemented control broiler breast tissue (P ≤ 0.05; Rymer and Givens, 
2010). In an experiment, Ross 308 broilers were fed either 0, 4, or 8% fish oil supplemented 
diets from 21 to 42 days of age using 4 pens per treatment with 5 broilers per experimental 
unit (Rymer and Givens, 2010). Skinless breast tissue from each treatment was analyzed for 
fatty acid composition at 42 days of age (Rymer and Givens, 2010). Breast tissue from 
broilers fed 4% fish oil supplemented diet contained 504 mg EPA and 1071 mg DHA per kg 
breast tissue and breast tissue from broilers fed 8% fish oil supplemented diets contained an 
average of 545 mg EPA and 1363 mg DHA per kg breast tissue (Rymer and Givens, 2010). 
The pattern of increasing EPA and DHA deposition from Rymer and Givens (2010) broiler 
breast tissue analysis was in agreement with results from Saleh et al. (2010) who used 0, 1.5, 
3.0, and 6.0% dietary fish oil treatments and Navidshad et al. (2012) who used 0, 2, and 4% 
dietary fish oil treatments in broiler experiments. Samples from the unsupplemented control 
group only contained 164 mg EPA and 259 mg DHA per kg breast tissue, demonstrating the 
effectiveness of dietary fish oil as an ingredient for enriching broiler breast tissue with EPA 
and DHA (P ≤ 0.05; Rymer and Givens, 2010).  
Dietary fish oil also influences how fatty acids are incorporated into tissues 
throughout the body (Newman et al., 2002a; Newman et al., 2002b). Fatty acid tissue 
incorporation was determined in a broiler study using dietary treatments containing 8% fish 
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oil, 8% sunflower oil, or 8% tallow fed from 21 to 35 days of age (Newman et al., 2002b). It 
was discovered that feeding 8% fish oil and 8% sunflower oil treatments to broilers resulted 
in an average reduction of abdominal fat pad weight by 59% and compared to broilers fed the 
8% tallow treatment (P ≤ 0.01; Newman et al., 2002b). The 8% fish oil and 8% sunflower oil 
treatments fed to broilers resulted in an average increase in breast muscle:fat pad ratio by 
180% compared to broilers fed the 8% tallow treatment (P ≤ 0.01; Newman et al., 2002b). 
This study demonstrated that diets high in polyunsaturated fatty acids shift fatty acid 
incorporation into lean muscle and away from adipose tissue (Newman et al., 2002b).  
A follow up study using the same broiler tissue confirmed that feeding the 8% fish oil 
treatments to broilers increased EPA and DHA deposition in muscle tissue compared to 
broilers fed the 8% sunflower oil and 8% tallow treatments (P ≤ 0.05, Newman et al., 2002a). 
When analyzing the phospholipid content of the muscle tissue, broilers fed the 8% fish oil 
treatment increased EPA and DHA incorporation into phosphatidylchoine and 
phosphatidylethanolamine and decreased arachidonic acid phospholipid incorporation 
compared to the other two treatment groups (P ≤ 0.05, Newman et al., 2002a). These findings 
were in agreement with Carragher et al. (2016) demonstrating EPA and DHA selective 
phospholipid remodeling and incorporation in broiler muscle tissues, which fundamentally 
alter cell membrane composition (Newman et al., 2002a). 
Consumer palatability is a factor that must be considered when using fish meal or fish 
oil to generate value-added produce, because EPA and DHA are highly volatile 
polyunsaturated fatty acids that may go rancid. Sensory panels were able to detect and taste 
unpleasant flavors in EPA and DHA enriched eggs from laying hens fed 4 to 8% fish meal 
supplemented diets (Nash et al., 1996). A sensory panel from another study detected 
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unpleasant flavors from enriched eggs from hens fed 2 and 4% fish oil supplemented diets 
(Gonzalez-Esquerra and Leeson, 2000a). The flavor of value-added broiler meat may also 
become compromised.  A study found that 23% of sensory panelists were able to detect 
“fishy taint” in meat from broilers fed diets containing 4 and 8% fish oil (Rymer and Givens, 
2010). These findings suggest fish oil supplementation may result in off flavors when 
approaching 4% in poultry diets. Further sensory evaluations should be conducted in value-
added industry applications to prevent production of unpalatable produce that may be 
rejected by consumers.  
 
1.4 Omega-3 Fatty Acid Functions 
1.4.1 Influence on Inflammation 
Omega-3 fatty acids EPA and DHA are known to influence the immune system in an 
anti-inflammatory manner through modulation of lymphocyte proliferation, cytokine 
synthesis, natural killer cell activity, and mononuclear phagocytosis (de Pablo et al., 2000; de 
Pablo et al., 2002). Pre-clinical studies using human and rodent models have shown that EPA 
and DHA perform anti-inflammatory functions that are associated with reducing circulating 
plasma C-reactive protein, an acute phase protein produced by the liver in response to 
inflammation and reduction of pro-inflammatory cytokine IL-6 (Cottin et al., 2011; Skulas-
Ray, 2015). However, C-reactive protein levels were not reduced in vivo compared to in vitro 
models (Cottin et al., 2011; Skulas-Ray, 2015). The scientific knowledgebase would benefit 
from further in vivo evaluation of omega-3 fatty acid mode of action, specifically in chicken 
models, during periods of inflammation based on omega-3 fatty acid form (ALA, EPA, and 
DHA).  
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Cytokine Modulation 
Omega-3 fatty acids EPA and DHA play a direct role in cell function and signaling 
by altering synthesis of cytokines produced by a range of immune cells (de Pablo et al., 
2002). Pro-inflammatory cytokines IL-1β, IL-6, IL-18, and interferon gamma (IFNγ) are 
increased during infection and acute inflammatory responses in avian species (Staeheli et al., 
2001). During an infection, activated macrophages produce IL-1β, which has pleiotropic 
functions including initiating the acute phase response, fever induction, T cell recruitment, 
IL-6 synthesis, and synergistically co-stimulates lymphocytes with IL-12 (Dinarello, 1998; 
Tominaga et al., 2000). Natural killer cells and TH1 lymphocytes stimulated by IL-18 
produce IFNγ (Wawrocki et al., 2016). Circulating extracellular IFNγ is a major macrophage 
activating factor and drives the TH1 immune response, characterized by bactericidal and 
virucidal clearance by macrophages and stimulated B cell antibody production (Irons and  
Fritsche, 2005; Spits et al., 2016). IL-18 also serves to enhance natural killer and CD8 T cell 
cytotoxic activity and promotes TH1 and TH2 differentiation (Staeheli et al., 2001; Liu et al., 
2006). Cytokine modulation or suppression via EPA or DHA would reduce activation and 
response of phagocytic immune cells such as monocytes and macrophages. 
IL-6 is critical in development of pathological pain and is one of the primary 
regulators of the acute phase inflammatory response in avian species along with IL- 1β (Zhou 
et al., 2016). During active infections or cellular trauma, monocytes, T and B lymphocytes, 
endothelial cells, and fibroblasts produce IL-6 (Staeheli et al., 2001). In addition to inducing 
the acute phase inflammatory response, IL-6 serves a multifunctional role including 
regulating immunoglobulin synthesis and initiating T lymphocyte activation for pathogen 
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clearance (Staeheli et al., 2001; Abdelsalam et al., 2011). Reduced IL-6 production in birds, 
influenced by dietary EPA and DHA, may result in shortened or less intense acute phase 
response.  
One mechanism of how EPA and DHA influence cell signaling is by acting as 
intracellular second messengers. Fatty acids released from membrane phospholipids function 
as cellular second messengers or substitute for classical second messengers modulating 
cellular gene expression (de Pablo and de Cienfuegos, 2000). Fatty acids, such as the omega-
6 fatty acid arachidonic acid, act in a reversible manner for short durations intracellularly at 
the level of cell membranes (Sumida et al., 1993; de Pablo and de Cienfuegos, 2000). 
Arachidonic acid activates enzymes and proteins from the cyclic AMP and protein kinase C 
cell signaling pathways, which increases intracellular protein phosphorylation shifting cell 
activity towards a pro-inflammatory state (Sumida et al., 1993; de Pablo and de Cienfuegos, 
2000). Whether through cellular pathway alterations or lipid mediator formation, EPA and 
Figure 1.3. Lipopolysaccharide (LPS) ligand complex inhibited stimulation of cell membrane Toll-like 
Receptor 4 (TLR4) and resulting inhibition of Nuclear Factor kappa B (NF-!B) activation by Inhibiting NF-!B 
Binding Protein (I!BP). Inactive NF-!B cannot translocate from cell cytoplasm into the nucleus, therefore 
preventing pro-inflammatory cytokine transcription and translation of interleukin 1β (IL-1β), IL-6 and acute 
phase protein serum amyloid A (SAA).   
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DHA modulate inflammatory cytokine gene activation and synthesis (Figure 1.3; Serhan, 
2014).  
 Alternatively, EPA and DHA may also be acting directly by suppressing immune cell 
activation and function (Shoda et al., 2015). In an experiment using mice with an 
autoimmune condition causing retinal inflammation, 6 week old female mice were fed EPA 
and DHA (1% and 1% of the diet, respectively) supplemented diets for 2 weeks (Shoda et al., 
2015). Feeding EPA and DHA supplemented diets to mice resulted in reduced intraocular 
IFNγ production by TH1 cells to undetectable levels and decreased IL-17 production by TH17 
cells to levels 7 times below what was observed in mice fed 2% arachidonic acid 
supplemented diets (P ≤ 0.01; Shoda et al., 2015). Short-term dietary supplementation of 
EPA and DHA in mice resulted in reduced inflammatory signaling by immune cells at the 
site of inflammation (Shoda et al., 2015). In a separate study performed in vitro, human 
macrophages and hepatocytes cultured in EPA-enriched media (100 µmol/L) were exposed 
to prostaglandin E2 (0.1 µg/mL) or lipopolysaccharide (0.1 µg/mL) to induce inflammation 
(Hao et al., 2010). Cells incubated in EPA reduced expression of tumor necrosis factor alpha 
and IL-6 by 50% compared to cells incubated in media containing arachidonic acid (100 
µmol/L) or media containing the combination of EPA and arachidonic acid (1:1 ratio, 100 
µmol/L; P ≤ 0.01; Hao et al., 2010). In a follow-up assay, cell cultures were stimulated with 
lipopolysaccharide (0.1 µg/mL) for 24 hours, and then EPA was added to the media (100 
µmol/L), which resulted in > 150% increased production of anti-inflammatory cytokine IL-
10 at 24 hours post-EPA addition (P ≤ 0.01; Hao et al., 2010). Modulation of cytokine 
production through direct contact with EPA or DHA suggests a mode of action involving cell 
surface receptor function.  
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Anti-inflammatory IL-10 is produced by T cells and monocytes, and resolves cell 
mediated immune cell function by inhibiting TH1 and Natural Killer cell IFNγ synthesis via 
counteracting synergistic IL-12, IL-1β, and co-stimulation of IL-18 (Tominaga et al., 2000; 
Skovbjerg et al., 2010). Along with resolving inflammation, IL-10 diminishes macrophage 
microbicidal activity and inhibits responsiveness to IFNγ; dysregulation of resolving 
inflammation is a factor development of autoimmune disorders (Duque and Descoteaux, 
2014; Varzaneh et al., 2014). In the case of modern poultry production, IL-10 serves to 
resolve systemic inflammation that may occur from environmental, management, or 
pathogenic stress.  
Infection via different bacterial species results in a specific characteristic cytokine 
production by immune cells. In an in vitro experiment, peripheral blood mononuclear cells 
collected from human donors were infected by a panel of 37 Gram-positive and -negative 
bacterial species representing 5 phyla and assessed for cytokine production (Skovbjerg et al., 
2010). Infection with Gram-positive bacteria stimulated 1.5 times more IL-1β, 7 times more 
IFNγ, and 9 times more IL-12 than Gram-negative species (P ≤ 0.05; Skovbjerg et al., 2010). 
Gram-negative bacterial infection induced an average of 1.5 times more IL-6 and 3.3 times 
more IL-10 than Gram-positive species (P ≤ 0.01), demonstrating fundamental differences in 
innate immune cell cytokine production based on pathogen membrane components 
(Skovbjerg et al., 2010).  
Proteins in serum are associated with regulation of host resilience to pathogen-
associated molecular patterns, which are how antigen presenting cells and lymphocytes 
recognize foreign microbes within the body (Warren et al., 2010). Macrophages from human 
and mouse blood were activated by lipopolysaccharide in vitro (≤ 2000 ng/mL) for 18 hours 
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and resulted in human macrophages producing 35 times more IL-6 compared to mouse 
macrophages (Warren et al., 2010). The more resilient a species is to lipopolysaccharide 
exposure in vivo, the greater the macrophages will tolerate the toxin and reduce response and 
expression of IL-6 in vitro, suggesting that immune cell responses are controlled by 
circulating cytokines (Warren et al., 2010). Measuring cytokine expression or production is a 
useful tool for evaluating inflammatory status and identifying patterns in live animal models.  
 In addition to cytokines, acute phase proteins like serum amyloid A secreted by the 
liver of chickens and other vertebrates are a useful way to measure stress as a result of 
infection, trauma, or inflammatory insult as a non-specific systemic reaction by the innate 
immune system (O'Reilly and Eckersall, 2014). The primary function of serum amyloid A is 
to transport lipoprotein and modulate metabolism during an acute phase inflammatory 
response, which allows cholesterol to remain in damaged tissues for repair and actively 
remove lipid debris from bacteria and tissue (O'Reilly and Eckersall, 2014). IL-1β and IL-6 
work in concert to stimulate hepatocellular production of serum amyloid A and increase 
circulating plasma concentrations by up to 1,000-fold (Uhlar and Whitehead, 1999). 
Prolonged chronic inflammation or infection may result in persistently elevated circulating 
serum amyloid A levels, which may result in amyloidosis where proteinaceous 
accumulations of amyloid A aggregate intercellularly among various tissues causing organ 
dysfunction or failure (Saif et al., 2008; O'Reilly and Eckersall, 2014). The anti-
inflammatory effects of EPA and DHA supplementation my help prevent or reduce chronic 
states of inflammation in poultry. 
Cellular storage of ALA and membrane incorporation of EPA and DHA are important 
for their effect on modulating inflammation. Peroxisome proliferator factor gamma (PPARγ) 
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in mammals and avian species is the master regulator of adipogensis (Sun et al., 2014). When 
PPARγ binds to polyunsaturated fatty acids such as EPA, the fatty acid functions as an 
activating ligand resulting in increased transcriptional activity for adipogenesis (Edwards and 
O'Flaherty, 2008). In a broiler study, genetically selected lean broilers expressed an average 
of 15% less PPARγ compared to heaver genetic lines in abdominal fat tissue and PPARγ 
genetic expression in abdominal fat tissue increased by an average of 35% from 2 to 7 weeks 
of age (P ≤ 0.01; Sun et al., 2014). The results of a broiler study demonstrated that PPARγ 
expression increased with age and was a factor in producing a phenotypically heavier bird 
(Sun et al., 2014). Consuming ALA, EPA, or DHA results in increased PPARγ expression 
and the expression levels are linked to the onset of oocyte maturation and egg laying (Sato et 
al., 2004). Further examination of PPARγ expression during periods of inflammation would 
help to characterize how specific omega-3 fatty acids exert effects on adipogenesis and 
cellular metabolism in a variety of poultry models.  
 
Lipid Metabolites 
In addition to indirect and direct effects on cytokine modulation, EPA and DHA are 
further metabolized to generate anti-inflammatory lipid metabolites (Serhan, 2014). Post-
absorptive modification by rate limiting elongases and desaturases results in competition 
among ALA and linoleic acid which generates a shift to less inflammatory eicosanoid 
(prostaglandins, leukotrienes, and lipoxins), resolvin, and protectin production (Figure 1.1; 
Voss et al., 1991; Bautista-Ortega et al., 2009). Many of the human health claims regarding 
the anti-inflammatory effects from ALA, EPA, or DHA consumption stems from competition 
and displacement of arachidonic acid from cell membranes and synthesis inhibition of pro-
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inflammatory lipid metabolites (de Pablo et al., 2002), which is another mechanism of how 
EPA and DHA modulate the inflammatory response (Figure 1.1).   
 
Membrane Fluidity and Peroxidation 
As previously discussed, cell membrane fatty acid incorporation of dietary EPA and 
DHA into cell membrane phospholipids displaces arachidonic acid (Newman et al., 2002a). 
The EPA and DHA displacement also causes changes in cell membrane fluidity which 
impacts cell phagocytic activity and expression of surface proteins including major 
histocompatibility complexes and adhesions (de Pablo and de Cienfuegos, 2000). In an in 
vitro experiment, EPA (66 µmol/L) or DHA (61 µmol/L) was added to media with human 
monocytes and then stimulated with IFNγ and incubated for 48 hours (Hughes et al., 1996). 
Monocytes supplemented with EPA inhibited relative median expression intensity of human 
leukocyte antigens-DR (HLA-DR), HLA-DP, and intracellular adhesion molecule-1 (ICAM-
1) by an average of 0.1-fold compared to control (P ≤ 0.05; Hughes et al., 1996). Antigen 
presenting cells require HLA-DR and -DP in order to express major histocompatibility 
complex class II molecules for adhesion via ICAM-1 to T cells during cell-cell contact, 
which results in T cell activation and initiation of an immune response (Hughes et al., 1996).  
In the same in vitro experiment, monocytes supplemented with DHA media 
suppressed expression of HLA-DR, HLA-DP, and ICAM-1 by an average of 0.07-fold 
compared to control, which would result in reduced initiation of immune responses (P ≤ 
0.05; Hughes et al., 1996). Supporting results were observed during an in vivo experiment 
with broilers fed diets supplemented with 0, 3, 5, and 6% fish oil from 19 to 47 days of age 
(Al-Khalifa et al., 2012). Broilers fed 6% fish oil diets responded with reduced monocyte 
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phagocytosis and lymphocyte proliferation compared to the 5% fish oil treatment (P ≤ 0.05; 
Al-Khalifa et al., 2012). The results from the human monocyte study and broiler experiment 
demonstrated that EPA and DHA decrease stimulated monocyte reactivity and antigen 
presentation due to changes in membrane fluidity, suggesting that immune cell responses 
may be muted during periods of inflammation or pathogenic infection. 
Omega-3 fatty acids ALA, EPA, and DHA are prone to peroxidation due to their 
polyunsaturated bonds. Cell membrane incorporation of EPA and DHA increases membrane 
lipid peroxidation and free radical formation, which suppresses antigen presentation and 
expression of cell surface molecules by lymphocytes (Gruner et al., 1986; de Pablo and de 
Cienfuegos, 2000). However, membrane incorporation of EPA and DHA also affects cellular 
production of reactive oxygen species used for oxidative bursts. Human monocytes were 
collected for a study from individuals supplemented with dietary fish oil containing EPA (3.6 
g/day) and DHA (2.4 g/day) for 6 weeks and the harvested monocytes were activated using 
latex particles (0.05 mL) to measure superoxide production (Fisher et al., 1990). Monocytes 
from EPA and DHA supplemented individuals reduced superoxide production by half 
compared to baseline control values (P ≤ 0.01; Fisher et al., 1990). Results from the study 
suggest that dietary EPA and DHA suppress oxidative bursts by activated monocytes, which 
would reduce cellular killing capacity when phagocytizing pathogens. In addition to reducing 
pro-inflammatory cytokine signaling, dietary EPA and DHA supplementation also reduce the 
activity of stimulated immune cells.  
Based on the immune cell types altered by dietary EPA and DHA either directly by 
acting as second messengers intracellularly, indirectly through modulating receptor activation 
and cytokine expression, or via their lipid products, functional omega-3 fatty acids regulate 
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anti-inflammatory effects multimodally (de Pablo and de Cienfuegos, 2000). Several studies 
have demonstrated that ALA, DHA, and EPA can be readily transferred into meat and egg 
products creating value-added foods (Fraeye et al., 2012; Ribeiro et al., 2013). Dietary ALA, 
EPA, and DHA supplementation are known to improve human health and reduce incidence 
of inflammatory health risks, which has generated a market for value-added egg and meat 
products (Skulas-Ray et al., 2011; Tur et al., 2012). Feeding an omega-3 fatty acid 
supplemented poultry diet to generate value-added eggs and meat may be providing a benefit 
to the bird as well.   
 
1.4.2 Influence on Bone Metabolism 
Laying hens often suffer from osteoporosis, commonly referred to as soft bones or 
layer fatigue, at the end of laying cycles due to their high demand for calcium (Saif et al., 
2008). It is common for broilers to develop lameness issues or bone deformities due to their 
prolific growth rate (Knowles et al., 2008; Grupioni et al., 2015). Bone turnover rate plays an 
important role in retention of bone mass and dietary ALA, EPA, and DHA may be able to 
improve bone health in these at-risk animals.  
Bone turnover rate is a balance between bone mineral resorption and synthesis, which 
is regulated by the RANKL/RANK/OPG pathway (Boyle et al., 2003). Dysregulation of 
bone resorption and synthesis may lead to bone pathology and problems with shell quality 
(Saif et al., 2008). Receptor activator of NF-!B ligand (RANKL) is secreted locally by 
osteoblasts in the bone marrow and systemically by lymph nodes and thymus when 
circulating calcium levels are low (Boyce and Xing, 2007; Boyce and Xing, 2008). The 
binding of RANKL to RANK cell surface receptors results in target cell activation and 
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mineral resorption (Boyle et al., 2003). Osteoclastic precursor cells differentiate into mature 
osteoclasts when activated by RANKL (Boyce and Xing, 2007; Boyce and Xing, 2008). With 
further maturation, osteoclasts become multinucleated and responsible for bone mineral 
resorption releasing calcium into the blood stream (Boyle et al., 2003; Boyce and Xing, 
2007). During inflammatory states where IL-1 and IL-6 are expressed, RANKL is up 
regulated and bone is in a resorptive state (Boyle et al., 2003; Boyce and Xing, 2008). When 
RANKL secretion is up regulated, the net state of bone becomes catabolic and osteoclastic 
resorptive activity dominates, out pacing bone mineral deposition by osteoblastic cells 
(Figure 1.4a; Boyle et al., 2003; Boyce and Xing, 2008).  
 
Osteoblastic cells and bone marrow are responsible for local secretion of 
osteoprotegerin when circulating calcium levels are high (OPG; Boyle et al., 2003; Boyce 
and Xing, 2007). Circulating OPG binds to free RANKL, making RANKL unavailable for 
RANK cell receptor binding (Boyle et al., 2003; Boyce and Xing, 2007). Reduced 
Figure 1.4. Adapted from Boyle et al. (2003). Bone remodeling and synthesis via RANKL/RANK/OPG 
pathway. A) Bone pro-resorptive state where receptor activator of Nuclear Factor Kappa B ligand (RANKL) 
is locally produced by osteoblasts and binds to RANK cell receptors activating dendritic cells, lymphocytes, 
fibroblasts, and bone resorptive osteoclasts. B) Bone anabolic state where osteoprotegerin (OPG) is 
predominantly produced by osteoblasts and binds to free RANKL resulting in inhibition of osteoclastic bone 
mineral resorption.  
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concentrations of free RANKL in bone results in inhibition of osteoclastic activation, 
osteoclastogenesis, and survival of pre-existing osteoclasts (Boyle et al., 2003; Boyce and 
Xing, 2007). Therefore, when OPG is up regulated, decreasing the RANKL:OPG ratio, bone 
shifts into a net anabolic state of bone synthesis where osteoblasts utilize blood calcium for 
bone mineral deposition at a faster rate than osteoclastic resorption (Figure 1.4b; Boyle et al., 
2003; Boyce and Xing, 2008).   
Omega-3 fatty acids EPA and DHA are involved in the cellular mechanisms of bone 
remodeling. Similar to inflammatory modulation, EPA and DHA regulate bone turnover 
through intracellular signaling pathways, cytokine synthesis, growth factors, and lipid 
metabolites (Kajarabille et al., 2013). Eicosanoid metabolites derived from EPA and applied 
to in vitro cell cultures containing primary osteoclasts from mouse bone marrow resulted in 
inhibition of growth and bone resorption due to reduced cell differentiation (Sun et al., 2003; 
Herrera et al., 2008). Eicosanoid metabolites from EPA and DHA were also hypothesized to 
modulate osteoblast function, thereby increasing bone formation rates in rodent models 
(Watkins et al., 2003). Possible mechanisms of action have been identified using in vitro 
models demonstrating that EPA and DHA exert anti-osteoclastogenic activity by suppressing 
proliferation and differentiation of osteoclast precursor cells (Nakanishi and Tsukamoto, 
2015; Kim et al., 2017). Using mouse bone marrow derived macrophages in vitro, DHA (0, 
12.5, 25, and 50 µM) application to the culture suppressed proliferation in a dose-dependent 
manner (Kim et al., 2017). Addition of DHA to media attenuated cell osteoclastic 
differentiation by blocking RANKL cell activation and inhibited intracellular NF-!B 
signaling cascades, which was demonstrated by suppression of NF-!B transcriptional activity 
(Kim et al., 2017). Additionally, mature osteoclasts treated with DHA media resulted in 
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accelerated apoptosis due to expression of Bim, a protein that controls osteoclastic apoptosis 
(Kim et al., 2017). This agreed with results from Nakaishi and Tsukamoto (2015) who found 
that in vitro EPA and DHA treatment of mouse bone marrow cells inhibited 
osteoclastogenesis by suppressing gene expression of RANKL, cyclooxygenase 2, and IL-6, 
which regulate and activate NF-!B. When comparing the potency of DHA to EPA, DHA 
application to murine monocyte cell lines reduced osteoclastic proliferation at concentrations 
> 100 µM and reduced intracellular NF-!B activation by 20% compared to EPA treated cells 
(P ≤ 0.05; Rahman et al., 2008). The modulating effects of EPA and DHA on bone 
metabolism appear to be associated with cytokine expression and regulation of the 
RANKL/RANK/OPG pathway. 
Cytokines IL-1β and IL-6 potentiate bone resorption (Kruger et al., 2010). Circulating 
IL-1β up regulates prostaglandin E2 (PGE2) production and inhibits OPG secretion, which 
induces osteoclast formation as previously described through the RANKL/RANK/OPG 
pathways (Boyce and Xing, 2007; Kruger et al., 2010). Circulating IL-6 induces osteoclast 
differentiation by up-regulating PGE2 production, which then increases RANKL synthesis 
shifting the RANKL:OPG ratio towards resorptive activity in bone (Boyce and Xing, 2007; 
Kruger et al., 2010). Both IL-1β and IL-6 up regulate expression of RANK cell surface 
receptors, enabling precursor osteoclastic cells to become activated via RANKL binding 
(Boyce and Xing, 2007; Kruger et al., 2010). It is possible that when EPA and DHA down 
regulate production of IL-1β, IL-6, and PGE2, the net effect would inhibit osteoclast 
formation and support an anabolic state of bone mineral synthesis by osteoblasts (Kruger et 
al., 2010). It is clear that EPA and DHA promote a state of bone mineral synthesis in vitro. 
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Further investigation using in vivo models would help determine if practical applications 
exist for improving bone health in poultry. 
A recent review of human studies reported that greater total polyunsaturated fatty acid 
consumption of both omega-3 and omega-6 fatty acids result in increased bone mineral 
density and reduced risk of fragility and fractures (Longo and Ward, 2016). The observed 
increase in bone mineral density may have been due to increased dietary PUFA consumption, 
which would aid in fat soluble vitamin D dependent calcium absorption (Longo and Ward, 
2016). The individual effects of ALA, EPA, and DHA were not clear from epidemiological 
reviews and additional experimentation is needed to elucidate their specific roles and 
influence on bone metabolism (Longo and Ward, 2016). Although not fully defined, dietary 
ALA, EPA, and DHA modulate aspects of bone metabolism, and supplementation may 
improve bone health by increasing bone strength for poultry that are prone to lameness or 
osteoporosis. 
Several studies have demonstrated that consuming functional ingredients containing 
dietary omega-3 fatty acids influence bone mineral metabolism. In a study using 8 week old 
ovariectomized mice that generated osteoporosis, it was found that feeding 5% fish oil diets 
to mice resulted in decreased osteoclastogenesis and increased bone mass retention compared 
to the unsupplemented control (P ≤ 0.01; Sun et al., 2003). A survey of human clinical cases 
positively correlated fish consumption with bone mass retention in women diagnosed with 
osteoporosis (Moon et al., 2012) and additional studies indicated that dietary ALA, EPA, and 
DHA resulted in increased bone formation and peak bone mass in adolescent teenagers 
(Kajarabille et al., 2013). Research in the UK using free-range brown laying hens associated 
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reduced broken bones and deformation with dietary ALA supplementation, which is a 
relevant health and animal welfare concern (Tarlton et al., 2013; Toscano et al., 2015). 
Dual-energy x-ray absorptiometry (DEXA) is used for diagnosis of osteoporosis in 
clinical practice and is the gold standard established by the World Health Organization 
(WHO Study Group, 1994). Scanning via DEXA quantifies bone mineral content and density 
within a defined area and has been used to assess poultry models since the mid-1990’s 
(Mitchell et al., 1997; Longo and Ward, 2016). A murine study using DEXA analysis found 
that feeding 12% tuna oil diets for 8 weeks to 5 week old female rats resulted in increased 
tibial bone mineral content by 10%, increased tibial bone density by 26%, and reduced blood 
serum peroxidation by 25% compared to the corn oil-fed control (P ≤ 0.05; Lukas et al., 
2011). Results from the murine study suggest that dietary EPA and DHA directly contributed 
to the increases observed in bone mineral retention (Lukas et al., 2011). Although bone 
mineral density is measured to assess bone structure and composition, it has a weak 
association with clinical signs of lameness in broiler chickens, such as limping or abnormal 
gait (Talaty et al., 2010). In order to gain a comprehensive understanding of bone health in 
poultry, imaging and quantitative techniques along with observation for phenotypic lameness 
should be examined. 
  
1.5 Lipopolysaccharide-Induced Systemic Inflammation 
1.5.1 Lipopolysaccharide Administration  
 Lipopolysaccharides (LPS) are structural components of Gram-negative bacteria 
outer membrane and are recognized by mammalian and avian immune cells as pathogenic 
foreign molecules (Schwechheimer and Kuehn, 2015). A “sickness behavior” can be induced 
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in chickens with LPS injection intraperitoneally or intracerebroventricularly, which has been 
observed in 5 week old chickens using doses of 0.5 to 5.0 mg LPS/bird (Johnson et al., 
1993). The behaviors described were clinical signs of an acute phase inflammatory response, 
which includes a febrile response, swelling, redness, elevated plasma corticosterone and 
increased pro-inflammatory cytokine synthesis of the affected area (Johnson et al., 1993; 
Leshchinsky and Klasing, 2001). Controlled LPS administration, although not identical to 
pathogenic infection, serves as a viable model for inducing systemic inflammation in poultry 
models due to the responses of depressed feed consumption, Toll-like receptor 4 stimulation, 
and increased splenic IL-1β, IFNγ, and IL-10 gene expression (Korver et al., 1998; Jiang et 
al., 2010; Munyaka et al., 2013). Further use of LPS administration in poultry experiments 
would be useful for evaluating protective anti-inflammatory effects of ALA, EPA, and DHA 
in an induced stress scenario. 
 
1.5.2 Toll-like Receptor 4 
Mammalian and avian species possess cells surface receptors known as toll-like 
receptor 4 (TLR4), which activate when LPS along with LPS binding protein, CD14, and 
MD-2 form a receptor ligand with a recognizable pathogen associated molecular pattern in 
the extracellular environment (Lu et al., 2008; Kannaki et al., 2010). Once TLR4 is activated 
via LPS stimulation, the receptor undergoes oligomerization and through a series of 
downstream amplifications mediate pro-inflammatory cytokine and interferon gene 
activation via NF-!B transcription factor which translocates from the cytosol to the cell 
nucleus when activated (Figure 1.2; Lu et al., 2008). Chickens have TLR4 membrane 
receptors on a wide variety of immune and tissue cell types including heterophils, 
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monocytes, macrophages, spleen, tonsil, bursa, thymus, liver, brain, kidney, lung, muscle, 
and heart cells (Kannaki et al., 2010). The relative ubiquity of TLR4 membrane expression 
throughout various chicken cell types suggests they would be reliable candidates for inducing 
LPS inflammatory responses. 
 
1.5.3 Lipopolysaccharide Poultry Models 
Intraperitoneal and intravenous LPS administration are consistent methods for 
inducing inflammatory states in laying hens and broilers (Table 1.2), establishing 
inflammatory LPS challenges as a viable model for investigating inflammation in poultry 
(Cheng et al., 2004; Jiang et al., 2010). The tolerance level to LPS administration is greater 
for poultry varieties compared to other species, where poultry LPS dosages may be ≥ 10 
times compared to swine models to stimulate systemic inflammation (Xie et al., 2000; 
Leshchinsky and Klasing, 2001). In a broiler experiment, 5.0 mg LPS/kg body weight was 
injected intravenously in broilers 21 days of age (Xie et al., 2000). The result of LPS 
administration was elevated plasma IL-6 and heterophil concentrations by 5 and 2 times, 
respectively, compared to saline injected control birds 12 and 24 hours post-injection (P < 
0.05; Xie et al., 2000). Total plasma proteins increased by 15% in the LPS injected broilers 
24 and 48 hours post-injection, demonstrating a functioning LPS inflammatory model at a 
5.0 mg/kg dosage (P < 0.05; Xie et al., 2000).  
For species comparison purposes, swine models require a much lower dosage of LPS 
than broilers to induce a similar response. Weaned swine were fed 5% fish oil diets from 21 
to 42 days of age followed by an intraperitoneal injection of LPS at 100 µg/kg (Liu et al.,  
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2012; Liu et al., 2013). Feeding 5% dietary fish oil treatments to pigs, 4 hours post-LPS 
administration, resulted in reduction of TLR4 gene expression in jejunum by 43% and ileum 
by 36% compared to control pigs fed 5% corn oil diets (P < 0.05; Liu et al., 2012; Liu et al., 
2013). Results from the swine experiment demonstrated a response to LPS administration at 
a lower dosage compared to chickens, which was attenuated by dietary fish oil 
supplementation. Investigation into dietary ALA, EPA, and DHA protective effects on 
poultry varieties during controlled LPS inflammation would help characterize poultry 
specific changes in inflammatory response due to dietary supplementation.   
Authors Model LPS Omega-3 Measure Outcome 
Korver et al. 
(1998) 
Broiler 14 d 
old 
0.3 mg/bird, 
3 IP doses 
once every 
2 d 
1.0, 1.5, 
2.0% fish oil 
Relative liver 
weight; 
hepatocellular 
cytosolic 
metallothionein 
LPS injection resulted in 
10% ↑ in relative liver 
weight; 19% ↑ 
metallothionein; no dietary 
effect. 
Korver and 
Klasing (1997) 
Broiler 14 d 
old 
0.3 mg/bird, 
3 IP doses 
once every 
2 d 
0.5, 1.0, 
2.0% 
flaxseed oil 
or fish oil 
In vitro macrophage 
cytokines; 
hepatocellular 
cytosolic 
metallothionein 
Fish oil enriched 
macrophages ↓ IL-1 
compared to control; 
metallothionein ↓ as fish oil ↑ 
post-LPS injections; LPS 
injections ↑ metallothionein 
by 125%. 
Leshchinsky 
and Klasing 
(2001) 
Broiler and 
layer chicks 
34 d old 
0 to 1000 
mg 
LPS/well 
None In vitro splenic cytokines 
IL-1β and IFNγ splenic gene 
expression ↓ in broilers 
compared to layers. 
De Boever et 
al. (2008) 
Broilers 21 d 
and 35 d old 
1.0 mg/kg, 
2 IV doses 
2 d or 7 d 
apart 
None Plasma cytokines 
IL-6 greatest plasma 
concentration 3 h post-initial 
LPS injection; second LPS 
injection ↓ IL-6 peak 
compared to initial injection. 
Sijben et al. 
(2003) 
Layer chicks 
37 to 38 d 
old 
1.0 mg/bird 
single IV 
dose 
5% flaxseed 
oil or fish oil Splenic cytokines 
IL-6, IL-8, IL-18, IFNγ ↑ 2 h 
post-LPS injection compared 
to saline injection; LPS 
injection in fish oil-fed birds 
↑ IFNγ compared to LPS 
injection in flaxseed oil and 
control fed layers. 
 
Table 1.2. Poultry models comparing dietary flaxseed oil and fish oil in response to inflammatory 
LPS challenge. 
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Previous experiments have evaluated a range of LPS dosages from 0.1 to 5.0 mg/kg 
intraperitoneally in laying hen and broiler varieties demonstrating differences in biologic 
response (Leshchinsky and Klasing, 2001). It was found that LPS injection in laying hens, 
regardless of dosage, resulted in elevated body temperature 4 to 12 h post-injection compared 
to control (P < 0.05; Leshchinsky and Klasing, 2001). Only injection of 5.0 mg LPS/kg body 
weight in broilers produced an elevated body temperature compared to control (P < 0.05; 
Leshchinsky and Klasing, 2001). The difference in body temperature response to LPS 
administration suggests that broilers have a greater tolerance to LPS compared to hens, which 
was an influence of genetics on biological response.  
Few poultry experiments using LPS and dietary omega-3 fatty acid supplementation 
have been performed that investigate protective anti-inflammatory effect or investigation into 
bone health (Table 1.2). In one experiment broilers were fed 2% fish oil supplemented diets 
from 0 to 14 days of age and then intraperitoneally injected with 0.3 mg LPS/bird at 10, 12, 
and 14 days of age (Korver and Klasing, 1997). Feeding the fish oil treatment to broilers 
resulted in reduced release of IL-1 by peritoneal macrophages by 20% compared to the 
control broilers fed corn oil diets (P < 0.01), which demonstrates inflammatory modulation 
by EPA and DHA treatment (Korver and Klasing, 1997). In a follow-up experiment, 
intraperitoneally injecting fish oil-fed broilers with 0.3 mg LPS/bird at 10, 12, and 14 d of 
age resulted in a 17% reduction in body weight and 11% reduction in feed intake from 10 to 
14 d of age (P < 0.05; Korver et al., 1998). The LPS administration also increased relative 
liver weight by 10% and liver cytosolic metallothionein by 19% (P < 0.05), a protein that 
binds heavy metal ions and is associated with the acute phase response when synthesized 
(Korver et al., 1998). The results from repeated low dose LPS injections suggest that broilers 
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may become refractory to the antigen and > 2% fish oil may be needed to attenuate 
inflammation. Additional experimentation using greater LPS dosages or investigation using 
greater dietary EPA and DHA supplementation may help better characterize responses to 
LPS administration and EPA and DHA supplementation in broilers. 
Data is limited regarding dietary omega-3 fatty acid supplementation (ALA, EPA, or 
DHA) and the responses of LPS exposure in pullets, laying hens in peak production, and end-
of-cycle laying hens. A study using 4 day old pullets fed diets containing 5% fish oil or 5% 
flaxseed oil until 37 and 38 days of age (Sijben et al., 2003). On day 37 and 38, pullets were 
administered a single 1.0 mg/kg intravenous LPS dose, and splenic cytokine gene expression 
was measured 2 hours post-injection (Sijben et al., 2003). Splenic cytokine gene expression 
increased 6-fold for IL-6, 5-fold for IL-18, and 12-fold for IFNγ compared to saline infused 
control, while IFNγ increased in fish oil-fed chicks but not flaxseed oil and control-fed 
chicks (P < 0.05; Sijben et al., 2003). Results from the pullet experiment support that 
inflammatory modulation differences are influenced by EPA and DHA. Dietary EPA and 
DHA from fish oil may have practical applications in reducing inflammation in laying hens 
once dose-dependent responses are better defined. 
Initial investigations of the potential health benefits from consuming dietary omega-3 
fatty acids were focused on human epidemiological and observational case studies (Cotton et 
al., 2011; Mozaffarian and Wu., 2011; Tur et al., 2012). The potential health benefits have 
led consumers to incorporate value-added foods like omega-3 fatty acid enriched eggs and 
meat into their diets demonstrated by specialty eggs making up 26.4% of the egg market 
(Fraeye et al., 2012; Goyal et al., 2014; USDA, 2017b). Producers use omega-3 fatty acid 
supplemented poultry diets to create these value-added meat and eggs (Fraeye et al., 2012; 
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Ribeiro et al., 2013). Dietary omega-3 fatty acid supplementation used to create these value-
added products may also be improving poultry health and welfare during commercial 
production (Tarlton et al., 2013; Toscano et al., 2015). Previous omega-3 fatty acid 
experiments used in vitro assays and cell cultures derived from murine models to investigate 
cell responses to ALA, EPA, or DHA media application (Rahman et al., 2008; Kruger et al., 
2010; Lukas et al., 2011); however, there has not been in vivo investigation into the 
protective effects of different omega-3 fatty acids on inflammation and how they may alter 
bone health in aged laying hens and growing broilers under periods of stress. This 
dissertation seeks to determine the responses to dietary ALA or EPA and DHA 
supplementation of an aged laying hen model with a developed immune system and active 
skeletal turnover. In addition, this dissertation will pursue how immunologically naïve 
broilers with a growing skeletal frame respond to dietary ALA or EPA and DHA 
supplementation. Dietary ALA or EPA and DHA supplementation in poultry diets may 
potentially serve a dual purpose of producing value-added healthy food for consumers and 
improving the health and welfare of commercial poultry. 
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CHAPTER 2. COMPARATIVE OMEGA-3 FATTY ACID ENRICHMENT OF 
EGG YOLKS FROM FIRST-CYCLE LAYING HENS FED FLAXSEED OIL OR 
GROUND FLAXSEED  
 
A manuscript published in Poultry Science adapted for this thesis 
 
I. J. Ehr1,2, M. E. Persia3, and E. A. Bobeck2,4 
 
2.1 Abstract 
Value-added eggs can be generated by supplementing laying hen diets with functional 
ingredients, such as flaxseed, containing the omega-3 fatty acid, alpha-linolenic acid (ALA). 
Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA), have anti-inflammatory properties and are linked to reducing heart disease. Flaxseed 
is commonly used for ALA supplementation; however, the impact of dietary flaxseed source 
(extracted degummed oil vs. ground seed) on fatty acid transfer to egg yolk in laying hens is 
unknown. Therefore, dietary flaxseed oil and ground flaxseed were evaluated for ALA, EPA, 
and DHA deposition in egg yolks of Hy-Line W-36 laying hens over an 8 wk feeding period 
(25 to 33 wk old). Hens (n = 132) were randomly housed 3 birds/cage (4 replicates/treatment) 
for each of 11 treatments. Diets consisted of a control diet, 5 flaxseed oil diets (0.5, 1.0, 2.0, 
3.0, or 5.0% flaxseed oil), and 5 ground flaxseed diets (calculated flaxseed oil concentration 
																																																								
1Primary researcher and author. 
2Graduate student and Assistant Professor, respectively, Department of Animal Science, 
Iowa State University. 
3Assistant Professor, Department of Animal and Poultry Science, Virginia Tech. 
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0.5, 1.0, 2.0, 3.0, 5.0% from ground flaxseed). Increasing dietary flaxseed oil and ground 
flaxseed concentrations led to increased egg yolk total omega-3 fatty acid (ALA, EPA, and 
DHA) concentration (P ≤ 0.01). Egg yolk EPA and DHA concentration were not different 
due to flax source (P = 0.21). Supplementing ≥ 3% dietary flaxseed oil resulted in > 2 times 
the egg yolk total omega-3 fatty acid deposition compared to the equivalent ground flaxseed 
inclusion (P ≤ 0.01). Hens receiving either flaxseed oil or ground flaxseed had reduced BW 
change as dietary concentrations increased (P = 0.02). Feed efficiency (egg mass ÷ feed 
intake) increased as flaxseed oil supplementation increased, whereas feeding ground flaxseed 
decreased feed efficiency (P ≤ 0.01). Determination of flaxseed oil nitrogen corrected 
apparent metabolizable energy resulted in 7,488 kcal/kg on an as-fed basis. Dietary flaxseed 
oil, with greater egg yolk total omega-3 fatty acid deposition and increased feed efficiency, 
proved to be an efficient alternative to ground flaxseed for producing value-added eggs, 
warranting further investigation of dietary ALA, EPA, and DHA to determine potential 
health and welfare benefits of supplementing poultry diets. 
Key words: ALA, EPA, DHA, value-added, energy 
 
2.2 Introduction 
 Health conscious consumers want to eat food that supports healthy lifestyles. Certain 
omega-3 fatty acids contained in functional ingredients and value-added foods are known to 
possess anti-inflammatory properties that are linked to reducing health risks, such as heart 
disease and osteoporosis (Kruger et al., 2010; Tur et al., 2012; Goyal et al., 2014). This has 
led to consumer demand for value-added omega-3 fatty acid enriched egg products, which 
now captures 10% of the marketing of retail shell eggs and egg products (USDA, 2016). 
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Dietary alpha-linolenic acid (ALA; 18:3 omega-3 fatty acid), found in flaxseeds, can be 
supplemented in poultry diets to generate value-added omega-3 fatty acid enriched eggs 
(Tarlton et al., 2013; Toscano et al., 2015). It is important to understand how ALA 
ingredients impact dietary omega-3 fatty acid transfer to the egg yolk and practical 
applications as a poultry feed ingredient so that producers will have a reference for making 
these value-added eggs. 
Hens readily absorb and transfer omega-3 fatty acids from dietary sources for 
deposition into the yolk (Cherian and Sim, 1991). On average, it takes 2 wk for a laying hen 
to adjust to an omega-3 fatty acid supplemented diet and reach a transfer plateau of dietary 
omega-3 fatty acid incorporation into developing ovarian follicles (Cherian and Sim, 1991; 
Nain et al., 2012). The beneficial anti-inflammatory properties for reducing health risks have 
been attributed to longer chain omega-3 fatty acids eicosapentaenoic (EPA; 20:5 omega-3 
fatty acid) and docosahexaenoic acids (DHA; 22:6 omega-3 fatty acid; Cottin et al., 2011; 
Tur et al., 2012). Laying hens have the ability, although not efficient (< 6%), to elongate and 
desaturate ALA, an essential fatty acid and predominant omega-3 fatty acid in flaxseed, to 
the functional omega-3 fatty acids EPA and DHA (Burdge and Calder, 2006; Zivkovic et al., 
2011; Gregory et al., 2013). Egg yolk fatty acid content is finite due to the 10% total fat 
contained within an egg and reaches a plateau of saturation, which is directly influenced by 
the total ALA, EPA, and DHA omega-3 fatty acid composition within the diet (Cherian and 
Sim, 1991; Nain et al., 2012).  
The fatty acid composition of a feed ingredient has a direct effect on fatty acid profile 
and deposition in poultry meat and eggs (Jia and Slominski, 2010; Nain et al., 2012). Similar 
to other monogastric animals, poultry species have a limited endogenous enzymatic ability to 
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modify the structure of dietary fatty acids compared to ruminant species (Haug et al., 2014). 
Poultry do not host the microbial populations responsible for the expression of elongases and 
desaturases like those contained within the rumen modifying dietary lipids (Haug et al., 
2014). Long chain fatty acids, such as ALA, are added to triglycerides for long-term energy 
storage during post-absorptive metabolism and contain the relatively unaltered fatty acids in 
adipocyte lipid droplets (Cherian and Sim, 1991). Longer chain fatty acids, including EPA 
and DHA, are almost exclusively deposited for storage in the form of phospholipids, 
particularly phosphatidylethanolamine in egg yolk (Jiang et al., 1991). Producers are able to 
create value-added omega-3 fatty acid enriched eggs by using the laying hen’s physiological 
ability to deposit dietary ALA, EPA, and DHA directly into egg yolk. 
Ground flaxseed, also known as linseed, is an ALA source and is used by poultry 
producers in the US for enriching commercial table eggs and meat products (Samman et al., 
2009; Petrovic et al., 2012; Lopes et al., 2013). Flaxseed contains 7 times the amount of ALA 
compared to soybean and corn oil with 3 times less omega-6 linoleic acid (LA; 18:2 omega-6 
fatty acid) content, properties which contribute to its use as an ALA supplement in poultry 
formulation (NRC, 1994). Whole flaxseed contains 30 to 40% fat with 50% of the fat 
composition consisting of ALA and 15% LA (Kratzer and Vohra, 1996). Flaxseed products 
effectively deliver ALA to poultry meat and eggs due to high concentration and 
bioavailability (Jia et al., 2008; Fraeye et al., 2012). However, the transfer rates of flaxseed 
ingredients have not been determined. Eggs from unsupplemented laying hens may contain 
93 mg ALA and 173 mg total omega-3 fatty acid (ALA, EPA, and DHA)/50 g egg (Jia et al., 
2008; Samman et al., 2009). Supplementation of 15% dietary flaxseed can increase ALA and 
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total omega-3 fatty acid content to 358 mg and 468 mg/50 g egg, respectively (Jia et al., 
2008; Samman et al., 2009). 
There appears to be a tolerable limit to how much flaxseed can be included in a 
ration, due to anti-nutrients or palatability, without negatively affecting bird performance and 
feed efficiency. Digestion and absorption may be impaired due to various anti-nutrients 
found in flaxseed such as cyanogenic glycosides and phytic acid, or due to increased 
viscosity of ingesta caused by mucilage (Alzueta et al., 2003; Goyal et al., 2014). Laying 
hens fed diets with 20% ground flaxseed, compared to 0 and 10% treatments, resulted in 
inadequate weight gain, reduced egg production, and increased feed intake, which 
significantly reduced feed efficiency (Leeson et al., 2000). Anti-nutrients or reduced nitrogen 
corrected apparent metabolizable energy (AMEn) due to flaxseed in the diet were suspected 
as the cause for the adjustment in laying hen feed intake (Leeson et al., 2000). Few energy 
values have been published for whole, ground, or oil flaxseed sources since the mid 1990’s 
(NRC, 1994; Lee et al., 1995). Determining a current AMEn value of flaxseed oil would be 
beneficial for future diet formulation and provide an update in oil characteristics from current 
flax crops. 
Yet to be investigated is how the source of flaxseed ingredient may affect the 
efficiency of ALA transfer from the laying hen diet into the developing egg yolk. Milled or 
ground flaxseed still contains the components of the seed’s cellular matrix that may trap 
some of the lipid fraction as seen with other seed types (Cassady et al., 2009). Trapped lipid 
may be a factor in reducing digestibility or availability of dietary ALA in ground flaxseed 
(Cassady et al., 2009). A human study comparing whole, ground, and oil flaxseed sources 
found that supplementing 6 g of ALA for 4 wk resulted in 77% greater plasma ALA levels in 
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test subjects fed flaxseed oil compared to test subjects fed ground flaxseed, while feeding 
whole flaxseed did not appear to increase plasma ALA levels (Austria et al., 2008). Test 
subjects from each treatment group experienced gastrointestinal discomfort, especially from 
those that consumed whole flaxseeds (Austria et al., 2008). The discomfort led to dietary 
non-compliance in the study, stressing the importance of how increased flaxseed or oil 
consumption may change the intestinal microenvironment (Austria et al., 2008).   
In order to further investigate how ALA sources affect the fatty acid transfer rate 
from laying hen diet to the egg yolk, extracted degummed flaxseed oil and conventional 
ground flaxseed ingredients were fed at increasing inclusions in experimental ALA 
supplemented laying hen diets. Dietary AMEn of flaxseed oil was determined to fill the gap 
in knowledge for future research and industry application. It was hypothesized that an 
extracted degummed flaxseed oil ingredient would have an improved rate of ALA deposition 
to egg yolk compared to a ground flaxseed ingredient when supplemented in a laying hen 
ration during peak production, with no adverse effects on AMEn and performance.  
  
2.3 Materials and Methods 
2.3.1 Animals and Housing 
The Institutional Animal Care and Use Committee (IACUC) at Iowa State University 
(Ames, IA) approved the protocol and the experiment was conducted in accordance with 
university policies and the Ag Guide (2010). Single-Comb White Leghorn laying hens (n = 
132, Hy-Line W-36, age = 25 wk old) were obtained from a commercial source (Bancroft, 
IA) as they were approaching peak production and reproductive efficiency. Laying hens were 
randomly placed into 3 tier conventional cages (Poultry Layer Cage, Safeguard, New 
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Holland, PA), resulting in 3 hens/cage at a density of 696 cm2/bird. Each single cage of 3 
hens represented an experimental unit (EU). Treatments were assigned in a completely 
randomized design, allowing for 11 dietary treatments with 4 replicates/treatment. Hens were 
allowed ad libitum access to feed and water during the 8 wk experiment from 25 to 33 wk of 
age. Lighting started at 13.5L:10.5D with 30 minutes of increasing light/wk until 15.5L:8.5D 
was achieved 4 wk into the experimental period. House temperature was maintained between 
18 to 27° C for the 8 wk experimental period.  
 
2.3.2 Flaxseed Source Supplemented Diets 
Experimental diets were formulated to meet or exceed the NRC (1994) requirements 
of commercial layer hens. Flaxseed oil diets were formulated by adding the degummed 
flaxseed oil at the expense of soy oil in the diet (Table 2.1). Formulations consisted of a 
control diet, 5 flaxseed oil diets, and 5 ground flaxseed diets (calculated flaxseed oil 
concentrations for treatment diets were 0.5, 1.0, 2.0, 3.0, and 5.0%). A twelfth treatment diet 
contained 5.0% added flaxseed oil with an antioxidant stabilizer (n = 12 additional hens, 
internal data not reported here). The ground flaxseed ingredient was created by grinding 
whole flaxseed through a 4.0 mm screen (Thomas-Wiley Laboratory Mill Model 4, Arthur H. 
Thomas Company, Philadelphia, PA) with corn as a carrier. To obtain the calculated oil 
concentrations in the ground flaxseed diets, the ground flaxseed was included at 1.5, 3.0, 6.0, 
9.0, and 15.0% in the diet (Table 2.2).  
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2.3.3 Performance 
Laying hens were monitored twice daily for the duration of the 8 wk experiment in 
accordance with IACUC policy. Eggs were collected daily for hen-housed egg production 
(HHEP; no mortality occurred, therefore hen-day egg production was not reported) 
calculation and average daily feed intake (ADFI) was determined by measuring weekly 
disappearance of feed: HHEP % = (eggs laid ÷ hens housed ÷ d) × 100; ADFI = start feed 
weight in kg – end feed weight in kg. Body weight (BW) was recorded at the start, 4 wk, and 
8 wk. Egg weight (EW), average daily egg mass (ADEM), and feed efficiency were 
measured weekly from 0 to 8 wk: ADEM = average EW in g × (HHEP % ÷ 100). Feed 
efficiency (FE) was reported as kg eggs per kg FI: FE = EM in kg ÷ FI in kg.  
 
2.3.4 Egg Yolk Analysis 
 A pooled sample of 5 egg yolks from each EU was used to measure egg solids and 
yolk fatty acid profile at 4, 6, and 8 wk of the experiment. Fatty acid analysis of egg yolk, as 
previously described by Sun et al. (2013) and Nam et al. (2001) using gas chromatography 
(HP 6890, Hewlett Packard Co., Palo Alto, CA), was performed starting at 4 wk to allow an 
adjustment period for maximal transfer of fatty acids to egg yolk. 
 Egg yolk total omega-3 fatty acid (ALA, EPA, and DHA) deposition in mg was 
calculated using the egg yolk omega-3 fatty acid content (%) obtained from the previously 
described egg yolk fatty acid analysis and applied to a 50 g egg with 10% fat content (AEB, 
2017). The extrapolated omega-3 fatty acid deposition values were calculated using the 
following formula: Egg yolk total omega-3 fatty acid deposition in mg = average egg yolk 
ALA, EPA, and DHA content in % ÷ 100 × 5000 mg fat. 
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2.3.5 AMEn Experiment 
After the initial 8 wk omega-3 fatty acid supplementation experiment, all birds (now 
33 wk of age) were utilized in a 2 wk study to determine the AMEn content of the flaxseed 
oil, as this information is currently lacking in the literature. The laying hens (n = 144, 
including the unreported 12th diet group) were removed from their respective cages and 
separated, randomly rearranged using the same 3 tier cages as previously described so that 
each cage contained 3 hens that were new cage-mates. This ensured that the previous 
flaxseed dietary supplementation would not adversely affect the AMEn experiment. 
Treatments were assigned in a completely randomized design allowing for 4 dietary 
treatments with 12 replicates/treatment for the AMEn experiment. Each EU consisted of 3 
hens/cage with identical bird density as previously mentioned in the flaxseed 
supplementation experiment. Hens were managed as previously described with ad libitum 
access to feed and water for the 2 wk AMEn experiment from 33 to 35 wk of age. 
Performance data during this 2 wk AMEn experiment was not reported, because the hens 
were adjusting to the new experimental diets. 
A basal diet with titanium dioxide (0.30%) and increasing levels of flaxseed oil (0.0, 
3.0, 6.0, and 9.0% added to the basal diet) were used to generate 4 AMEn treatment diets. 
Experimental diets were formulated to meet or exceed the NRC (1994) requirements of 
commercial laying hens (Table 2.3). These diets were fed for a 2 wk adjustment period, 
which served as a transition period for the previous flaxseed egg yolk fatty acid deposition 
experiment, in order to collect excreta on d 14 for AMEn determination and regression 
analysis.  
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Feed samples were ground through a 0.5 mm screen and subsequently dried for 24 h 
at 100°C for DM determination. Pooled excreta samples were dried at 75°C in a convection 
oven for 3 d and subsequently ground through a 1.0 mm screen as previously described by 
Ehr et al. (2015). The ether extract of the feed samples was determined by AOAC (2010) 
Official Method 920.39, traditional Soxhlet extraction using diethyl ether at the University of 
Missouri Agricultural Experiment Station Chemistry Laboratories (AESCL, Columbia, MO). 
For the feed and excreta samples, N concentration was determined by thermal combustion 
(TruMac N Analyzer, LECO Corp., St. Joseph, MI); gross energy (GE) was determined using 
an adiabatic oxygen bomb calorimeter (Parr Instrument Co., Moline, IL); and Ti 
concentration was determined using the method outlined by Leone (1973). All samples of 
excreta and feed were analyzed in duplicate. The diet AMEn determination was calculated 
using the following formula from Leeson and Summers (2001) modified for Ti: AMEn = 
GEDiet – (GEExcreta × TiDiet ÷ TiExcreta) – 8.22 × (NDiet – NExcreta × TiDiet ÷ TiExcreta). 
 
2.3.6 Statistical Analysis 
Data were analyzed by repeated measures ANOVA using SAS (SAS 9.4, 2012, SAS 
Institute Inc., Cary, NC) with diet, week, and diet × week interaction included in the model. 
The 11 dietary treatments were assigned to the EU (3 hen/cages) following a completely 
randomized design, with 4 replicates/treatment. Orthogonal contrasts were used to test the 
response variables of the control against the 10 flax source supplemented diets and the 5 
flaxseed oil vs. 5 ground flaxseed supplemented diets. There was only one control group for 
the experiment, therefore responses variables were tested for linear, quadratic, and cubic 
orthogonal contrasts of dietary oil % (0.5, 1.0, 2.0, 3.0, 5.0%) and dietary oil % × flax source 
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(flaxseed oil or ground flaxseed) interaction for the 5 flaxseed oil and 5 ground flaxseed 
supplemented treatments. For the purposes of this experiment, linear and quadratic functions 
were used to explain responses in the biological model. Linear fitment indicated progressive 
response to dietary inclusion and quadratic fitment represented an upper limit for response in 
relation to dietary inclusion. Cubic contrasts were included for the reader to make further 
inferences if desired. In all cases P ≤ 0.05 was accepted as significant. 
 
2.4 Results 
2.4.1 Supplementation Period Performance  
During the dietary flax source supplementation period, no differences were observed 
for FI, EM, or egg solids for any of the orthogonal contrasts tested (P ≥ 0.07). Quadratic 
contrast of oil % × flax source resulted in increasing then plateauing HHEP as inclusion rate 
of flaxseed oil increased (P = 0.01). As ground flaxseed inclusion rate increased, HHEP 
declined then plateaued (P = 0.01). Linear contrast of oil % × flax source resulted in 
increasing FE as dietary flaxseed oil was increased in the flaxseed oil treatments (P = 0.01). 
Increasing ground flaxseed dietary inclusion resulted in decreasing FE (P = 0.01). Linear 
contrast of dietary oil % resulted in decreasing EW as increasing inclusion of either flax 
source (flaxseed oil or ground flaxseed equivalent) was added to the diet (P = 0.05). Gains in 
BW decreased as oil % increased in flaxseed oil or ground flaxseed equivalent diets linearly 
(P = 0.02). Change in BW decreased for ground flaxseed fed hens 24 times more compared 
to flaxseed oil fed hens as dietary inclusion of each respective flax source increased (P = 
0.02; Table 2.4).  
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2.4.2 Egg Yolk Omega-3 Fatty Acid Deposition 
Egg yolk total omega-3 fatty acid (ALA, EPA, and DHA) concentration increased 
linearly as oil % increased for flaxseed oil and ground flaxseed supplemented dietary 
treatments (P < 0.01). Increasing inclusion of flaxseed oil supplementation resulted in an egg 
yolk total omega-3 fatty acid deposition rate (slope value) that was approximately 2 times 
greater compared to equivalent inclusion of ground flaxseed dietary treatments (P < 0.01). 
Specifically, the flaxseed oil treatments resulted in a linear equation where the egg yolk lipid 
fraction omega-3 fatty acid (%) = 1.604 × flaxseed oil concentration (% of diet) + 2.171 (R² 
= 0.880; P < 0.01) while ground flaxseed treatments resulted in a linear equation where the 
egg yolk lipid fraction omega-3 fatty acid (%) = 0.783 × flaxseed oil concentration (% of 
diet) + 2.310 (R² = 0.808; P < 0.01; Figure 2.1). No differences were observed for oil % 
inclusion and flax source on egg yolk total omega-3 fatty acid concentration or egg yolk EPA 
and DHA concentration using quadratic and cubic analysis (P ≥ 0.30). Egg yolk EPA and 
DHA concentration was not affected by flax source (P = 0.26). However, as oil % increased 
in flaxseed oil and mill flaxseed dietary treatments, egg yolk EPA and DHA concentration 
increased linearly (P < 0.01; Figure 2.2). 
The average total omega-3 fatty acid concentration values from each level of flaxseed 
oil and ground flaxseed treatments were used to extrapolate the total omega-3 fatty acid 
deposition (mg) for a 50 g egg containing 10% fat. The linear equation for flaxseed oil 
supplementation was y (mg/50 g egg) = 80.184 × x (% ingredient in diet) + 108.5 (R2 = 
0.999) and ground flaxseed supplementation was y (mg/50 g egg)  = 13.055 × x (% 
ingredient in diet) + 115.5 (Figure 2.3; R2 = 0.990), also as shown in Figure 2.3.  
 
		
62 
2.4.3 Oil AMEn Determination 
The linear regression equation of AMEn vs. dietary flaxseed oil concentration was y 
(kcal/kg as fed) = 74.88 × x (flaxseed oil concentration % of diet) + 2,750 (P < 0.01; R2 = 
0.941). The slope of the regression line equated to the AMEn value of the flaxseed oil 
ingredient, which was 7,488 kcal/kg on an as-fed basis (Figure 2.4). The mean analyzed 
AMEn values for the experimental diets were 2,762, 2,948, 3,218, and 3,421 kcal/kg as the 
flaxseed oil concentration increased from 0.0, 3.0, 6.0, and 9.0 % for each diet, respectively. 
 
2.5 Discussion 
This experiment was designed to evaluate the impact of different dietary omega-3 
fatty acid sources (extracted degummed oil vs. ground seed) on egg yolk deposition and to 
determine the AMEn of flaxseed oil. No significant differences were observed in ADFI for 
hens fed diets containing ground flaxseed. If any were to be observed, the 5.0% ground 
flaxseed treatment would have been expected to suppress ADFI due to anti-nutrients present 
in or palatability of the ground seeds (Table 2.4). However, the rate of BW gain of hens fed 
ground flaxseed declined 24 times more than hens fed flaxseed oil as dietary inclusions 
increased. The difference in rate of BW change may have been due to anti-nutrients present 
in the ground flaxseed causing impaired digestion or absorption of the dietary nutrients 
(Gonzalez-Esquerra and Leeson, 2000; Leeson et al., 2000).  
Cyanogenic glycosides including linustatin, neolinustatin, and linmarin present in the 
ground flaxseed may have caused a reduction in BW change due to loss of effective intestinal 
epithelial cell absorptive function (Oomah et al., 1992; Feng et al., 2003; Kajla et al., 2015). 
In addition, phytic acid present in ground flaxseed may result in protein-mineral-phytic acid 
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complexes that are not bioavailable, reducing BW gain by exacerbating impaired nutrient 
absorption (Erdman, 1979; Feng et al., 2003; Goyal et al., 2014). Trypsin inhibitors present 
in flaxseed may have played a minor role in decreasing nutrient bioavailability, but the 
quantity found in flaxseed is insignificant compared to levels found in soybean (Bhatty, 
1993; Feng et al., 2003). It has been well documented that mucilage, a water-soluble 
polysaccharide found in flaxseed, increases chicken intestinal content viscosity (Rodriguez et 
al., 2001). The increased viscosity inhibits nutrient digestion and absorption of the intestinal 
ingesta (Alzueta et al., 2003). Similar declines in performance were observed in FE for hens 
fed ground flaxseed diets as the inclusion increased. Data from this current work suggests 
that feeding hens ground flaxseed exerted physiologic effects impairing nutrient storage and 
anabolic activity compared to equivalent inclusions of supplemental flaxseed oil. 
 When analyzing the total omega-3 fatty acid (ALA, EPA, and DHA) transfer from the 
diet into the egg yolk, dietary inclusions of flaxseed oil incorporated total omega-3 fatty 
acids into yolks at 2.0 times the rate of ground flaxseed (Figure 2.1). This difference in rates 
was likely because the structural components of the cell wall entrapped the lipid fraction, as 
seen in other types of seeds such as almonds (Ellis et al., 2004; Mandalari et al., 2008). The 
presence of anti-nutrients likely contributed to the decreased transfer of ALA due to reduced 
bioavailability or absorption of the dietary lipids. Extracted degummed flaxseed oil 
treatments resulted in delivering dietary ALA to egg yolk without seed components 
interfering with intestinal utilization. In an experiment with up to 7% dietary flaxseed oil 
inclusion, total omega-3 fatty acid deposition in the muscle tissue of broiler chickens was 
increased in a curvilinear manner (Kartikasari et al., 2012). The lack of quadratic fit or 
plateau in the work reported here suggests that the maximum saturation limit of total omega-
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3 fatty acid deposition to the egg yolk was not reached and would explain the linear fit of 
omega-3 fatty acid egg yolk content as dietary oil % increased in the flax source treatment 
groups. EPA and DHA egg yolk inclusion was not different based on flax source 
supplemented treatments suggesting that laying hens deposited modified portions of ALA to 
egg yolk at a finite but constant rate. 
 Flaxseed oil has 2 distinct advantages over ground flaxseed when comparing egg yolk 
total omega-3 fatty acid deposition into a 50 g egg. The first advantage is that flaxseed oil has 
a more efficient ALA transfer rate compared to ground flaxseed (Figure 2.1 and 2.2). 
Flaxseed oil, as an ingredient, only requires 1.8% dietary inclusion to achieve a target 250 
mg total omega-3 fatty acid content for a 50 g egg (Figure 2.3). It would require 10.3% 
ground flaxseed to achieve the same target 250 mg total omega-3 fatty acid content per 50 g 
egg (Figure 2.3). The second advantage lies in the economics when applying wholesale 
flaxseed oil ($1.41/kg) and flaxseed crop ($0.45/kg) prices to the diets (USDA, 2015). Using 
1.8% dietary flaxseed oil would cost $20.52 flaxseed oil/metric ton of finished feed 
compared to using 10.3% ground flaxseed, which would cost $46.35 ground flaxseed/metric 
ton of finished feed. Flaxseed oil takes up less volume in a finished feed and delivers targeted 
mg of total omega-3 fatty acids into a 50 g egg for less than half the cost than ground 
flaxseed. The advantages of flaxseed oil suggest that it is a superior dietary supplement for 
generating value-added omega-3 fatty acid enriched eggs than ground flaxseed.  
The AMEn of the flaxseed oil ingredient was determined after the 8 wk omega-3 fatty 
acid flaxseed source supplementation to egg yolk experiment, as few data are published 
regarding the metabolizable energy of flaxseed oil. The energy value found was 7,488 
kcal/kg of flaxseed oil as fed, which was a less than the AMEn value of 8,100 ± 540 kcal/kg 
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reported by Lee et al. (1995). Flaxseed oil may be used as an energy source when 
formulating diets, but with less energy compared to the corn and soy oil values listed in the 
NRC (1994). Previous investigations of flaxseed AMEn reported different age-sensitive 
tolerances to dietary flaxseed by poultry. In an experiment feeding 10% flaxseed 
supplemented diets to broiler chicks, significantly lower tolerance was observed, manifesting 
as diarrhea, compared to mature single comb white leghorn roosters fed flaxseed diets 
(Gonzalez-Esquerra and Leeson, 2000).  
Processing also affects AMEn of flaxseed supplemented diets. Pelleting (4,578 
kcal/kg) or crumbling (4,277 kcal/kg) significantly increases AMEn fed to roosters compared 
to mash (3,659 kcal/kg; Gonzalez-Esquerra and Leeson, 2000). Extrusion processing of an 
ALA feed supplement containing 60% flaxseed improved AMEn by 18% (Bean and Leeson, 
2002). The additional pressure and heat of processing may release trapped oil from the 
matrix of the cell or the additional heat may destroy some of the toxic anti-nutrients in the 
feed (Calet, 1965; Gonzalez-Esquerra and Leeson, 2000). Therefore, pelleting and extrusion 
may be a method to offset the energy deficit of flaxseed oil compared to soy oil. 
Flaxseed ingredients are an effective laying hen feed supplement for generating 
value-added omega-3 fatty acid enriched eggs. The results reported here demonstrate that 
degummed flaxseed oil is a well-tolerated, energy dense feed ingredient with a more efficient 
ability to transfer ALA, but not EPA and DHA, to egg yolk as compared to ground flaxseed. 
Producers can benefit from using flaxseed oil as an alternative to ground flaxseed because it 
takes less feed volume for supplementation and it is more cost effective (about half of the 
cost). Producers can use the regression equations from this experiment to develop custom 
omega-3 fatty acid supplemented diets to adapt to changes in consumer egg preferences. 
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Future investigation should include characterization of performance and more importantly 
the health benefits of poultry consuming ALA, EPA, and DHA supplemented diets. 
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Table 2.2. Analyzed crude fat, fatty acid, and total omega-3 fatty acid concentrations in 
extracted degummed flaxseed oil and ground flaxseed ingredients.  
Fatty acid1 (C:double bond) Flaxseed oil % Ground flaxseed % 
Myristic acid (14:0) 0.06 0.08 
Palmitic acid (16:0) 5.72 6.06 
Palmitoleic acid (16:1) 0.13 0.70 
Margaric acid (17:0) 0.05 0.00 
Stearic acid (18:0) 3.72 4.05 
Oleic acid (18:1) 18.49 18.66 
Vaccenic acid (18:1) 0.69 0.00 
Linoleic acid (18:2) 15.19 15.24 
Alpha-linolenic acid (18:3) 54.21 55.21 
Arachidic acid (20:0) 0.58 0.00 
Arachidonic acid (20:4) 0.09 0.00 
Eicosapentaenoic acid (20:5) 0.16 0.00 
Docosapentaenoic acid (22:5) 0.38 0.00 
Docosahexaenoic acid (22:6) 0.46 0.00 
Crude fat (%)2 > 99 34 
Total omega-3 fatty acid (%)3 54.83 55.21 
1The fatty acid values represent the composition (%) of the crude fat in each ingredient. 
2Crude fat (%) was the analyzed fat content of each feed ingredient.  
3Total omega-3 fatty acid (%) was the sum of alpha-linolenic acid, eicosapentaenoic acid, 
and docosahexaenoic acid.  
	 74 
Table 2.3. Calculated compositions and analyzed values of 4 laying hen diets used for the 
apparent metabolizable energy, nitrogen corrected (AMEn) assay fed from 33 to 35 wk of 
age. 
 Basal Flaxseed oil concentration (%) 
Ingredients 0.0 3.0 6.0 9.0 
Corn 60.18 58.37 56.57 54.76 
Meat and bone meal 2.00 1.94 1.88 1.82 
Soybean meal 48 25.01 24.26 23.51 22.76 
Soy oil 1.33 1.29 1.25 1.21 
Flaxseed oil 0.00 3.00 6.00 9.00 
Sodium chloride 0.42 0.40 0.39 0.38 
DL-methionine 0.15 0.15 0.14 0.14 
Calcium carbonate1 9.24 8.96 8.68 8.40 
Dicalcium phosphate 0.87 0.84 0.82 0.79 
Titanium dioxide 0.30 0.29 0.28 0.27 
Phytase 0.00075 0.00073 0.00071 0.00068 
V and M premix2 0.50 0.49 0.47 0.46 
Calculated values (%)     
ME (kcal/kg) 2800 - - - 
Calcium 4.00 3.88 3.76 3.64 
Available phosphorus 0.35 0.34 0.33 0.32 
Analyzed values (%)     
Dietary AMEn as-fed (kcal/kg) 2762 2948 3218 3421 
Crude protein 18.02 17.72 17.13 16.76 
Crude fat 2.95 4.84 7.89 10.80 
Crude fiber 3.18 2.30 2.35 2.19 
Moisture 10.14 9.99 9.68 9.61 
Ash 14.04 14.29 11.21 10.63 
1Calcium carbonate added was a 50/50 mixture of small (≤ 2 mm) and large particle (> 2 
mm). 
2Vitamin and mineral premix provided per kg of diet: selenium 200 µg; vitamin A 6,600 
IU; vitamin D3 2,200 IU; vitamin E 14.3 IU; menadione 880 µg; vitamin B12 9.4 µg; 
biotin 33 µg; choline 358 mg; folic acid 1.1 mg; niacin 33 mg; pantothenic acid 8.8 mg; 
pyridoxine 880 µg; riboflavin 4.4 mg; thiamine 1.1 mg; iron 226 mg; magnesium 100 
mg; manganese 220 mg; zinc 220 mg; copper 22 mg; iodine 675 µg. 	
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FIGURES 
 
Figure 2.1. Egg yolk total omega-3 fatty acid content (ALA, EPA, and DHA) from hens (25 
to 33 wk of age) fed one of the following experimental diets: flaxseed oil (FSO) treatments 
containing 0.5, 1.0, 2.0, 3.0, or 5.0% FSO content, or ground flaxseed (GFS) treatments 
containing 0.5, 1.0, 2.0, 3.0, or 5.0% FSO concentration (GFS included at 1.5, 3.0, 6.0, 9.0, 
or 15.0% of the diet respectively). Increasing dietary inclusions of FSO or GFS resulted in 
linear increases of total omega-3 fatty acid deposition into egg yolk (P ≤ 0.01). FSO slope SE 
= ± 0.0779; intercept SE = ± 0.2184. GFS slope SE = ± 0.0501; intercept SE = ± 0.1403. 
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Figure 2.2. Egg yolk EPA and DHA content from hens (25 to 33 wk of age) fed one of the 
following experimental diets: flaxseed oil (FSO) treatments containing 0.5, 1.0, 2.0, 3.0, or 
5.0% FSO content, or ground flaxseed (GFS) treatments containing 0.5, 1.0, 2.0, 3.0, or 5.0% 
FSO concentration (GFS included at 1.5, 3.0, 6.0, 9.0, or 15.0% of the diet respectively). 
Increasing dietary inclusions of FSO or GFS resulted in increased EPA and DHA deposition 
into egg yolk (P ≤ 0.01); however, there was no difference in EPA and DHA egg yolk 
deposition based on flaxseed ingredient (P = 0.21). FSO slope SE = ± 0.0351; intercept SE = 
± 0.0984. GFS slope SE = ± 0.0389; intercept SE = ± 0.1091. 
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Figure 2.3. Calculated egg yolk total omega-3 fatty acid (ALA, EPA, and DHA) deposition 
(mg) per 50 g egg containing 10% total fat (AEB, 2017). Extrapolated omega-3 fatty acid 
deposition values were calculated using egg yolk total omega-3 fatty acid content (%) from 
hens (25 to 33 wk of age) fed the following experimental diets: flaxseed oil (FSO) treatments 
containing 0.5, 1.0, 2.0, 3.0, or 5.0% FSO content, or ground flaxseed (GFS) treatments 
containing 0.5, 1.0, 2.0, 3.0, or 5.0% FSO concentration (GFS included at 1.5, 3.0, 6.0, 9.0, 
or 15.0% of the diet respectively). FSO slope SE = ± 3.8950; intercept SE = ± 10.92. GFS 
slope SE = ± 0.8350; intercept SE = ± 7.02. 
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Figure 2.4. Dietary AMEn values on an as-fed basis for hens fed diets containing 0.0, 3.0, 
6.0, and 9.0% extracted degummed flaxseed oil (FSO) added to a basal diet for 2 wk (33 to 
35 wk of age). Increasing dietary inclusion of FSO resulted in a linear increase in AMEn (P ≤ 
0.01). Slope SE = ± 2.771; intercept SE = ± 15.6. 
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CHAPTER 3. PRODUCTION AND HEALTH RESPONSES OF AGED LAYING 
HENS TO DIETARY FLAXSEED OIL OR FISH OIL SUPPLEMENTATION 
 
A manuscript to be submitted to Poultry Science 
 
I. J. Ehr1,2, A. K. Johnson2, H. Xin2,3, and E. A. Bobeck2,4 
 
3.1 Abstract 
Supplementation of omega-3 fatty acids in laying hen diets generates value-added 
eggs for consumers, and may also improve laying hen performance and health. Alpha-
linolenic (ALA), eicosapentaenoic (EPA), and docosahexaenoic acids (DHA) are omega-3 
fatty acids linked to exerting positive bone health and anti-inflammatory effects. Two sources 
of dietary omega-3 fatty acids, flaxseed and fish oils, were evaluated over a 12-wk period in 
end-of-second-cycle Hy-Line W-36 laying hens (n = 234; 122 to 134 wk of age). 
Experimental diets consisted of a 4% flaxseed oil diet (2,200 mg ALA/100 g feed), a 4% fish 
oil diet (1,200 mg EPA + DHA/100 g feed), and a 4% soy oil diet as control (280 mg 
ALA/100 g feed). Hens were randomly housed 6 birds/cage (13 replicates/treatment) for each 
of the 3 treatments. Production performance, bone strength, bone conformation, and bone 
mineral content were evaluated during the 12-wk trial period. Immediately following the 
supplementation period, 1 hen/experimental unit (EU) received saline and another hen/EU 																																																								1Primary researcher and author. 
2Graduate student, Associate, Distinguished, and Assistant Professors, respectively, 
Department of Animal Science, Iowa State University. 
3Distinguished Professor, Department of Agricultural & Biosystems Engineering, Iowa State 
University. 
4Corresponding author.	
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received a single lipopolysaccharide (LPS; 1 mg/kg) injection to induce acute systemic 
inflammation. Liver was harvested 12 h post-LPS challenge for qRT-PCR cytokine analysis. 
Dietary treatments were independently contrasted to the control using PROC MIXED in SAS 
with significance considered at P ≤ 0.05. During the supplementation period, hens fed 
flaxseed oil consumed 1.2 ± 0.19 g/hen/d more feed than the control, while hens fed fish oil 
consumed 0.8 ± 0.19 g/hen/d less feed and laid 2.39 g ± 0.556 lighter eggs than the control (P 
≤ 0.01). No differences were observed in bone strength, conformation, or ash comparing 
either dietary treatment to the control (P ≥ 0.40). Hens fed the control diet and injected with 
LPS resulted in increased IL-1β, IL-6, IL-18, and PPARγ expression by > 4-fold compared to 
saline-injected control hens (P ≤ 0.05). Feeding flaxseed oil or fish oil to hens resulted in an 
intermediate response in inflammatory cytokine gene expression compared to control (P ≥ 
0.06), demonstrating anti-inflammatory protection. The data from this experiment 
demonstrated that flaxseed oil or fish oil supplementation did not improve performance and 
did not have an effect on bone health in aged laying hens. Although both oils provided anti-
inflammatory protection, it is unclear if that effect is beneficial when generating value-added 
eggs in commercial applications. 
Key words: ALA, EPA, DHA, inflammation, lipopolysaccharide 
 
3.2 Introduction 
 Feeding laying hens diets supplemented with omega-3 fatty acids can yield value-
added enriched eggs, as demonstrated in Chapter 2 of this dissertation (Fraeye et al., 2012). 
The essential omega-3 fatty acid alpha-linolenic acid (ALA; C18:3), found in flaxseed oil, is 
the precursor for endogenously synthesized eicosapentaenoic acid (EPA; C20:5) and 
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docosahexaenoic acid (DHA; C22:6; Burdge and Calder, 2006). Dietary omega-3 fatty acids 
found in fish oil, specifically EPA and DHA, have been reported to modulate bone 
remodeling activity and exhibit anti-inflammatory properties in murine and in vitro 
experiments (Sun et al., 2003; Moon et al., 2012; Tur et al., 2012). Laying hens are at risk for 
and often suffer from osteoporosis near or at the end of production cycles, a condition 
commonly referred to as soft bones or layer fatigue (Saif et al., 2008). Dietary ALA 
supplementation has been linked to reducing the incidence of fractures in free-range laying 
hens (Tarlton et al., 2013). Laying hens are also under physical and environmental stress 
during commercial egg production, which contributes to inflammation (Lay et al., 2011; 
Zhao et al., 2016). Dietary ALA or EPA and DHA supplementation for these vulnerable hens 
may help mitigate bone and inflammation related health concerns, serving an overlooked 
second benefit to generating value-added enriched eggs for consumers. 
Flax plant species naturally produce the essential omega-3 fatty acid ALA, which is 
stored in their seeds (Goyal et al., 2014). Flaxseeds contain 40% total fat and have been used 
as a dietary ALA source in laying-hen diets (Fraeye et al., 2012). The abundance of ALA in 
flaxseed ranges from 39 to 60% of the fatty acid profile, dependent upon genetic variety 
(Goyal et al., 2014). Omega-3 fatty acid-containing ingredients from marine sources, such as 
fish and microalgae, naturally contain EPA and DHA in varying quantities, which can be 
concentrated and blended into different concentrations during oil extraction (Gunstone, 2006; 
Mozaffarian and Wu, 2011; Fraeye et al., 2012). Although plant-derived ALA can be 
converted into EPA and DHA through endogenous elongation, desaturation, and beta-
oxidative reactions, birds have a limited ability to do so (Harris et al., 2008; Gregory et al., 
2011; Gregory et al., 2013). Depending on avian species, only 5% of dietary ALA is 
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endogenously converted to EPA and < 1% to DHA (Burdge and Calder, 2006; Zivkovic et 
al., 2011). Because not all omega-3 fatty acids (ALA, EPA, and DHA) have the same 
biological functions, consuming different proportions of the fatty acids may result in 
different effects on bone remodeling and attenuating inflammation.  
 Previous studies investigating end-of-cycle laying hens (≥ 72 wk of age) housed in 
cage systems concluded that up to 29% of broken bones were attributed to removal from 
cages and placement onto processing lines (Gregory and Wilkins, 1989; Knowles and 
Wilkins, 1998). Regardless of housing system, the incidence of broken bones, especially the 
keel (sternum), remains quite high for laying hens, 28 to 89% in aviary systems and 22 to 
44% in furnished caged systems (Wilkins et al., 2011; Nasr et al., 2012). Tarlton et al. (2013) 
reported that a 10% dietary inclusion of an ALA feed additive (50% flaxseed and 50% carrier 
grain) reduced incidence of fracture and bone deformity in free-range laying hens compared 
to hens fed unsupplemented conventional diets. Further investigation is needed to evaluate 
the health benefits of ALA or EPA and DHA supplementation in end-of-cycle laying hens 
with weakened bones, susceptible to fractures, using the predominant laying hen strain and 
housing system found in the US (Hy-Line W-36 in a conventional cage system). 
Aged laying hens housed in commercial environments are exposed to bacterial and 
physical stressors, such as commensal E. coli and feeder competition (Lay et al., 2011; Zhao 
et al., 2016). Overstimulation of the immune system and chronic inflammation by pathogenic 
infections reduce laying hen performance, which includes egg production and quality (Saif et 
al., 2008; Bai et al., 2014). Dietary EPA and DHA were found to play functional anti-
inflammatory roles in pre-clinical human studies, where the test subjects receiving the dietary 
supplementation had reduced hepatic synthesis of acute phase proteins and pro-inflammatory 
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cytokine IL-6 (Cottin et al., 2011; Skulas-Ray, 2015). Therefore, dietary supplementation of 
omega-3 fatty acids (ALA or EPA and DHA) may mitigate inflammatory stress encountered 
by laying hens in commercial environments by reducing the intensity of an inflammatory 
acute phase response (Korver and Klasing, 1997; Bai et al., 2014).  
End-of-cycle laying hens make an ideal model for investigating the effect of dietary 
supplements on bone health and mitigation of inflammatory stress because of their rapid 
bone turnover and physiological stress (Cook, 2000; Rodenburg et al., 2008; Wilkins et al., 
2011). Commercial environments are dynamic, potentially posing physiological stress in a 
multifactorial fashion with housing, management, handling, infectious disease, and nutrition 
impacting hen health and performance (Silversides et al., 2006, 2012; Van Hoorebeke et al., 
2010). An inducible stress model needs to be applied to aged laying hens in order to 
investigate the protective effects that supplementation of dietary ALA or EPA and DHA may 
offer.  
Previous experiments have demonstrated that lipopolysaccharide (LPS) 
administration to laying hens and broilers resulted in controlled pro-inflammatory acute 
phase response and systemic inflammation (Korver et al., 1998; Leshchinsky and Klasing, 
2001; Munyaka et al., 2013). Lipopolysaccharides are structural outer membrane components 
of Gram-negative bacteria and recognized as pathogenic molecules (Schwechheimer and 
Kuehn, 2015). Although not identical to pathogenic challenges, LPS administration is a well-
described model for induced systemic inflammation in poultry (Korver et al., 1998; Jiang et 
al., 2010; Munyaka et al., 2013). Lipopolysaccharide exposure in laying hens and broilers 
resulted in depressed feed consumption, Toll-like receptor 4 stimulation, and increased 
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splenic interleukin-1 beta (IL-1β), interferon gamma (IFNγ), and IL-10 cytokine gene 
expression (Korver et al., 1998; Jiang et al., 2010; Munyaka et al., 2013).  
The objective of this experiment was to investigate the effect of dietary omega-3 fatty 
acid supplementation (flaxseed oil as ALA source; fish oil as EPA and DHA source) on end-
of-second-cycle laying hens with regards to a) performance and bone health of the hens 
during and at the end of a supplementation period, and b) inflammatory response (cytokine 
gene expression) of the hens to a post-supplementation acute LPS challenge. The hypothesis 
of this experiment was that bioactive EPA and DHA supplementation would improve the 
bone health of aged laying hens and provide anti-inflammatory protection during a period of 
stress without negatively impacting performance, which may be beneficial for the producer 
and commercial hens. 
 
3.3 Materials and Methods 
3.3.1 Animals and Housing 
The experimental protocol was approved by the Iowa State University Institutional 
Animal Care and Use Committee. Laying hens were cared for in accordance with the FASS 
Guide for the Care and Use of Agricultural Animals in Research and Teaching (2010). Two 
hundred thirty-four Hy-Line W-36 laying hens (122 wk of age; BW 1.628 ± 0.0078 kg) were 
obtained from a commercial producer (Litchfield, MN) and transported to the Poultry 
Research and Teaching Unit at Iowa State University, where they were housed in single-tier 
conventional cages (W 30.5 × D 43.2 × H 45.2 cm) with 360° nipple waterlines at a stocking 
density of 438 cm2/hen. The lighting program was 15.5L:8.5D (light from 5:00 am to 8:30 
pm) with 30 lux light intensity, as recommended by the Performance Standards Manual (Hy-
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Line, 2012). Manure was collected in shallow pits below the cages for the duration of the 
experiment. All hens were observed twice daily and house temperature ranged from 20 to 
27°C.   
 
3.3.2 Omega-3 Fatty Acid Supplementation Period 
Hens were fed corn-soybean meal-wheat middlings-based experimental diets as 
follows: 1) basal diet + 4% soy oil (280 mg ALA/100 g feed; control); 2) basal diet + 4% 
flaxseed oil (2,200 mg ALA supplemented/100 g feed; flaxseed oil); or 3) basal diet + 4% 
fish oil (720 mg EPA and 480 mg DHA omega-3 fatty acids supplemented/100 g feed; fish 
oil). All diets were mixed every 2 wk and met or exceeded the NRC (1994) nutritional 
requirements for laying hens (Table 3.1). Experimental units (EU) consisted of 2 adjacent 
cages housing 3 hens/cage (438 cm2/hen stocking density) that shared a single feed trough (6 
hens/EU). Experimental diets were assigned in a randomized complete block design to 13 
EU/diet. The 4% flaxseed oil and 4% fish oil dietary inclusions resulted in unequal total 
omega-3 fatty acid concentrations in the treatment diets (Table 3.2). Therefore, the flaxseed 
oil and fish oil treatments were independently compared to the soy oil control in this 
experiment. Each hen was offered a range of 95 to 100 g/d feed in an attempt to control and 
equalize feed consumption across the dietary regimens. Previous work has demonstrated that 
it may take laying hens up to 6 wk to reach an omega-3 fatty acid transfer rate plateau (Ehr et 
al., 2017). Therefore, the dietary supplementation period lasted 12 consecutive wk (122 to 
134 wk of age) to allow for omega-3 fatty acid incorporation into laying hen tissues and egg 
yolk.  
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3.3.3 Feed Sample Measurements  
Feed samples were collected for every batch generated and stored at -20°C. Samples 
were ground through a 0.5 mm screen (Thomas-Wiley Laboratory Mill Model 4, Arthur H. 
Thomas Company, Philadelphia, PA) and dried at 100°C (Precision, Jouan, Inc., Winchester, 
VA) for 18 h to determine dry matter (DM) content. Ground feed samples for each regimen 
were pooled by 4-wk period. Fat content was measured by Soxhlet extraction using diethyl 
ether at the University of Missouri Agricultural Experiment Station Chemistry Laboratories 
(Method 920.39; AOAC, 2010; AESCL, Columbia, MO). Nitrogen concentration was 
determined by thermocombustion (TruMac N Analyzer, LECO Corp., St. Joseph, MI) and 
GE was determined using an adiabatic oxygen bomb calorimeter (Parr Instrument Co., 
Moline, IL). 
 
3.3.4 Production Performance Measurements 
Feed disappearance, which included wasted feed from the trough, was measured 
weekly for feed intake and feed efficiency (FE) calculations: Average daily feed intake 
(ADFI) = start feed weight in kg – end feed weight in kg after 7 d ÷ 7 d ÷ hens in cage; FE = 
egg mass in kg ÷ FI in kg. Eggs were collected and recorded daily and used for calculation of 
hen-day egg production (HDEP, %), i.e., HDEP% = (eggs laid ÷ living hens ÷ d) × 100. Eggs 
from 2 consecutive d of production were weighed weekly and used together with HDEP in 
calculating average daily egg mass (g/hen), i.e., average daily egg mass (ADEM) = average 
egg weight in g × (HDEP% ÷ 100). Hens were individually weighed with a digital scale 
(Defender 3000, Ohaus Corp., Parsippany, NJ) at the start of the experiment for a baseline 
body weight (BW), and then at 4, 8 and 12 wk during the dietary supplementation period.  
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Eggs from each EU were individually measured over 2 consecutive d for egg quality 
parameters at the start of the experiment, 4, 8, and 12 wk into the dietary supplementation 
period using a Digital Egg Tester (DET6000, Nabel Co., Ltd., Kyoto-shi, Japan). The 
recorded egg quality parameters included egg weight, albumen height, Haugh unit, shell 
breaking strength, and shell thickness. The Haugh unit was calculated as follows from 
Silversides and Villeneuve (1994): Haugh unit = 100 × Log[albumen height in mm – (1.7 × 
egg weight in g0.37 + 7.6)]. 
 The albumen and yolk of 4 eggs from 8 replicates of each dietary treatment were 
pooled and homogenized (Immersion Hand Blender 59735, Hamilton Beach/Proctor-Silex, 
Inc., Southern Pines, NC) for egg solids DM analysis. Five g of each homogenized sample 
was weighed onto a dry, pre-weighed aluminum dish in duplicate and placed in a 100°C 
drying oven. Samples were removed from the oven after 18 h and placed into a desiccator, 
allowed to cool to 21°C, and then weighed. Egg solids content was calculated as follows: egg 
solids content = (dried egg sample in g ÷ wet egg sample in g) × 100. 
 
3.3.5 Fatty Acid Analysis  
 A pooled sample of 13 egg yolks, 1 egg from each EU, was collected for fatty acid 
analysis at 4, 8, and 12 wk during the dietary supplementation period. The analysis started at 
4 wk to allow an adjustment period for maximal transfer of omega-3 fatty acids to egg yolk 
(Cherian and Sim, 1991). The fatty acid analysis of the egg yolks and ground feed samples 
was performed as described by Nam et al. (2001) and Sun et al. (2013) using gas 
chromatography (HP 6890, Hewlett Packard Co., Palo Alto, CA).  
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3.3.6 Bone Measurements 
 Laying hens were evaluated for keel (sternum) bone conformation at the start of 
the experiment and then at 4, 8, and 12 wk of the dietary supplementation period. Each hen 
was supported by the thighs and dorsal surface of the back and held in a vertical position to 
allow the entire length of the keel to be palpated using the index finger and thumb. Every 
hen was examined and assigned a keel bone conformation palpation score on a 3-point 
scale (Table 3.3) adapted from Wilkins et al. (2004) and Tarlton et al. (2013). 
 At the conclusion of the 12-wk dietary supplementation period, one hen randomly 
selected from each of 8 separate EU was euthanized via CO2 asphyxiation following the 
AVMA (2013) euthanasia guidelines. The use of 8 replicates per dietary regimen, rather than 
13, was due to financial constraints. The left tibia was collected for bone ash analysis and the 
right tibia was used for breaking strength analysis. The left tibia soft tissue was manually 
removed after being autoclaved for 45 min at 121°C at 18 psi. Cleaned tibiae were placed in 
a drying oven at 100°C for 18 h before fat extraction in a Soxhlet fat extractor for 48 h using 
hexane as a solvent. Fat extracted bones were placed back into a drying oven for 18 h at 
100°C to obtain their dry weight. The dried fat-extracted bone were ashed in a muffle furnace 
(Model 550-126, Fisher Scientific, Pittsburg, PA) at 580°C for 18 h. All dried and ashed 
samples were stored in a desiccator after immediate removal from ovens and furnaces and 
were allowed to cool to room temperature (21°C) prior to recording dry weight. Bone ash 
was calculated as follows: bone ash% = (bone ash weight ÷ dried fat-extracted bone weight) 
× 100.  
To determine bone breaking strength, soft tissue was manually removed from the 
right tibia without autoclaving to preserve the structural integrity of the bone. Individual 
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tibiae were broken at the midpoint using methods adapted from Fleming et al. (1998) to 
measure bone breaking strength using Texture Exponent Software and TA.XTPlus Texture 
Analyzer fit with a TA-92A Self Supporting 3-Point Bend Rig (Texture Technologies Corp., 
Hamilton, MA). 
 
3.3.7 Post-supplementation Inflammatory Challenge 
 At the end of the 12 wk dietary supplementation period, one randomly selected hen 
from each EU was injected intraperitoneally with 1 mg/kg LPS in sterile saline vehicle 
(L2630, E. coli 0111:B4 LPS, Sigma-Aldrich Co. LLC., St. Louis, MO) and a second 
randomly selected hen per EU was injected with the equivalent volume of sterile saline. Hens 
were given ad libitum access to experimental diets (control, flaxseed oil, or fish oil) and 
water throughout the inflammatory challenge. Twelve hours post-injection of LPS or saline, 
hens were euthanized via CO2 asphyxiation and liver was harvested, flash frozen in liquid 
nitrogen, and stored at -80°C for further analysis. 
 
3.3.8 Quantitative Real-Time PCR 
RNA extraction and DNase cleanup followed manufacturer directions using flash 
frozen liver samples (RNeasy Mini Kit, Qiagen, Valencia, CA). Samples of RNA were 
analyzed in triplicate by quantitative real-time PCR (qRT-PCR; DNA Engine Opticon 2 
System, Bio-Rad Lab. Inc., Hercules, CA) using 1-step SYBR Green master mix (QuantiTect 
SYBR Green RT-PCR, Qiagen, Valencia, CA) adapted from methods described by Kaiser et 
al. (2006). Relative RNA expression levels were measured for IL-1β, IL-6, IL-18, IFNγ, 
serum amyloid A (SAA), IL-10, and peroxisome proliferator-activated receptor gamma 
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(PPARγ) using ribosomal 28s subunit as a reference gene. Forward and reverse primers were 
generated (Integrated DNA Technologies, Coralville, IA) from sequences listed in Table 3.4 
with referenced source. Adjusted cycle threshold (Adj. Ct) value and normalized gene 
expression level (fold change) were calculated using the following adapted formulas 
(Eldaghayes et al., 2006; Kaiser et al., 2012): Adj. Ct = 40 − [mean Cttest gene + (median28s – 
mean Ct28s)] × (slopetest gene ÷ slope28s); fold change = 2[ – (Cttest gene treatment – Ct28s treatment) – (Cttest 
gene control
 – Ct
28s control
)]. 
 
3.3.9 Statistical Analysis 
Data from the 12-wk supplementation period were analyzed by repeated measures 
ANOVA using the MIXED procedure in SAS (SAS 9.4, 2012, SAS Institute Inc., Cary, NC). 
Experimental diets were assigned in a randomized complete block design with each treatment 
consisting of 13 replicates with 6 hens/EU. Experimental diet (diet), time (wk), and the 
interaction (diet*wk) were used as fixed effects in the model with the random effect of cage 
nested within experimental diet. In all cases, flaxseed oil and fish oil treatments contained 
different total omega-3 fatty acid inclusions and were therefore not directly comparable.  
Significant effects within the model included the soy oil control, flaxseed oil, and fish 
oil experimental diets, hence orthogonal contrasts were used to separate and test the 
individual dietary effect of flaxseed oil or fish oil treatment compared to the soy oil control 
diet. These data included HDEP, ADFI, egg weight, ADEM, FE, BW, egg quality 
parameters, and bone measurements with an experimental focus on the main effect of 
individual dietary treatment compared to control. Significant differences within the model 
due to time (wk) were presented for completeness. 
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The data from the LPS inflammatory challenge were analyzed using the MIXED 
procedure in SAS. Experimental diet (diet) and inflammatory challenge (challenge) and their 
interaction (diet*challenge) were used as fixed effects in the model with cage nested within 
experimental diet included as a random effect. Significant effects within the model included 
soy oil control, flaxseed oil, and fish oil experimental diets, therefore orthogonal contrasts 
were used to separate and test the individual dietary effect of flaxseed oil or fish oil treatment 
compared to the soy oil control. Orthogonal contrasts were used to test the effect of challenge 
(saline injection vs. LPS injection) and interactions (diet*challenge) separated by using 
flaxseed oil or fish oil treatment independently compared to the soy oil control. In all cases, 
significance was considered at P ≤ 0.05.  
 
3.4 Results 
3.4.1 Omega-3 Fatty Acid Supplementation Impact on Production Performance 
All inferences were based on orthogonal contrasts. Interactions (diet*wk) within the 
overall model were not considered significantly different because flaxseed oil and fish oil 
dietary treatments were independently contrasted to the soy oil control.  
No differences were observed between hens receiving the flaxseed oil diet compared 
to the control hens in HDEP, FE, egg weight, ADEM, BW (P ≥ 0.56; Table 3.5) or egg 
quality parameters (P ≥ 0.42; Table 3.6) throughout the supplementation period. However, 
ADFI was 1.2 ± 0.19 g/hen greater for hens fed the flaxseed oil diet than for the control hens 
(P ≤ 0.01).  
Hens receiving the fish oil diet consumed 0.8 ± 0.19 g/hen/d less feed and laid 2.39 ± 
0.556 g lighter eggs compared to the control hens (P ≤ 0.01). No differences were detected 
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between hens fed the fish oil diet and the control hens in HDEP, FE, ADEM, or BW (P ≥ 
0.17; Table 3.5); and the same was true with egg quality measurements (P ≥ 0.13; Table 3.6).  
Time (wk) affected the production performance of HDEP, FI, FE, ADEM, BW, egg 
weight, albumen height, Haugh unit, and shell thickness for hens fed experimental diets (P ≤ 
0.01). All hens steadily declined in HDEP until wk 7 and then increased wk 10 through wk 
12 of the dietary supplementation period, which was a result of hens progressing towards the 
end of production and the start of natural molt. The difference in HDEP over time affected 
ADEM and FE for all hens (P ≤ 0.01). All hens consumed more feed as the supplementation 
period progressed (P ≤ 0.01; Figure 3.1) and lost an average of 60 ± 10.5 g body weight until 
8 wk, which normalized to baseline weight by 12 wk of dietary supplementation (P ≤ 0.01; 
Figure 3.2A).  
Time (wk) affected the albumen height and Haugh unit for all hens, which remained 
the same for 4 to 8 wk then increased wk 12 by 0.4 ± 0.08 mm and 2.3 ± 0.57 units, 
respectively (P ≤ 0.01; Figure 3.2B). Egg weight increased for all hens compared to the 
starting value at 0 wk (P ≤ 0.01; Figure 3.2C). Shell thickness increased for all hens from wk 
4 to wk 8 by 0.05 ± 0.003 mm average and the thicker shell was maintained until the end of 
the 12 wk supplementation period (P ≤ 0.01; Figure 3.2D).  
 
3.4.2 Omega-3 Fatty Acid Transfer to Egg Yolk 
 Egg yolk fatty acid analysis confirmed that ALA, EPA, and DHA transfer occurred 
due to flaxseed oil and fish oil dietary supplementation, which followed their respective 
dietary fatty acid profiles. Egg yolks from hens fed the flaxseed oil diet contained the greatest 
ALA content (6.91%), resulting in 7 times lower omega-6:omega-3 fatty acid ratio compared 
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to yolks from the control hens. Egg yolks from hens fed the fish oil diet contained a greater 
EPA and DHA content (0.57% and 2.74%, respectively), resulting in 4 times lower omega-
6:omega-3 fatty acid ratio compared to yolks from the soy oil-diet control hens (Table 3.7). 
 
3.4.3 Omega-3 Fatty Acid Supplementation Impact on Bone Measurements 
No dietary effects of the flaxseed oil supplementation were observed on keel bone 
conformation score, tibia bone ash, or bone breaking strength compared to the soy oil control 
diet (P ≥ 0.72; Table 3.8). The same held true with the fish oil supplementation on bone 
conformation score (P = 0.79), tibia bone ash and bone breaking strength (P ≥ 0.40; Table 
3.8). 
Differences in keel bone conformation score were detected over time (wk) for all 
hens, where the average score increased by 0.29 ± 0.035 from 4 to 8 wk and then decreased 
by 0.23 ± 0.035 from 8 to 12 wk back to baseline level (P ≤ 0.01; Figure 3.2A).  
 
3.4.4 Responses to Post-supplementation Inflammatory Challenge 
To obtain baseline reference values and confirm immune system stimulation, the 
control hens were administered LPS or saline injections. Lipopolysaccharide administration 
given to the control hens caused increased relative gene expression of inflammatory 
cytokines IL-β, IL-6, and IL-18 by 4.4, 26.2, and 7.2-fold, respectively, compared to the 
control hens injected with saline (P ≤ 0.05). Lipopolysaccharide injection to the control hens 
caused a 5.4-fold increase of PPARγ, the gene responsible for stimulating lipid uptake and 
adipogenesis, compared to the control hens injected with saline (P = 0.02; Figure 3.3A). 
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Hens fed the flaxseed oil supplemented diets and administered LPS or saline injection 
were contrasted to the respective reference hens fed the control diet. No differences due to 
dietary effect were observed for mRNA inflammatory cytokine gene expression, acute phase 
protein SAA, anti-inflammatory cytokine IL-10, or PPARγ for hens fed the flaxseed oil diet 
or soy oil control diet (P ≥ 0.79). Lipopolysaccharide injection given to hens fed the flaxseed 
oil and control diets caused an increase in gene expression of inflammatory cytokines IL-6 
and IL-18 by 10.0 and 4.4-fold, respectively, compared to hens fed flaxseed oil and control 
hens injected with saline (P ≤ 0.01). Gene expression for PPARγ was 3.1-fold more in hens 
fed flaxseed oil and control hens injected with LPS compared to the hens fed flaxseed oil and 
control hens injected with saline (P ≤ 0.01; Figure 3.3B).  
Both LPS and saline injections given to hens fed the flaxseed oil diet resulted in a 
trending reduction in gene expression of inflammatory cytokines IL-1β, IL-6, IL-18 and 
PPARγ when compared to the LPS-injected control hens (P ≥ 0.08). In addition, both LPS 
and saline injections given to hens fed the flaxseed oil diet responded with a trending 
increase in gene expression of inflammatory cytokines IL-1β, IL-6, IL-18 and PPARγ 
compared to the saline-injected control hens (P ≥ 0.08). Overall, feeding flaxseed oil diets to 
hens demonstrated a trending intermediate response in gene expression of inflammatory 
cytokines at levels between those of the reference control hens injected with LPS or saline (P 
≥ 0.08; Figure 3.3A). 
Additional laying hens were injected with LPS or saline to evaluate the protective 
anti-inflammatory effects of dietary fish oil supplementation. Hens fed the fish oil diet and 
injected with LPS or saline were contrasted to the reference control hens. Feeding the fish oil 
dietary treatment or the soy oil control diet to hens did not cause differences in mRNA gene 
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expression of inflammatory cytokines, acute phase protein SAA, anti-inflammatory cytokine 
IL-10, or PPARγ (P ≥ 0.43). Lipopolysaccharide injection to hens fed the fish oil and control 
diets caused increased gene expression for inflammatory cytokines IL-6 and IL-18 by 7.5 and 
4.3-fold, respectively, compared to saline injected hens fed the fish oil and control diets (P ≤ 
0.01). Lipopolysaccharide administration to hens fed the fish oil and control diets resulted in 
a 2.9-fold increase in gene expression of PPARγ compared to hens fed fish oil and control 
diets injected with saline (P ≤ 0.01; Figure 3.3B).  
Administration of LPS and saline injections to hens fed the fish oil diet resulted in a 
trending reduction in gene expression of inflammatory cytokines IL-1β, IL-6, IL-18 and 
PPARγ when compared to hens fed the soy oil control diet injected with LPS (P ≥ 0.06). In 
addition, LPS and saline injection given to hens fed the fish oil diet resulted in a trending 
increase in gene expression of inflammatory cytokines IL-1β, IL-6, IL-18 and PPARγ 
compared to hens fed the soy oil control diet injected with saline (P ≥ 0.06). Overall, feeding 
fish oil dietary treatments to hens resulted in a trending intermediate response in gene 
expression of inflammatory cytokines at levels between those of the reference control hens 
injected with LPS and saline (P ≥ 0.06; Figure 3.3A). 
 
3.5 Discussion 
3.5.1 Production Performance during the Supplementation Period 
Prior to the dietary supplementation period (122 to 134 wk of age), the hens 
performed to the expected breed standards. They were molted from 65 to 70 wk of age, then 
continued into second-cycle production. Upon experimental initiation at 122 wk of age, the 
hens had declined in HDEP to < 65 ± 1.8%, which was in agreement with previous work 
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reporting declining performance in hens 85 to 102 wk old (Khalaji et al., 2014). Furthermore, 
molting the hens in the current experiment caused a negative impact on eggshell proportion 
and increased egg deformities, which was in agreement with data reported by Arpášová et al. 
(2010) in 70 to 110 wk old molted hens.  
The extended length of second-cycle production may have contributed to the 
declining flock performance observed in this experiment. Pooled average flock HDEP 
declined linearly from 122 to 130 wk of age and stabilized at approximately 50 ± 1.8% 
HDEP, as did FE, which eventually stabilized at 0.330 ± 0.0112 kg egg mass/kg feed (Figure 
3.1). The flock started their second-cycle of egg production at 70 wk of age and had been in 
continuous production for 64 wk by the end of the 12 wk experiment. Physiological 
exhaustion may have caused the hens to decrease or go out of production and enter a natural 
molt to recover from such a long laying cycle. This may explain why BW and egg quality 
was lowest at 4 and 8 wk in this experiment. The 4 to 8 wk period (126 to 130 wk of age) of 
low performance may have provided time for recuperation, which allowed the flock to 
rebound by 12 wk (134 wk of age) and recover BW and egg quality losses, specifically 
Haugh unit, albumen height, and shell thickness (Figure 3.2A, 3.2B, and 3.2D). The flock 
performance data suggest that laying hens can persist in second-cycle egg production for a 54 
wk timeframe until spontaneously going out of production or molting. 
The pooled average flock BW was lowest (1.559 ± 0.0105 kg) at 8 wk in the 
experiment, which may have contributed to the elevated 8 wk flock bone conformation score 
of 1.95 ± 0.035. Leaner hens have less muscle and fat to impede fracture and lesion detection 
during keel bone examination and palpation (Wilkins et al., 2004; Casey-Trott et al., 2015). 
In addition, the tissue surrounding bone acts as protective padding, therefore reduced muscle 
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and fat on a skeletal frame may have allowed for more fractures or bone lesions to occur. The 
bone conformation scores returned to baseline levels at 12 wk in the experiment, which 
coincided with BW values returning back to baseline levels.  
Feeding dietary flaxseed oil or fish oil supplementation to aged laying hens did not 
improve performance, egg quality, or bone health compared to hens fed the soy oil control 
diet. The lack of performance improvements was in agreement with the report by Toscano et 
al. (2012, 2015) who found that high inclusions of dietary omega-3 fatty acid 
supplementation (1,978 mg ALA, 346 mg EPA, and 303 mg DHA/100 g feed) fed to brown 
laying hens in aviary housing reduced performance with minimal increases in biomechanical 
bone strength. These findings contrast with Tarlton et al. (2013) reporting that dietary ALA 
supplementation (≥ 2,500 mg ALA/100 g feed) fed to free-range brown laying hens 
decreased keel fractures by 60% and increased keel bone breaking strength by 5 N   
compared to hens fed unsupplemented conventional diets, due to the dietary omega-6:omega-
3 fatty acid ratio (Toscano et al., 2015). The conflicting results from the previously described 
studies suggest that further experimentation is needed. 
The laying hens fed fish oil supplemented diets in this experiment consumed 0.8 ± 
0.19 g feed/hen/d less compared to the control hens, which may have contributed to the 2.39 
± 0.556 g reduced egg weight. In a separate experiment, 36 wk old laying hens were fed 6% 
microencapsulated fish oil supplemented diets over a 3 wk supplementation period (Lawlor 
et al., 2010). Feed intake was not suppressed over the course of the 3 wk experiment, 
suggesting that microencapsulated oil might be better tolerated by laying hens than a free fish 
oil (Lawlor et al., 2010). Free fish oil supplementation included at ≥ 4% may be unpalatable 
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to laying hens, and microencapsulation of oil may be able to mask the unpleasant odors or 
flavors (Lawlor et al., 2010).  
Environmental housing, management, and genetics are contributing factors in keel 
bone fractures and should be considered when evaluating the dietary effects of ALA or EPA 
and DHA supplementation on modulating bone and overall bone health (Silversides et al., 
2012; Campbell et al., 2016; Stratmann et al., 2016). This experiment has shown that ALA or 
EPA and DHA supplementation did not decrease egg production or bone health in aged 
laying hens. In order to improve laying hen bone health in dynamic housing systems, the 
combination of genetic selection and dietary omega-3 fatty acid supplementation may be 
required to generate stronger bone biomechanical properties rather than supplementation 
alone (Fleming et al., 2004; Stratmann et al., 2016).  
 
3.5.2 Responses to Post-supplementation Inflammatory Challenge 
After the 12-wk omega-3 fatty acid (ALA or EPA and DHA) supplementation period, 
mRNA gene expression in the liver was altered in end-of-second-cycle laying hens due to the 
LPS challenge. Clinical signs of inflammation, such as fever and swelling, that manifest due 
to LPS exposure are modulated by activated immune cells producing cytokines, resulting in a 
pro-inflammatory state (MacKay and Lester, 1992; Nakamura et al., 1998; Xie et al., 2000). 
The LPS injection in hens resulted in increased gene expression of inflammatory cytokines 
IL-6 and IL-18 compared to saline injected hens regardless of experimental diet (flaxseed oil, 
fish oil, and soy oil control), demonstrating the influence of 1.0 mg/kg LPS dosage in 134 wk 
old hens. Pro-inflammatory cytokine production was expected from the LPS challenge due to 
previous experiments demonstrating acute phase response in 34 d old broiler and layer lines 
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(Leshchinsky and Klasing, 2001; Warren et al., 2010). The LPS injection in hens also 
resulted in increased expression of PPARγ, which is the master regulator of adipogenesis 
(Sun et al., 2014). When PPARγ is up-regulated, cells are signaled to store fatty acids (Sun et 
al., 2014), including ALA, EPA, and DHA that possess anti-inflammatory properties. The 
data between the two dietary treatments cannot be directly compared, as the same 4% dietary 
oil inclusion yielded unequal total omega-3 fatty acid supplementation, with the fish oil 
providing 45% less total omega-3 fatty acids than the flaxseed oil. Although unequal in total 
omega-3 fatty acid supplementation, hens fed flaxseed oil (ALA source) and fish oil (EPA 
and DHA source) diets generated similar responses to the inflammatory challenge. 
An interaction occurred where hens in the flaxseed oil and fish oil dietary treatments 
(LPS and saline-injected) produced intermediate mRNA expression levels of inflammatory 
cytokines IL-1β, IL-6, IL-18 and PPARγ when compared to hens in the soy oil control group 
injected with LPS or saline. The control hens injected with LPS generated ≥ 4.4-fold 
increases in inflammatory cytokine expression compared to their saline-injected control 
counterparts. The lower peak inflammatory cytokine expression of hens fed ALA and EPA 
and DHA supplemented diets compared to the LPS-injected control hens, while not 
significant, indicated that the supplementation diminished cellular response to inflammatory 
stimulation. Dietary ALA or EPA and DHA supplementation was able to mute the acute 
phase inflammatory response without shutting down the immune system in aged laying hens. 
These results imply that even though inflammation is suppressed the immune system may 
still be able to clear out pathogens and prevent infections. Further investigation would be 
necessary to determine the effect of dietary omega-3 fatty acid supplementation on pathogen 
clearance during active infection of laying hens.  
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Inflammation may potentially result in discomfort and loss of performance in 
production animals, but inflammatory signaling serves an important function in the event of 
pathogenic infection. Interferon γ gene expression is up regulated through IL-1β, IL-18, and 
IL-12, synergistically activating T cell subsets (Tominaga et al., 2000). Several mechanisms 
have been proposed for the inflammatory actions of EPA and DHA, including competition 
with omega-6 fatty acids for rate limiting enzymes (Voss et al., 1991), synthesis of less 
inflammatory prostaglandin variants (Gonzalez et al., 2011), and modulation of macrophage 
pro-inflammatory cytokine synthesis (Hao et al., 2010). The intermediate IL-1β and IL-18 
gene expression in this experiment suggests that circulating IFNγ would be greater in the 
ALA or EPA and DHA supplemented hens compared to the control hens injected with saline.  
Circulating levels of IFNγ at primed concentrations could potentially reduce 
pathogenic infection by increasing detection and elimination of invading bacteria and viruses 
before cellular infection and replication occurs (Irons and Fritsche, 2005; Spits et al., 2016). 
However, the reduced peak expression of IFNγ in hens supplemented with ALA or EPA and 
DHA compared to hens fed the soy oil control and injected with LPS suggests that 
macrophage activation and microbial clearance via the TH1 immune response may be 
reduced (Irons and Fritsche, 2005; Spits et al., 2016). Suppressing inflammatory signaling in 
extreme conditions, such as sepsis, could theoretically result in prolonged infection of Gram-
positive bacteria or viruses normally eliminated by IL-10 and IFNγ (de Pablo et al., 2002; 
Irons and Fritsche, 2005; Skovbjerg et al., 2010). Dietary ALA or EPA and DHA 
supplementation appears to mute the immune response, but may still be effective at 
pathogenic elimination despite blunting peak inflammatory gene expression levels. 
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As previously mentioned, immunologically developed end-of-second cycle laying 
hens are able to endogenously metabolize ≤ 5% of dietary ALA to EPA and DHA (Burdge 
and Calder, 2006; Zivkovic et al., 2011). The flaxseed oil treatment may have provided 
enough ALA substrate for adequate endogenous EPA and DHA synthesis over the 12 wk 
experiment to attenuate inflammation in a similar fashion as the fish oil treatment. 
Mechanistically, the current gene expression data may support that EPA and DHA cell 
membrane incorporation interferes with toll-like receptor 4 (TLR4) signaling, the cell surface 
receptor that dimerizes and signals when bound to LPS (Rockett et al., 2011). Membrane 
lipid raft clusters that contain TLR4 protein components become disorganized spatially and 
in size due to the presence of EPA and DHA in the lipid bilayer (Rockett et al., 2011). 
Membrane fluidity also becomes impaired due to EPA and DHA incorporation, further 
preventing protein recruitment into lipid raft region for TLR4 activation (Hao et al., 2010). 
Intracellular EPA and DHA may also directly inhibit the TLR4 pathway by acting as second 
messengers that inhibit pro-inflammatory gene transcription and translation (Hao et al., 
2010). In this current experiment, it may be speculated that feeding flaxseed oil and fish oil 
supplemented diets inhibited the TLR4 pathway resulting in the intermediate cytokine 
responses during LPS inflammatory stimulation. 
Collecting liver samples from hens 12 h post-LPS challenge allowed adequate time 
for physiological changes in gene expression to occur. These data parallel with the 
phenotypic changes observed by Cheng et al. (2004) who found that relative liver weights 
increased 15% in 6 wk old pullets that exhibited clinical lethargy 12 h post-LPS injection. 
Additional time point sampling before and after LPS administration would provide insight 
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into whether the dietary treatments accelerated, resolved, or prolonged inflammatory gene 
expression over time in response to LPS stimulation. 
This is the first time hens of this age and stage of production have been utilized for 
investigation into omega-3 fatty acid anti-inflammatory protection and immune responses. 
Previous work in mouse models reported anti-inflammatory effects on CD8+ T cells and 
adipocytes using 3.5% dietary flaxseed oil (Monk et al., 2016). The dietary oil inclusion level 
in this experiment was commercially relevant at 4%, which is the upper limit of what feed 
mills can handle when manufacturing an omega-3 fatty acid enriched diet. If producers in the 
industry are using oil supplementation at levels to generate value-added eggs, then they 
should be made aware of the effects that flaxseed oil and fish oil have on their laying hens’ 
immune system. As previously discussed, reducing inflammation may not always be in an 
animals best interest. Immune suppression may improve laying hen production performance 
in a clean research environment where disease challenge and feed competition are not 
factors. However, in commercial environments that contain bacteria and competition, anti-
inflammatory immune suppression may not be ideal for eliminating certain pathogens, such 
as viruses. Further investigation is needed to verify the role EPA and DHA play in vivo 
during pathogenic infections. 
This experiment disproved the hypothesis that fish oil supplementation, providing 
EPA and DHA, would improve aged laying hen bone health. Omega-3 fatty acid 
supplementation in laying hen diets can generate value-added enriched eggs, and provide 
some level of anti-inflammatory protection but this protection may not be a practical benefit 
for producers faced with disease challenges. It is up to producers to consider the pros and 
cons related to health of using feed additives or supplements in animal diets.  
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TABLES 
Table 3.1. Calculated and analyzed values for experimental soy oil (control), flaxseed oil, or 
fish oil diets1 fed to Hy-Line W-36 laying hens for a 12-wk supplementation period used to 
evaluate dietary alpha-linolenic acid (ALA) or eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). 
 Experimental diet formulations (%) 
Ingredient Soy oil control Flaxseed oil Fish oil 
Corn 49.53 49.53 49.53 
Soybean meal 48% crude protein 21.57 21.57 21.57 
DDGS2 5.00 5.00 5.00 
Wheat middlings 5.00 5.00 5.00 
Meat and bone meal 4.00 4.00 4.00 
Soy oil 4.00 0.00 0.00 
Flaxseed oil 0.00 4.00 0.00 
Fish oil 0.00 0.00 4.00 
Calcium carbonate3 9.76 9.76 9.76 
Dicalcium phosphate 0.07 0.07 0.07 
Salt 0.33 0.33 0.33 
Methionine hydroxy analogue 0.15 0.15 0.15 
Choline chloride 0.10 0.10 0.10 
V and M premix4 0.50 0.50 0.50 
Calculated values  
Calcium 4.23 4.23 4.23 
Available Phosphorus 0.33 0.33 0.33 
Analyzed values  
Crude protein 18.59 17.65 18.40 
Crude fat 4.15 4.83 4.94 
Moisture 10.56 10.06 10.30 
Ash 13.85 14.49 14.47 
1Experimental diets used a basal diet combined with 4% soy oil (control), 4% flaxseed oil 
(2,200 mg ALA/100 g diet), or 4% fish oil (720 mg EPA + 480 mg DHA/100 g diet) fed 
from 122 to 134 wk of age (12-wk supplementation period). Control and dietary treatments 
contained 78 laying hens with 13 replicate experimental units. Calculated ME for the soy oil 
control diet was 2,889 kcal/kg. 
2DDGS = distillers dried grains with solubles. 
3Calcium carbonate added was a 50/50 mixture of small (< 2 mm) and large (≥ 2 mm) 
particle. 
4Vitamin and mineral premix provided per kg of diet: selenium 200 µg; vitamin A 6,600 IU; 
vitamin D3 2,200 IU; vitamin E 14.3 IU; menadione 880 µg; vitamin B12 9.4 µg; biotin 33 µg; 
choline 358 mg; folic acid 1.1 mg; niacin 33 mg; pantothenic acid 8.8 mg; pyridoxine 880 
µg; riboflavin 4.4 mg; thiamine 1.1 mg; iron 226 mg; magnesium 100 mg; manganese 220 
mg; zinc 220 mg; copper 22 mg; iodine 675 µg.  
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Table 3.2. Analyzed fatty acid profile of experimental soy oil (control), flaxseed oil, or fish 
oil diets1 fed to Hy-Line W-36 laying hens for a 12-wk supplementation period used to 
evaluate dietary alpha-linolenic acid (ALA) or eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). 
 Diet fatty acid composition (%) 
Fatty acid2 (C:double bond) Control  Flaxseed oil Fish oil 
Myristic acid (14:0) 0.24 0.29 4.78 
Palmitic acid (16:0) 15.43 10.69 18.57 
Palmitoleic acid (16:1) 0.37 0.45 5.26 
Margaric acid (17:0) 0.00 0.00 0.34 
Stearic acid (18:0) 4.15 3.79 4.23 
Oleic acid (18:1) 20.87 20.99 17.85 
Linoleic acid (18:2) 52.82 30.16 25.97 
Alpha-linolenic acid (18:3) 5.44 32.95 2.17 
Arachidic acid (20:0) 0.32 0.30 0.33 
Arachidonic acid (20:4) 0.00 0.00 0.66 
Eicosapentaenoic acid (20:5) 0.00 0.37 11.62 
Behenic acid (22:0) 0.35 0.00 0.00 
Docosapentaenoic acid (22:5) 0.00 0.00 1.39 
Docosahexaenoic acid (22:6) 0.00 0.00 6.84 
Calculated values    
Total saturated fat 20.49 15.09 28.25 
Total unsaturated fat 79.51 84.91 71.75 
Total omega-3 fatty acid3 5.44 33.32 20.63 
Total omega-6 fatty acid4 52.82 30.16 26.63 
Omega-6:omega-3 ratio 9.70 0.91 1.29 
1Experimental diets were made every 2 wk and a pooled sample using feed from each new 
batch was used for fatty acid analysis. Experimental diets used a basal diet combined with 
4% soy oil (control), 4% flaxseed oil (2,200 mg ALA/100 g diet), or 4% fish oil (720 mg 
EPA + 480 mg DHA/100 g diet) fed from 122 to 134 wk of age. Control and dietary 
treatments contained 78 laying hens with 13 replicate experimental units. 
2Analyzed dietary crude fat was 4.15, 4.83, and 4.94% for the soy oil control, flaxseed oil, 
and fish oil diets respectively. The fatty acid values represent the percent composition within 
the crude fat for each experimental diet. 
3Total omega-3 fatty acid was the sum of alpha-linolenic acid, eicosapentaenoic acid, and 
docosahexaenoic acid.  
4Total omega-6 fatty acid was the sum of linoleic acid and arachidonic acid. 
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Table 3.3. Keel (sternum) bone conformation palpation scale for laying hens fed 
experimental soy oil (control), flaxseed oil, or fish oil diets1 for a 12-wk supplementation 
period used to evaluate dietary alpha-linolenic acid (ALA) or eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA). 
Score Definition 
0 Normal keel (sternum) with no fractures 
1 Presence of keel damage from a minor fracture 
2 Presence of keel damage from a moderate fracture and calcification 
3 Presence of damage from a severe fracture, sigmoid calcification, or multiple fracture sites on keel 
1Experimental diets were applied for a 12-wk dietary supplementation period (122 to 134 wk 
of age). Laying hens were fed experimental diets containing 4% soy oil (control), 4% 
flaxseed oil (2,200 mg ALA/100 g diet), or 4% fish oil (720 mg EPA + 480 mg DHA/100 g 
diet). 
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Table 3.7. Analyzed fatty acid profile of dietary omega-3 fatty acid transfer to egg yolk1 
from Hy-Line W-36 laying hens fed experimental soy oil (control), flaxseed oil, or fish oil 
diets2 for a 12-wk supplementation period used to evaluate dietary alpha-linolenic acid 
(ALA) or eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). 
 Egg yolk fatty acid composition (%)
 
Fatty acid3 (C:double bond) Control Flaxseed oil Fish oil 
Myristic acid (14:0) 0.22 0.20 0.93 
Palmitic acid (16:0) 26.86 23.98 30.35 
Palmitoleic acid (16:1) 1.84 2.06 3.64 
Margaric acid (17:0) 0.00 0.00 0.00 
Heptadecanoic (17:1) 0.19 0.07 0.23 
Stearic acid (18:0) 9.43 9.08 9.52 
Oleic acid (18:1) 35.29 38.25 35.57 
Linoleic acid (18:2) 22.37 16.98 14.41 
Alpha-linolenic acid (18:3) 0.90 6.91 0.53 
Arachidic acid (20:0) 0.00 0.00 0.00 
Arachidonic acid (20:4) 2.24 1.19 0.78 
Eicosapentaenoic acid (20:5) 0.00 0.00 0.57 
Behenic acid (22:0) 0.00 0.00 0.26 
Docosapentaenoic acid (22:5) 0.00 0.00 0.46 
Docosahexaenoic acid (22:6) 0.65 1.28 2.74 
Calculated values    
Saturated fat 36.51 33.26 41.06 
Unsaturated fat 63.49 66.74 58.94 
Total omega-3 fatty acid4 1.55 8.19 3.84 
Total omega-6 fatty acid5 24.61 18.17 15.19 
Omega-6:omega-3 ratio 15.86 2.22 3.96 
1Egg yolks were sampled at 0, 4, 8, and 12-wk during the 12-wk supplementation period (122 
to 134 wk of age). Eggs sampled at the start (0-wk) were used as a baseline for the 
supplementation period. One egg yolk per experimental unit was pooled by treatment diet for 
fatty acid analysis.  
2Experimental diets used a basal diet combined with 4% soy oil (control), 4% flaxseed oil 
(2,200 mg ALA/100 g diet), or 4% fish oil (720 mg EPA + 480 mg DHA/100 g diet) from 
122 to 134 wk of age. Control and dietary treatments contained 78 laying hens with 13 
replicate experimental units. 
3Analyzed egg yolk crude fat was 31.01, 30.96, and 31.32% for the soy oil control, flaxseed 
oil, and fish oil-fed hens respectively. The egg yolk fatty acid values represent the percent 
composition within the egg yolk crude fat for each experimental diet. 
4Total omega-3 fatty acid was the sum of alpha-linolenic acid, eicosapentaenoic acid, and 
docosahexaenoic acid.  
5Total omega-6 fatty acid was the sum of linoleic acid and arachidonic acid. 
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Table 3.8. Bone evaluation of Hy-Line W-36 laying hens fed experimental soy oil (control), 
flaxseed oil, or fish oil diets for a 12-wk supplementation period used to evaluate dietary 
alpha-linolenic acid (ALA) or eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA). 
Experimental diet1 
Bone conformation 
score (0 to 3)2 
Tibia bone 
ash (%) 
Bone breaking 
strength (N) 
Soy oil control 1.8 65.3 171.4 
Flaxseed oil 1.8 64.8 169.1 
Fish oil 1.8 64.4 161.7 
SEM 0.04 0.86 7.96 
Contrast P-value3   
Flax vs. Con 0.86 0.72 0.84 
Fish vs. Con 0.79 0.50 0.40 
1Control and dietary treatments contained 78 laying hens with 13 replicate experimental 
units. Experimental diets used a basal diet combined with 4% soy oil (control), 4% flaxseed 
oil (2,200 mg ALA/100 g diet), or 4% fish oil (720 mg EPA + 480 mg DHA/100 g diet) from 
122 to 134 wk of age (12-wk supplementation period). 
2Bone conformation palpation score was measured at the start and every 4 wk (0, 4, 8, 12-
wk) during the 12-wk dietary supplementation period. Starting conformation score (0-wk) 
was used to attain a baseline value. Keel bone conformation palpation was scored on a 3 
point scale where 0 = normal keel, 1 = keel with presence of damage from minor fracture, 2 
= keel with presence of damage from moderate fracture, and 3 = presence of damage from 
multiple or severe keel fractures. 
3Orthogonal contrasts of flaxseed oil dietary treatment (Flax) vs. soy oil control (Con) and 
fish oil dietary treatment (Fish) vs. Con. 
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FIGURES 
 
Figure 3.1. Pooled average flock performance for laying hens fed experimental soy oil 
control, flaxseed oil, and fish oil diets over a 12-wk experimental supplementation period 
(122 to 134 wk of age). Experimental diets used a basal diet combined with 4% soy oil 
(control), 4% flaxseed oil (2,200 mg ALA/100 g diet), or 4% fish oil (720 mg EPA + 480 mg 
DHA/100 g diet). Control and dietary treatments contained 78 laying hens with 13 replicate 
experimental units. The hens were given the first 2 wk of the experiment to adjust to their 
rations, data not included. Data shown as LS Means ± SEM for the effect of time (wk) on 
pooled values of average daily feed intake (; g/hen), feed efficiency (; kg egg/kg feed), 
hen-day egg production (; %), and average daily egg mass (; g/egg; P ≤ 0.01). 
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Figure 3.2. Pooled average flock bone conformation score, BW, and egg quality for 
laying hens fed experimental soy oil control, flaxseed oil, and fish oil diets over a 12-wk 
experimental supplementation period (122 to 134 wk of age). Experimental diets used a 
basal diet combined with 4% soy oil (control), 4% flaxseed oil (2,200 mg ALA/100 g 
diet), or 4% fish oil (720 mg EPA + 480 mg DHA/100 g diet). Control and dietary 
treatments contained 78 laying hens with 13 replicate experimental units. Data shown as 
LS Means ± SEM for the effect of time (wk) on pooled values of A) bone conformation 
score (×; P ≤ 0.01) and BW (; P ≤ 0.01), B) Haugh unit (; P ≤ 0.01) and albumen 
height (; P ≤ 0.01), C) egg weight (; P ≤ 0.01) and egg solids (; P = 0.12), and D) 
shell breaking strength (; P = 0.30) and shell thickness (; P ≤ 0.01). 
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CHAPTER 4. DIETARY FLAXSEED OIL OR FISH OIL SUPPLEMENTATION ON 
BONE HEALTH AND PERFORMANCE IN GROWING BROILERS 
 
A manuscript to be submitted to Poultry Science 
 
I. J. Ehr1,2, A. K. Johnson2, S. Azarpajouh2, B. Kerr3, N. Gabler2, and E. A. Bobeck2,4 
 
4.1 Abstract 
Broiler diets supplemented with omega-3 fatty acids can generate value-added meat 
for consumers and may provide a second benefit by improving broiler health. Rapid muscle 
and skeletal growth rates that have allowed broilers to become efficient production animals 
have also caused an increase in lameness and leg issues. Dietary alpha-linolenic acid (ALA), 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to modulate bone 
mineral resorption in vitro. In order to investigate the effects of dietary flaxseed oil (ALA 
source) or fish oil (EPA and DHA source) supplementation on broiler bone health and 
performance, 6 d old Ross 308 broilers (n = 240) were fed experimental diets containing 
4.1% omega-3 fatty acids or a palm oil control diet over a 28 d dietary supplementation 
period (6 to 34 d old, final BW of 2.412 ± 0.318 kg). Lameness, bone conformation, bone 
mineral content (BMC), and bone mineral density (BMD) were used to quantify bone health. 
Lameness score was assessed every 7 d based on locomotion; keel, legs, and wings were 																																																								
1Primary researcher and author. 
2Graduate student, Associate Professor, Postdoc, Associate Professor, and Assistant 
Professor, respectively, Department of Animal Science, Iowa State University. 
3Collaborator Associate Professor, USDA-ARS-National Laboratory for Agriculture and the 
Environment. 
4Corresponding author.	
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palpated on each bird for bone conformation score using a 3-point scale. After the dietary 
supplementation period, 1 bird/experimental unit (EU; 4 broilers = EU) was imaged with 
dual-energy x-ray absorptiometry (DEXA) for BMC, BMD, lean mass, and fat mass 
accretion, and a second bird/EU for breast yield. Performance and DEXA data were analyzed 
using PROC MIXED in SAS; lameness and bone conformation were analyzed using PROC 
GLIMMIX with Poisson distribution. Significant means were separated using Tukey’s Test 
(P ≤ 0.05). Feeding fish oil decreased BMD by 0.015 ± 0.0041 g/cm2 compared to broilers 
fed flaxseed oil diets (P ≤ 0.05), the control was intermediate. Broilers fed fish oil resulted in 
lower BW by 0.234 and 0.264 ± 0.0318 kg compared to feeding control and flaxseed oil 
diets, respectively (P ≤ 0.01). Feeding the fish oil diet to broilers decreased breast yield by 
1.301 ± 0.3553% compared to the control (P ≤ 0.05). Feeding fish oil reduced performance 
even though feed intake was not different among treatments (P = 0.43). The combined results 
from bone analysis and performance suggest that the fish oil may not have been as stable as 
flaxseed oil, affecting fatty acid utilization. In order to avoid performance losses when 
generating value-added meat, flaxseed oil may be a more consistent ingredient for producers 
to use when supplementing broiler diets. However, the results from this experiment did not 
demonstrate a secondary benefit of improving broiler bone health or performance when 
supplemented with flaxseed oil or fish oil.   
Key words: ALA, EPA, DHA, performance, DEXA 
 
4.2 Introduction 
Poultry diets supplemented with omega-3 fatty acids can create value-added foods, 
such as omega-3 fatty acid enriched broiler meat, for consumers of the health and functional 
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food markets (Ribeiro et al., 2013; Zhong et al., 2014). Genetic selection for efficient 
performance has created broilers with high metabolic demands that rapidly grow muscle and 
bone (Julian, 1998; Cook, 2000; Julian, 2005). Rapid growth rates and production stress in 
commercial flocks has lead to leg deformities and lameness becoming a common occurrence 
(Bradshaw et al., 2002; Saif et al., 2008; Grupioni et al., 2015). Omega-3 fatty acids, 
specifically bioactive eicosapentaenoic acid (EPA; C20:5) and docosahexaenoic acid (DHA: 
C22:6), are known for possessing anti-inflammatory properties and the ability to modulate 
bone remodeling activity in vitro (Sun et al., 2003; Herrera et al., 2008; Lukas et al., 2011). 
Alpha-linolenic acid (ALA; C18:3), the omega-3 fatty acid precursor of EPA and DHA, has 
been linked to reducing the occurrence of keel bone fractures in free-range laying hens by ≤ 
60% (Tarlton et al., 2013; Toscano et al., 2015). Dietary omega-3 fatty acid supplementation 
used to generate value-added meat for health conscious consumers may also be able to 
provide health and welfare benefits for growing broilers.  
Dietary ALA supplementation using flaxseed oil appears to influence bone mineral 
density in broilers (Zhong et al., 2014). A previous study fed a diet containing 3% flaxseed 
oil and 2% palm oil to broilers from 0 to 42 d of age reported increased tibial bone mineral 
density by 0.1 g/cm2, average daily weight gain by 6.1 g, and average daily feed intake by 7.4 
g compared to broilers fed a 5% lard diet (P < 0.05; Zhong et al., 2014). The observed 
increase in bone mineral density may have resulted from suppressed resorptive osteoclastic 
activity, which would allow osteoblasts to deposit mineral faster than it can be resorbed 
(Nakanishi and Tsukamoto, 2015; Kim et al., 2017). Previous experiments reported that EPA 
and DHA addition into bone marrow cell cultures resulted in apoptosis of mature osteoclasts 
and attenuated proliferation and differentiation of osteoclastic precursor cells, with DHA 
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having a stronger attenuating effect on osteoclasts than EPA (Rahman et al., 2008; Kim et al., 
2017). However, poultry can only metabolize ≤ 5% dietary ALA to EPA and DHA due to 
over saturation of endogenous elongases and desaturases (Burdge and Calder, 2006; Zivkovic 
et al., 2011). Therefore, dietary fish oil supplementation, providing EPA and DHA, fed to 
broilers may result in greater bone mineral density compared to broilers fed dietary ALA 
supplemented diets, when provided at equivalent total omega-3 fatty acid concentrations. 
Dietary ALA from flaxseed oil or EPA and DHA from fish oil have to be tested at 
levels that will induce a biological response when fed to broilers. Previous broiler 
experiments have ranged in maximum dietary oil inclusion from 4 to 10% for their high 
inclusion omega-3 fatty acid treatments (Ferrini et al., 2008; Navidshad et al., 2012). Other 
studies testing omega-3 fatty acid meal ingredients used a maximum of 15% ground flaxseed 
in supplemented broiler diets to evaluate growth performance (Jia et al., 2010; Ribeiro et al., 
2013). Because a slight difference in broiler bone mineral density was detected using 3% 
flaxseed oil supplementation (Zhong et al., 2014), a higher dietary inclusion was used in the 
current experiment in order to induce a therapeutic response in broiler bone activity. 
In order to investigate and compare the effects of dietary ALA from flaxseed oil or 
EPA and DHA from fish oil on broiler performance and bone health, equal concentrations of 
total omega-3 fatty acids at potentially therapeutic levels were supplemented in broiler diets 
for this experiment. The hypothesis was that dietary omega-3 fatty acid supplementation 
would improve bone characteristics without compromising performance compared to control, 
thereby improving animal health and welfare. Furthermore, it was hypothesized that dietary 
EPA and DHA supplementation would outperform dietary ALA supplementation.  
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4.3 Material and Methods 
4.3.1 Animals and Housing  
 The protocol for this study was approved by the Iowa State University Institutional 
Animal Care and Use Committee. Broilers were cared for in accordance with the FASS 
Guide for the Care and Use of Agricultural Animals in Research and Teaching (2010). Two 
hundred and forty male Ross 308 hatching-day broiler chicks were obtained from a 
commercial hatchery (Bancroft, IA) and transported to the Poultry Research and Teaching 
Unit at Iowa State University. The poultry house was enclosed with cross ventilation and 
divided in half, resulting in 2 rooms containing 30 pens in each half of the house. Chicks 
were housed in floor pens (121.9 cm length × 121.9 cm width; 3,600 cm2/bird at placement) 
with a supplemental 125-watt clear incandescent heat bulb in each pen. Each pen contained 
10 cm of pine shavings placed on the concrete floor. Rooms were heated to 29°C at time of 
placement using a vented gas-fired heater (Modine High Efficiency, PDP300AE010SBAN, 
Modine Manufacturing Co., Racine, WI) and room temperature was reduced by 2.5°C every 
7 d until 21°C was attained (by experimental d 15). The light program was 23L:1D for the 
first 7 d of life (experimental d -6 to 1) and then adjusted to 20L:4D for the duration of the 
experiment. Light intensity was 30 to 40 lux at bird level, as recommended by the Ross 
Broiler Management Manual (2009). Feed was provided ad libitum in one circular hanging 
feeder (30.5 cm diameter × 29.2 cm height) per pen (Model HF30, Brower Equipment, 
Houghton, IA). The feeders were placed at bedding level at the start of the experiment, and 
then were raised as the birds grew (7 cm at 10 d of age, 10 cm at 17 d of age, 13 cm at 21 d 
of age, and 15 cm from 28 to 34 d of age). Water was provided via Ziggity 360° nipple 
waterlines with 5 nipples per pen (Ziggity System Inc., Middlebury, IN) set to 7 cm of 
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column pressure and suspended 12 cm above bedding level from 0 to 14 d of age. Column 
pressure was increased to 10 cm from 14 to 28 d of age and then increased to 15 cm column 
pressure for the remainder of the experiment. Waterlines were raised to 22 cm above bedding 
level 14 to 21 d of age, 25 cm from 21 to 28 d of age, and 29 cm for the remainder of the 
experiment.  
 
4.3.2 Treatments 
 Broilers were given a 5 d environmental acclimation period (0 to 5 d of age) prior to 
starting the experiment. At 6 d of age (baseline; experimental d 0) each bird was wing 
banded (Tab End Wing Band, Style 898, National Band & Tag Co., Newport, KY into the 
chicks’ right wing web), weighed on a digital gram scale (Defender 3000, Ohaus Corp., 
Parsippany, NJ), sorted by 5 g increments, distributed equally by body weight (BW) to pens, 
and randomly assigned an experimental diet. All birds were physically examined for clinical 
signs of illness, stress, and were categorized as normal with a bone conformation palpation 
score of 0 before being enrolled into the experiment (Table 4.1). Broilers were fed diets for 
28 consecutive d, from 6 to 34 d of age, which served as the dietary supplementation period 
allowing for omega-3 fatty acid incorporation into the broiler tissues. 
The experiment was a randomized complete block design where pen was the 
experimental unit (EU) consisting of 4 broilers/pen with 20 EU/diet. Each half of the poultry 
house was a block with equal assignment of experimental diets. In order to evaluate broiler 
performance and bone remodeling responses to omega-3 fatty acid supplementation, 4.1% 
dietary ALA or EPA and DHA was supplemented into the treatment diets, which was a 50% 
increase in omega-3 fatty acid concentration from previous work (Lopes et al., 2013; Tarlton 
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et al., 2013; Zhong et al., 2014). Palm oil was used as the control fat source because it was 
composed of 50% saturated fatty acids, 42% monounsaturated fatty acids, and ≤ 8% 
polyunsaturated fatty acids with little to no omega-3 or omega-6 fatty acids. Addition of 
palm oil to experimental diets had little impact on omega-6:omega-3 fatty acid ratios, due to 
its fatty acid profile. Three experimental diets were compared using a corn-soybean meal-
wheat middlings basal diet (Table 4.2) formulated to meet or exceed NRC (1994) 
requirements: 1) palm oil control (no supplemental omega-3 fatty acids; BW 0.157 kg ± 
0.0010), 2) flaxseed oil (4.1% ALA; BW 0.157 ± 0.0010), and 3) fish oil (2.5% EPA and 
1.6% DHA; BW 0.158 ± 0.0010) diet. A starter diet was formulated for 0 to 21 d of the 
experiment and a grower formulation was used from 22 to 28 d. All feeders were manually 
agitated daily to keep feed flow uniform across experimental pens. 
 
4.3.3 Fatty Acid Analysis 
Feed samples from each experimental diet were collected for every batch generated 
and stored at -20°C. Samples were ground through a 0.5 mm screen (Thomas-Wiley 
Laboratory Mill Model 4, Arthur H. Thomas Company, Philadelphia, PA) and were analyzed 
for fatty acid profiles using gas chromatography (HP 6890, Hewlett Packard Co., Palo Alto, 
CA). The fatty acid analysis was performed using methods previously described by Nam et 
al. (2001) and Sun et al. (2013). 
 
4.3.4 Bone Health  
 Visually assessed lameness, bone conformation, mineral content, and mineral 
density were measured to determine the bone health of broilers fed experimental diets. All 
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broilers were visually assigned a lameness score in their home pens every 7 d. A single 
handler selected 1 bird to move using a plastic paddle (50 cm length handle; 13 cm length × 
10 cm width paddle surface) that was positioned behind the bird. After the bird had attempted 
or completed a 1-m walk, a second researcher assigned a lameness score using a 3-point 
lameness scale (Table 4.1). This method was repeated until all birds in each pen had been 
assigned a lameness score. Broilers were evaluated for bone conformation at the start of the 
experiment (6 d of age) and then every 7 d. Keel (sternum), leg, and wing bones were gently 
palpated and a bone conformation score was assigned on a 3-point scale (Table 4.1). 
At the beginning of the experiment (6 d of age), 8 broilers were euthanized by CO2 
asphyxiation following guidelines from the AVMA Panel on Euthanasia (2013) for 
subsequent imaging using dual-energy x-ray absorptiometry (DEXA; Discovery A, Hologic 
Inc., Marlborough, MA) following methods previously described by Mitchell et al. (1997). 
Baseline imaging provided starting bone mineral content (BMC; g) and bone mineral density 
(BMD; g/cm2). BMC was measured to evaluate total mineral content within bone and BMD 
was measured to evaluate the distribution of mineral in an aerial plane. At the end of the 
experiment, 1 broiler/EU (240 = 80 broilers/diet) was euthanized and imaged to obtain BMC 
and BMD values after the 28 d dietary supplementation period.  
 
4.3.5 Production Performance 
All broilers were observed twice daily in accordance with university policy. Broilers 
were weighed individually on a digital gram scale at the start of the experiment (6 d of age) 
and then every 7 d for 28 consecutive d of dietary supplementation. Feed disappearance was 
measured every 7 d for feed intake (FI), feed conversion ratio (FCR), and average daily gain 
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(ADG) was calculated as follows: FI = start feed weight kg – end feed weight kg; FCR = FI ÷ 
(end BW kg – start BW kg); and ADG = (end BW kg – start BW kg) ÷ d.  
Baseline DEXA imaging provided starting total body mass (kg), fat mass (kg), and 
lean tissue + BMC (kg). After the 28 d dietary supplementation period, 1 bird/EU (240 birds 
= 80/diet) was euthanized and imaged to obtain the 28 d performance values. The breast 
muscle (Pectoralis major and minor) were excised and weighed to obtain breast yield 
calculated as follows: Breast yield (%) = breast muscle weight ÷ total BW × 100. 
   
4.3.6 Statistical Analysis 
Data were analyzed using the UNIVARIATE procedure in SAS 9.4 (SAS Institute 
Inc., Cary, NC) to test for normality by plotting the predicted residuals and the quantile-
quantile values. The experiment was a randomized complete block design consisting of 3 
experimental diets (palm oil control, flaxseed oil, and fish oil) and 20 EU replicates for each 
diet (n = 240 broilers). Each half of the poultry house was a block with experimental diets 
equally assigned to each block. Performance measurements (BW, ADG, FI, FCR, and breast 
yield) and DEXA data (fat accretion, lean accretion, BMC, and BMD) were analyzed 
separately using the MIXED procedure in SAS. The statistical model included experimental 
diet (palm oil control, flaxseed oil, and fish oil) as fixed effects. The random effect of pen 
nested within experimental diet was used in the model. 
Lameness and bone conformation data were non-normally distributed and therefore 
were analyzed using the GLIMMIX procedure in SAS with Poisson distribution. The 
statistical model included experimental diet (control, flaxseed oil, and fish oil), time (7 d 
intervals for 28 consecutive d), and the interaction of diet*time as fixed effects. Three 
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random effects, pen nested within diet, pen nested within time and bird nested within pen and 
diet were included in the model. The I-Link option was used to transform the data back to its 
original scale and the PDIFF option was used to obtain the LS-means. Tukey’s Honestly 
Significant Difference (HSD) Test was used to separate means and identify significant 
differences. In all cases, a P-value ≤ 0.05 was considered to be significant. 
 
4.4 Results 
4.4.1 Fatty Acid Analysis 
 The control diet, containing 14% palm oil, contained double the concentration of 
palmitic acid compared to the flaxseed oil and fish oil diets. The flaxseed oil diet contained 
12 times the ALA concentration compared to the palm oil control and fish oil diets. The fish 
oil diet contained 19.55% EPA and 10.87% DHA. Neither of the longer chain omega-3 fatty 
acids EPA or DHA were detected in the palm oil control diet. The use of palm oil allowed 
the omega-6:omega-3 fatty acid ratios to be maintained at 9.46, 0.64, and 0.39 in the palm oil 
control, flaxseed oil, and fish oil diets, respectively (Table 4.3). 
 
4.4.2 Bone Health 
Bone health was investigated by visually and physically assessing each broiler using 
3-point scales (Table 4.1), where a score of 0 was considered normal and a score of 3 
considered severe (non-ambulatory or broken bone). There was no significant interaction of 
diet*time or changes over time observed for lameness score or bone conformation in broilers 
fed experimental diets (P ≥ 0.96). Feeding the palm oil control, flaxseed oil, or fish oil 
supplemented diets to broilers from 6 to 34 d of age did not result in observable differences 
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in lameness score (P = 0.83) or bone conformation score and broilers remained normal (P = 
1.00; Table 4.4). Feeding the experimental diets to broilers did not result in differences when 
DEXA scanned for BMC, which averaged 28.57 ± 0.810 g across the 3 diets (P = 0.21). 
However, feeding the flaxseed oil diet to broilers resulted in increased BMD by 0.015 ± 
0.0041 g/cm2 compared to broilers fed the fish oil diet (P =0.04; Table 4.4).  
 
4.4.3 Production Performance  
 Starting BW was not different (P = 0.42) with broiler chicks weighing an average of 
0.157 ± 0.0010 kg. After the 28 d dietary supplementation period, the 34 d old broilers fed 
the palm oil control and flaxseed oil diets increased in BW gain by 0.234 and 0.264 ± 0.0318 
kg, respectively, compared to broilers fed the fish oil diet (P ≤ 0.01). No differences were 
observed in feed intake among broilers fed the experimental diets from 6 to 34 d of age with 
an average consumption of 4.250 ± 0.0413 kg/bird (P = 0.43). Over the 28 d experiment, 
feeding the palm oil control and flaxseed oil diets to broilers resulted in a 10% improvement 
in FCR compared to the fish oil-fed broilers (P ≤ 0.01). Fat accretion was not different 
among broilers fed experimental diets, averaging 0.140 ± 0.0160 kg/bird (P = 0.87). Feeding 
the flaxseed oil diet to broilers resulted in a trending increase in lean tissue accretion, where 
0.183 ± 0.0563 kg more lean tissue was gained compared to broilers fed the fish oil diet (P = 
0.07). Feeding the fish oil diet to broilers resulted in decreased breast yield by 1.301 ± 
0.3553% compared to broilers fed the palm oil control diet (P = 0.05; Table 4.5). 
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4.5 Discussion 
The hypothesis that broilers fed the fish oil diet, supplying EPA and DHA, would 
outperform broilers supplemented with ALA was not supported by the current data. Feeding 
the fish oil diet to broilers resulted in lower BMD than feeding the flaxseed oil diets that 
provided ALA. Previous experiments have demonstrated that EPA and DHA addition to 
bone marrow cell cultures in vitro inhibited osteoclastic bone mineral resorption and allowed 
for increased osteoblastic bone mineral deposition (Watkins et al., 2000; Watkins et al., 
2003; Lukas et al., 2011). However, in the current experiment dietary flaxseed oil or fish oil 
supplemented diets fed to broilers from 6 to 34 d of age did not improve bone characteristics 
measured in vivo. A positive correlation between BW to BMD has been reported, with lean 
mass more associated with BMD than fat mass (Ho-Pham et al., 2014). The broilers in the 
current experiment fed the palm oil control and flaxseed oil diets were heavier in BW 
compared to broilers fed the fish oil diet, which may have contributed to the differences 
reported in BMD. 
In vitro and murine studies have demonstrated that EPA and DHA are bioactive 
omega-3 fatty acids that attenuate activity, differentiation, and proliferation of osteoclastic 
precursor cells (Rahman et al., 2008; Lukas et al., 2011; Kim et al., 2017). However, Zhong 
et al. (2014) reported that broiler tibia weight, length, and BMD were not influenced by 
flaxseed oil supplementation alone, but in combination with palm oil as a saturated fat 
stabilizing the polyunsaturated fatty acids. The 3 diets in the current experiment contained 
some level of palm oil in their composition to maintain an equal fat concentration of 14% 
across all 3 diets. The palm oil control diet contained 14% palm oil, the flaxseed oil diet 
(4.1% ALA) contained 6.53% palm oil and 7.48% flaxseed oil, and the fish oil diet (4.1% 
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EPA and DHA) contained 0.33% palm oil and 13.68% fish oil. The increased BMD observed 
in broilers fed the flaxseed oil diet may be attributed to alteration of lipid stability with the 
addition of saturated fats supplied by 6.53% palm oil compared to the fish oil diet, which 
only contained 0.33% palm oil. A study by Kang et al. (2001) reported that 3.5% dietary 
palm oil supplementation mixed with ground flaxseed, fish meal, and fish oil fed to laying 
hens resulted in reduced thiobarbituric acid reactive substances in egg, muscle, and liver by ≥ 
10% compared to hens fed a 0% palm oil diet (P < 0.05). These findings suggest that dietary 
saturated fat content and oxidative stability are critical factors along with the omega-
6:omega-3 fatty acid ratio in attenuating osteoclastic bone resorption in vivo. 
 In the current experiment, significant differences were observed in performance. 
Feeding the fish oil diet to broilers resulted in reduced BW gain, breast muscle yield, and 
increased FCR even though FI was not different among broilers fed the 3 experimental diets. 
Part of these performance differences may be attributed to nutrient partitioning influenced by 
fatty acid type and deposition into tissue, where it has been reported that muscle 
preferentially metabolizes polyunsaturated fatty acids (Newman et al., 2002a, 2002b; Ferrini 
et al., 2008). A study that fed 8% fish oil, 8% sunflower oil, or 8% tallow diets to broilers 
from 21 to 56 d of age reported that feeding 8% fish oil or 8% sunflower oil diets, high in 
polyunsaturated fatty acids, to broilers resulted in a 50% reduction of abdominal fat pad 
weight compared to broilers fed the 8% tallow diet (P < 0.01; Newman et al., 2002b). Breast 
muscle yield and total fat content within the breast muscle tissue was not different among the 
treatments of that experiment (Newman et al., 2002b). The performance data from the current 
experiment agreed with Newman et al. (2002b) that total fat accretion was not altered by 
dietary supplementation. However, decreased lean tissue accretion and breast muscle yield in 
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broilers fed the fish oil diet in the current experiment suggest that 13.68% fish oil 
supplementation alters metabolic muscle activity in growing broilers. In the event that 
nutrient partitioning was occurring, there appears to be an upper limit for dietary inclusion of 
polyunsaturated fatty acids in broiler diets and once that limit is reached growth performance 
may become impaired.  
 A similar decrease in broiler performance was reported by Ferrini et al. (2008) who 
fed 10% tallow, 10% flaxseed oil, 10% sunflower oil, or 10% mixed fat (55% tallow, 35% 
flaxseed oil, and 10% sunflower oil resulting in equal parts saturated, mono- and 
polyunsaturated fatty acids) diets to broilers from 8 to 42 d of age. No differences were 
observed in feed intake among broilers fed the treatment diets, which was in agreement with 
the results from the current experiment (Ferrini et al., 2008). However, feeding a 10% mixed 
fat diet to broilers resulted in 7% increased final BW, 50% increased abdominal fat pad 
weight, and 10% increased skin weight compared to broilers fed the 10% flaxseed oil and 
10% sunflower oil diets (P < 0.05; Ferrini et al., 2008). In agreement with Ferrini et al. 
(2008), feeding the fish oil diet in the current experiment, highest in polyunsaturated fatty 
acids, to broilers resulted in reduced muscle accretion and reduced BW compared to the diets 
containing a mixture of saturated and unsaturated fatty acid sources. These findings support 
that the dietary balance of saturated and unsaturated fatty acids is more important for overall 
broiler performance than prophylactic EPA and DHA supplementation.  
Although it is common to encounter lameness and bone deformities in commercial 
broiler flocks (Sørensen et al., 2000; Bizeray et al., 2002; Grupioni et al., 2015), the broilers 
in this experiment did not exhibit clinical signs of leg weakness, abnormal gait, 
dyschondroplasia, or rotation deformities. The experiment was designed to investigate if 
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dietary omega-3 fatty acid supplementation fed to broilers would prophylactically improve 
the bone characteristics of an “at risk” model prone to lameness and bone lesions. Lameness 
may be caused by increased competition for feeder space based on stocking density 
(Sørensen et al., 2000), use of abrasive straw bedding (Su et al., 2000), or opportunistic 
bacterial infections (Dumas et al., 2011) in commercial environments. Further investigation 
while actively inducing lameness or stress may elucidate if dietary omega-3 fatty acid 
supplementation may serve a therapeutic purpose for real world applications.  
Dietary flaxseed oil and fish oil supplementation in broilers still serve a useful role 
for creating value-added enriched meats; however, the results from the current experiment 
did not demonstrate improved broiler bone health with therapeutic levels of omega-3 fatty 
acid supplementation. Due to the potential for performance losses when using fish oil, further 
investigation is recommended to evaluate the stability of fish oil sources prior to commercial 
applications in broiler diets.  
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Table 4.2. Calculated and analyzed values for palm oil control, flaxseed oil, and fish oil 
experimental starter diets1 fed to Ross 308 broiler chickens for a 28 consecutive d dietary 
supplementation period to evaluate the effects of dietary alpha-linolenic (ALA) or 
eicosapentaenoic acid (EPA) and docosahexaenoic (DHA). 
 Experimental diet (%) 
Ingredients Palm oil control Flaxseed oil Fish oil 
Corn 26.60 26.61 26.61 
Soybean meal 48% crude protein 50.00 50.00 50.00 
Wheat middlings 5.00 5.00 5.00 
Palm oil 14.00 6.53 0.33 
Flaxseed oil 0.00 7.48 0.00 
Fish oil 0.00 0.00 13.68 
Dicalcium phosphate 1.76 1.76 1.76 
Calcium carbonate2 1.06 1.07 1.07 
Sodium chloride 0.50 0.50 0.50 
Methionine hydroxy analogue 0.32 0.30 0.30 
Choline chloride 0.10 0.10 0.10 
L-threonine 0.03 0.03 0.03 
V and M premix3 0.63 0.63 0.63 
Calculated values  
Calcium 1.00 1.00 1.00 
Available phosphorus 0.45 0.45 0.45 
Analyzed values  
Crude fat 13.61 15.15 13.21 
1Experimental diets used a common basal diet combined with 14% palm oil, 7.48% flaxseed 
oil, or 13.68% fish oil. Calculated ME for each diet was 3,400 kcal/kg. Control and dietary 
treatments contained 80 broilers each with 20 replicate experimental units. 
2Calcium carbonate added was a 50/50 mixture of small (< 2 mm) and large (≥ 2 mm) 
particle. 
3Vitamin and mineral premix provided per kg of diet: selenium 250 µg; vitamin A 8,250 IU; 
vitamin D3 2,750 IU; vitamin E 17.9 IU; menadione 1.1 mg; vitamin B12 12 µg; biotin 41 µg; 
choline 447 mg; folic acid 1.4 mg; niacin 41.3 mg; pantothenic acid 11 mg; pyridoxine 1.1 
mg; riboflavin 5.5 mg; thiamine 1.4 mg; iron 282 mg; magnesium 125 mg; manganese 275 
mg; zinc 275 mg; copper 27.5 mg; iodine 844 µg. 
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Table 4.3. Dietary fatty acid analysis for palm oil control, flaxseed oil, and fish oil 
experimental starter diets1 fed to Ross 308 broiler chickens for a 28 consecutive d dietary 
supplementation period used to evaluate the effects of dietary alpha-linolenic (ALA) or 
eicosapentaenoic acid (EPA) and docosahexaenoic (DHA). 
 Experimental diet (%) 
Fatty acid (C:double bond) Palm oil control Flaxseed oil Fish oil 
Myristic acid (14:0) 1.04 0.67 7.99 
Palmitic acid (16:0) 39.34 21.46 19.96 
Palmitoleic acid (16:1) 0.00 0.33 8.63 
Margaric acid (17:0) 0.00 0.00 0.42 
Stearic acid (18:0) 3.82 3.48 3.56 
Oleic acid (18:1) 35.49 25.49 11.61 
Linoleic acid (18:2) 18.06 18.81 11.74 
Alpha-linolenic acid (18:3) 1.91 28.39 2.32 
Arachidic acid (20:0) 0.33 0.22 0.24 
Arachidonic acid (20:4) 0.00 0.00 1.07 
Eicosapentaenoic acid (20:5) 0.00 1.16 19.55 
Behenic acid (22:0) 0.00 0.00 0.00 
Docosapentaenoic acid (22:5) 0.00 0.00 2.04 
Docosahexaenoic acid (22:6) 0.00 0.00 10.87 
Crude fat2 13.61 15.15 13.21 
Saturated fat 44.53 25.83 32.17 
Unsaturated fat 55.47 74.17 67.83 
Total omega-3 fatty acid3 1.91 29.55 32.73 
Total omega-6 fatty acid4 18.06 18.81 12.82 
Omega-6:omega-3 ratio 9.46 0.64 0.39 
1Experimental diets used a common basal diet combined with 14% palm oil, 7.48% flaxseed 
oil, or 13.68% fish oil. Control and dietary treatments contained 80 broilers each with 20 
replicate experimental units. 
2Crude fat was the analyzed fat content of pool feed samples. The fatty acid values represent 
the percent composition of the crude fat for each diet. 
3Total omega-3 fatty acid was the sum of alpha-linolenic acid, eicosapentaenoic acid, and 
docosahexaenoic acid.  
4Total omega-6 fatty acid was the sum of linoleic acid and arachidonic acid. 
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Table 4.4. Bone health measurements of Ross 308 male broiler chickens fed palm oil 
control, flaxseed oil, or fish oil experimental diets1 for a 28 consecutive d dietary 
supplementation period to evaluate the effects of dietary alpha-linolenic (ALA) or 
eicosapentaenoic acid (EPA) and docosahexaenoic (DHA).2 
 Experimental diet
3, 4  SEM P-value 
 Palm oil control Flaxseed oil Fish oil Diet Diet Time Diet*Time 
Lameness score   0.05   0.04   0.03 0.039 0.83 0.98 1.00 
Conformation score   0.04   0.01   0.02 0.034 1.00 0.96 1.00 
BMC (g) 27.53 29.56 28.60 0.810 0.21 - - 
BMD (g/cm2)   0.157ab   0.164a   0.149b 0.0041 0.04 - - 
1Experimental diets were applied for a 28 consecutive d dietary supplementation period (6 to 
34 d of age). Broiler birds were fed a palm oil control diet (basal diet + no supplemental 
omega-3 fatty acid source), flaxseed oil (basal + 4.1% ALA), or fish oil (4.1% EPA and 
DHA blend). Control and dietary treatments contained 80 broilers each with 20 replicate 
experimental units. 
2A 5 d environmental acclimation period was given to broiler chickens (n = 240). 
3One bird per experimental unit (EU) was measured for bone mineral content (BMC) and 
bone mineral density (BMD) after the 28 consecutive d dietary supplementation period using 
dual-energy x-ray absorptiometry.  
4Individual birds per EU were scored every 7 d for lameness in gait (scale; 0 = normal to 3 = 
severe, non-ambulatory) and palpated for bone conformation (scale of 0 = normal to 3 = 
severe curvature or broken).  
a-bLeast square means without a common superscript differ significantly within a row (P ≤ 
0.05). 
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Table 4.5. Performance of Ross 308 male broiler chickens fed palm oil control, flaxseed oil, 
or fish oil experimental diets1 for a 28 consecutive d dietary supplementation period to 
evaluate the effects of dietary alpha-linolenic (ALA) or eicosapentaenoic acid (EPA) and 
docosahexaenoic (DHA).2 
 Experimental diet
3 
  
 Palm oil control Flaxseed oil Fish oil SEM P-value 
BW (kg; 34 d of age)4 2.480a 2.510a 2.246b 0.0318 ≤ 0.01 
ADG (kg) 0.083a 0.084a 0.075b 0.0011 ≤ 0.01 
FI (kg/bird) 4.292 4.217 4.240 0.0413 0.43 
FCR 1.857b 1.791b 2.023a 0.0358 ≤ 0.01 
Fat accretion (kg) 0.139 0.146 0.135 0.0160 0.87 
Lean accretion (kg) 2.245 2.307 2.124 0.0563 0.07 
Breast yield (%) 13.894a 13.522ab 12.593b 0.3553 0.05 
1Experimental diets were applied for a 28 consecutive d dietary supplementation period (6 to 
34 d of age). Broiler birds were fed a palm oil control diet (basal diet + no supplemental 
omega-3 fatty acid source), flaxseed oil (basal + 4.1% ALA), or fish oil (4.1% EPA and 
DHA blend). Control and dietary treatments contained 80 broilers each with 20 replicate 
experimental units. 
2A 5 d environmental acclimation period was given to broiler chickens (n = 240). 
3Values represent measurements after 28 consecutive d dietary supplementation period. Body 
weight (BW) and feed disappearance were measured every 7 d for feed intake (FI), feed 
conversion ratio (FCR), and average daily gain (ADG) calculations. Fat mass and lean 
accretion were obtained using dual-energy x-ray absorptiometry imaging. 
4Starting BW at 6 d of age was not different among the broilers fed experimental diets (P = 
0.42). 
a-bLeast square means without a common superscript differ significantly within a row (P ≤ 
0.05). 
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CHAPTER 5. DIETARY FISH OIL REDUCED INFLAMMATORY CYTOKINE 
GENE EXPRESSION AND INCREASED BONE MINERAL RETENTION IN 
BROILERS SUBJECTED TO A REPEATED INFLAMMATORY CHALLENGE 
 
A manuscript to be submitted to Poultry Science 
 
I. J. Ehr1,2, A. K. Johnson2, S. Azarpajouh2, B. J. Kerr3, N. K. Gabler2, and E. A. Bobeck2,4 
 
5.1 Abstract 
Growing broilers are susceptible to pathogenic infection due to their naïve immune 
systems. Broilers are efficient production animals genetically selected for prolific growth 
rates, which has resulted in a model at risk for stress and leg bone pathology. The omega-3 
fatty acids: alpha-linolenic (ALA), eicosapentaenoic (EPA), and docosahexaenoic (DHA) 
acids possess anti-inflammatory properties and modulate bone mineral deposition in vitro. 
Dietary omega-3 fatty acid supplementation in broiler diets may be able to mitigate 
performance losses due to inflammation or bone health issues. Experimental palm oil control, 
flaxseed oil (4.1% ALA), and fish oil (2.6% EPA and 1.5% DHA) diets were fed for a 28 d 
dietary supplementation period (6 to 34 d old; n = 120). To evaluate the protective anti-
inflammatory and bone modulating effects of dietary flaxseed and fish oils on performance 
and health under stress, a repeated inflammatory challenge was induced by administering 																																																								
1Primary researcher and author. 
2Graduate student, Associate Professor, Postdoc, Associate Professor, and Assistant 
Professor, respectively, Department of Animal Science, Iowa State University. 
3Collaborator Associate Professor, USDA-ARS-National Laboratory for Agriculture and the 
Environment. 
4Corresponding author.	
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lipopolysaccharide injections (LPS) every 48 h at 35, 37, 39, and 41 d of age. Broilers 
received intraperitoneal injections of LPS solution in increasing dosage (1.0 to 1.7 mg/kg) or 
equal volume sterile saline assigned randomly by pen (2 broilers/pen = experimental unit). 
Performance was evaluated during the repeated inflammatory challenge with liver, muscle, 
and whole carcass dual-energy x-ray absorptiometry images collected at d 7 of the LPS 
challenge for body composition and mRNA gene expression. Data were analyzed using 
PROC MIXED in SAS with significant means separated using Tukey’s Test (P ≤ 0.05). 
Repeated LPS injection in broilers reduced BW by 0.133 ± 0.0183 kg and FI by 0.102 ± 
0.0198 kg compared to saline (P ≤ 0.01). Feeding broilers fish oil increased total lean tissue 
body composition by 4.3 and 7.2 ± 0.97% compared to control and flaxseed oil (P ≤ 0.01). 
Feeding fish oil to broilers reduced liver IL-1β, IL-6, IL-18 and IFNγ expression by ≥ 0.21-
fold compared to the control (P ≤ 0.05). Feeding broilers flaxseed oil or fish oil increased 
total bone mineral content and accretion by ≥ 0.2 ± 0.03 g and ≥ 3.625 ± 0.9263%, 
respectively, compared to control (P ≤ 0.01). Although ALA or EPA and DHA provided 
anti-inflammatory effects and bone health improvements to broilers, it did not mitigate 
performance losses during the repeated inflammatory challenge. Therefore, flaxseed oil and 
fish oil supplementation in broiler diets is recommended for enriching broiler muscle tissue 
and providing secondary health benefits to the bird during periods of inflammation. 
Key words: ALA, EPA, DHA, lipopolysaccharide, DEXA 
 
5.2 Introduction 
 Growing broilers have a naïve immune system and are susceptible to environmental 
stress and infection by opportunistic bacteria and pathogens (Saif et al., 2008; Langkabel et 
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al., 2015). Furthermore, broiler varieties used for meat production have been genetically 
selected for rapid muscle growth, which has resulted in increased reports of lameness 
observed in commercial flocks (Knowles et al., 2008; Grupioni et al., 2015). Previous in vitro 
studies demonstrated that omega-3 fatty acids, specifically eicosapentaenoic acid (EPA; 
C20:5) and docosahexaenoic acid (DHA; C22:6) found in fish oil, exhibited anti-
inflammatory properties and increased bone mineral retention (Sun et al., 2003; Tur et al., 
2012; Kim et al., 2017). Alpha-linolenic acid (ALA; C18:3), the omega-3 fatty acid precursor 
to EPA and DHA, found in flaxseed oil has been linked to reducing keel bone breakage in 
free-range laying hens (Tarlton et al., 2013; Toscano et al., 2015). Omega-3 fatty acid 
supplementation in broiler diets may potentially provide commercial broilers anti-
inflammatory protection and improved bone health during periods of production stress. 
Omega-3 fatty acid supplementation in broiler diets may be able to mitigate the 
intense inflammatory reaction and subsequent performance losses that result from infection 
or due to environmental stress (de Pablo and de Cienfuegos, 2000; Serhan, 2014; Shoda et 
al., 2015). Omega-3 fatty acids, specifically EPA and DHA, perform multiple anti-
inflammatory functions at a cellular level, such as displacing pro-inflammatory omega-6 fatty 
acids from cell membranes (Newman et al., 2002a), acting as intracellular second messengers 
(de Pablo and de Cienfuegos, 2000), and acting as a substrate for generating pro-resolving 
lipid metabolites (Serhan, 2014). When incorporated into cell membranes, EPA and DHA 
decrease cell membrane fluidity, lipid raft formation and size, which results in reduced 
inflammatory cell receptor activation and cytokine signaling (Rockett et al., 2011; Hou et al., 
2015; Shoda et al., 2015). Dietary omega-3 fatty acid supplementation in broiler diets may be 
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able to provide some form of relief to commercial broilers under production stress or disease 
challenge through multimodal anti-inflammatory action. 
Chapter 4 of this dissertation demonstrated that prophylactic supplementation of 4.1% 
dietary ALA or EPA and DHA did not improve broiler bone characteristics when fed from 6 
to 34 d of age. However, other work reported that feeding broilers a 3% flaxseed oil and 2 % 
palm oil diet from 0 to 42 d of age increased tibial bone mineral density by 0.1 g/cm2 
compared to broilers fed a 5% lard diet (P < 0.05; Zhong et al., 2014). The slight increase in 
broiler bone mineral density was detected using 3% flaxseed oil supplementation (Zhong et 
al., 2014), therefore a higher dietary concentration was used in the current experiment in 
order to generate a therapeutic response in broiler bone activity. It appeared that osteoclastic 
bone resorption was inhibited by ALA supplementation in the study by Zhong et al. (2014), 
allowing for increased osteoblastic bone mineral deposition (Nakanishi and Tsukamoto, 
2015; Kim et al., 2017). The in vitro effects of EPA and DHA include inducing mature 
osteoclasts to undergo apoptosis and attenuating osteoclastic precursor cells from 
proliferation and differentiation, DHA attenuating osteoclasts more than EPA (Rahman et al., 
2008; Kim et al., 2017). However, poultry are only able to metabolize ≤ 5% dietary ALA to 
EPA and DHA because endogenous elongases and desaturases become overwhelmed 
(Burdge and Calder, 2006; Zivkovic et al., 2011). Even though prophylactic use of dietary 
omega-3 fatty acid supplementation did not definitively improve bone mineral density in a 
research setting, it may be providing protective effects only detectable during times of 
physical or biological stress.  
In order to study the protective effects of dietary omega-3 fatty acids on broiler health 
during a stressful period, a controlled inflammatory challenge was induced. Previous 
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research has established that lipopolysaccharide (LPS) administration can generate a 
controlled acute phase inflammatory response in broilers and laying hens through the Toll-
like receptor 4 (TLR4) pathway (Korver et al., 1998; Leshchinsky and Klasing, 2001; 
Munyaka et al., 2013). Inflammation generates clinical signs such as fever, swelling, and 
redness that are modulated by pro-inflammatory cytokines synthesized by stimulated immune 
cells (MacKay and Lester, 1992; Nakamura et al., 1998; Xie et al., 2000). Many LPS models 
are challenged using a short time frame with measurements taken from 1 to 72 h after a 
single LPS dose (Xie et al., 2000; Cheng et al., 2004; Kaiser et al., 2012). In the few broiler 
experiments where repeated LPS injections were administered, the repeated inflammatory 
challenges lasted for ≤ 7 d with a constant LPS dosage for each injection (Korver and 
Klasing, 1997; Korver et al., 1998; Jiang et al., 2010). Administering repeated LPS injections 
to broilers using the same dosage resulted in a reduced inflammatory response, which 
suggests immunotolerance with repeated exposure (De Boever et al., 2008). A novel 
approach used in the current experiment to prevent immunotolerance was increasing the LPS 
dosage with each successive LPS injection to ensure an inflammatory reaction occurred 
throughout a repeated LPS inflammatory challenge. Although different from pathogenic 
infection and commercial stress, a repeated LPS inflammatory challenge can be used on 
growing broilers to generate stress in order to help evaluate the protective health benefits of 
dietary omega-3 fatty acid supplementation. 
The objective of this experiment was to feed growing broilers a flaxseed oil (4.1% 
ALA source) or fish oil (4.1% EPA and DHA source) supplemented diet and induce a 
repeated LPS inflammatory challenge using 20% increasing LPS dosage (1.0 to 1.7 mg/kg) 
with each successive injection in order to investigate the protective effects on growth 
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performance, liver inflammatory gene expression, muscle metabolic gene expression, and 
bone mineral characteristics. The hypothesis of this experiment was that bioactive EPA and 
DHA supplementation from fish oil would mitigate broiler performance losses, improve bone 
health, and provide anti-inflammatory protection during a repeated inflammatory challenge 
better than ALA when fed at equivalent 4.1% concentrations. 
 
5.3 Materials and Methods 
5.3.1 Animals and Housing  
 The current experiment was a continuation of the previously described experiment in 
Chapter 4 of this dissertation. Therefore, the descriptions of the animals and housing, omega-
3 fatty acid supplementation period from 6 to 34 d of age, production performance, and fatty 
acid analysis in these materials and methods were identical or adapted from those described 
in Chapter 4. The protocol for this experiment was approved by the Iowa State University 
Institutional Animal Care and Use Committee. Broilers were cared for in accordance with the 
FASS Guide for the Care and Use of Agricultural Animals in Research and Teaching (2010). 
Two hundred and forty male Ross 308 hatching-day broiler chicks were obtained from a 
commercial hatchery (Bancroft, IA) and transported to the Poultry Research and Teaching 
Unit at Iowa State University. The poultry house was enclosed with cross ventilation and 
divided in half, resulting in 2 rooms containing 30 pens in each half of the house. Chicks 
were housed in floor pens (121.9 cm length × 121.9 cm width; 3,600 cm2/bird at placement) 
with a supplemental 125-watt clear incandescent heat bulb in each pen. Each pen contained 
10 cm of pine shavings placed on the concrete floor. Rooms were heated to 29°C at time of 
placement using a vented gas-fired heater (Modine High Efficiency, Modine Manufacturing 
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Co., Racine, WI) and room temperature was reduced by 2.5°C every 7 d until 21°C was 
attained (by experimental d 15). The light program was 23L:1D for the first 7 d of life 
(experimental d -6 to 1) and then adjusted to 20L:4D for the duration of the experiment. 
Light intensity was 30 to 40 lux at bird level, as recommended by the Ross Broiler 
Management Manual (2009). Feed was provided ad libitum in one circular hanging feeder 
(30.5 cm diameter × 29.2 cm height) per pen (Model HF30, Brower Equipment, Houghton, 
IA). The feeders were placed at bedding level at the start of the experiment, and then were 
raised as the birds grew (7 cm at 10 d of age, 10 cm at 17 d of age, 13 cm at 21 d of age, and 
15 cm from 28 to 43 d of age). Water was provided via Ziggity 360° nipple waterlines with 5 
nipples per pen (Ziggity System Inc., Middlebury, IN) set to 7 cm of column pressure and 
suspended 12 cm above bedding level from 0 to 14 d of age. Column pressure was increased 
to 10 cm from 14 to 28 d of age and then increased to 15 cm column pressure for the 
remainder of the experiment. Waterlines were raised to 22 cm above bedding level 14 to 21 d 
of age, 25 cm from 21 to 28 d of age, and 29 cm respectively for the remainder of the 
experiment.  
 
5.3.2 Omega-3 Fatty Acid Supplementation Period 
 Broilers were given a 5 d environmental acclimation period (0 to 5 d of age) prior to 
starting the experiment. At 6 d of age (baseline; experimental d 0) each bird was wing 
banded (Tab End Wing Band, Style 898, National Band & Tag Co., Newport, KY into the 
chick’s right wing web), weighed on a digital gram scale (Defender 3000, Ohaus Corp., 
Parsippany, NJ), sorted by 5 g increments, distributed equally by body weight (BW) to pens, 
and randomly assigned an experimental diet. Broilers were fed diets for 28 consecutive d, 
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from 6 to 34 d of age, which served as the dietary supplementation period allowing for 
omega-3 fatty acid incorporation into the broiler tissues. 
The experimental design was a randomized complete block design where pen was the 
experimental unit (EU) consisting of 4 broilers/pen with 20 EU/diet. Each half of the poultry 
house was a block with equal assignment of experimental diets. In order to evaluate broiler 
health responses to omega-3 fatty acid supplementation, 4.1% dietary ALA or EPA and DHA 
was supplemented into the treatment diets, which was a 50% increase in omega-3 fatty acid 
concentration from previous work (Lopes et al., 2013; Tarlton et al., 2013; Zhong et al., 
2014). Palm oil was used as the control fat source because it was composed of 50% saturated 
fatty acids, 42% monounsaturated fatty acids, and ≤ 8% polyunsaturated fatty acids with little 
to no omega-3 or omega-6 fatty acids. Addition of palm oil to experimental diets had little 
impact on omega-6:omega-3 fatty acid ratios, due to its fatty acid profile. Three experimental 
diets were compared using a corn-soybean meal-wheat middlings basal diet (Table 5.1) 
formulated to meet or exceed NRC (1994) requirements: 1) palm oil control (no 
supplemental omega-3 fatty acids; BW 0.157 ± 0.0010 kg), 2) flaxseed oil (4.1% ALA; BW 
0.157 ± 0.0010 kg), and 3) fish oil (2.5% EPA and 1.6% DHA; BW 0.158 ± 0.0010 kg) diet. 
A starter diet was formulated for 0 to 21 d of the experiment and a grower-finisher 
formulation was used from 22 to 36 d. All feeders were manually agitated daily to keep feed 
flow uniform across experimental pens. 
 
5.3.3 Post-supplementation Inflammatory Challenge 
 In order to evaluate the protective anti-inflammatory effects of dietary ALA or EPA 
and DHA supplementation fed to growing broilers, a repeated inflammatory challenge was 
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applied over a 7 d inflammatory challenge period (35 to 42 d of age). Following the 28 d 
dietary supplementation period, 10 pens/diet each containing 2 broilers were injected 
intraperitoneally with 1 mg/kg LPS (L2630, E. coli 0111:B4 LPS, Sigma-Aldrich Co. LLC., 
St. Louis, MO) resuspended in sterile saline. A further 10 pens/diet each containing 2 broilers 
were injected with the equivalent volume of sterile saline. Broilers were injected every 48 h 
(35, 37, 39, and 41 d of age) with each successive dosage being increased by 20% (from 1 to 
1.7 mg/kg). Twenty-four h post-final injection, birds were euthanized via CO2 asphyxiation 
following the AVMA Panel on Euthanasia (2013). Right liver lobe and left pectoralis major 
sections were harvested (2 cm3) and flash frozen in liquid nitrogen and stored at -80°C for 
further analysis. 
 
5.3.4 Production Performance 
All broilers were observed twice daily in accordance with university policy. Broilers 
were weighed individually on a digital gram scale at the start of the inflammatory change (35 
d of age) and then every 48 h for 7 consecutive d. Feed disappearance was measured over the 
7 d challenge for feed intake (FI), feed conversion ratio (FCR), and average daily gain 
(ADG) was calculated as follows: FI = start feed weight kg – end feed weight kg; FCR = FI ÷ 
(end BW kg – start BW kg); and ADG = (end BW kg – start BW kg) ÷ d. 
At the start of the inflammatory challenge (35 d of age), 1 broiler/EU was euthanized 
by CO2 asphyxiation for imaging using dual-energy x-ray absorptiometry (DEXA; Discovery 
A, Hologic Inc., Marlborough, MA) following methods previously described by Mitchell et 
al. (1997). Baseline DEXA imaging provided starting fat mass (kg), lean mass (kg), and total 
mass (kg). After the 7 d inflammatory challenge, 1 broiler/EU (120 = 40 broilers/diet) was 
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euthanized and imaged to obtain the end DEXA performance values. The difference between 
the end and baseline values equated to tissue accretion for the 7 d inflammatory challenge 
period (35 to 42 d of age).  
 
5.3.5 Fatty acid analysis 
Feed samples from each experimental diet were collected for every generated batch 
and stored at -20°C, and fatty acid analysis was performed using methods previously 
described by Nam et al. (2001) and Sun et al. (2013). Samples were ground through a 0.5 
mm screen (Thomas-Wiley Laboratory Mill Model 4, Arthur H. Thomas Company, 
Philadelphia, PA) and fatty acid profiles were analyzed using gas chromatography (HP 6890, 
Hewlett Packard Co., Palo Alto, CA). Fatty acid profiles from frozen muscle samples (3 EU) 
from each factorial arrangement of experimental diet by inflammatory challenge 
(diet*challenge) were analyzed post-inflammatory challenge period (35 to 42 d of age).  
 
5.3.6 Quantitative Real-Time PCR 
Flash frozen liver samples were stored at -80°C. RNA extraction and DNase cleanup 
followed manufacturer directions (RNeasy Mini Kit, Qiagen, Valencia, CA). RNA samples 
from 5 EU for each factorial arrangement (diet*challenge) were analyzed in triplicate by 
quantitative real-time PCR (qRT-PCR; DNA Engine Opticon 2 System, Bio-Rad Lab. Inc., 
Hercules, CA) using 1-step SYBR Green master mix (QuantiTect SYBR Green RT-PCR, 
Qiagen, Valencia, CA) adapted from methods described by Kaiser et al. (2006). Relative 
RNA expression levels were measured for interleukin-1 beta (IL-1β), IL-6, IL-18, interferon 
gamma (IFNγ), serum amyloid A (SAA), IL-10, and peroxisome proliferator-activated 
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receptor gamma (PPARγ) using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a 
reference gene. Forward and reverse primers were generated (Integrated DNA Technologies, 
Coralville, IA) from sequences listed in Table 5.2 with referenced source. Adjusted cycle 
threshold (Adj. Ct) value and normalized gene expression level (fold change) were calculated 
using the following adapted formulas (Eldaghayes et al., 2006; Kaiser et al., 2012): Adj. Ct = 
40 − [Mean Cttest gene + (MedianGAPDH – Mean CtGAPDH)] × (Slopetest gene ÷SlopeGAPDH); Fold 
change = 2( – (Cttest gene treatment – CtGAPDH treatment) – (Cttest gene control – CtGAPDH control)). 
Flash frozen muscle samples were stored at -80°C. RNA extraction followed 
manufacturer directions (Ambion TRIzol Reagent, Life Technologies, Carlsbad, CA). RNA 
samples from 5 EU for each factorial arrangement (diet*challenge) were analyzed in 
triplicate by qRT-PCR (MyiQ Optical Module with iCycler, Bio-Rad Lab. Inc., Hercules, 
CA) using 1-step SYBR Green master mix as previously described. Relative RNA expression 
levels were measured for IL-6, SAA, eukaryotic translation initiation factor 4E binding 
protein 1 (4EBP1), ribosomal protein S6 kinase 1 (RPS6K1), ubiquitin, calpain-2 (CAPN2), 
and proteasome 26S subunit ATPase 2 (PSMC2) using ribosomal 28S subunit (28S) as a 
reference gene (Table 5.2). Adjusted Ct and fold change were calculated as previously 
described using 28S.  
 
5.3.7 Bone Mineral Absorptiometry 
Baseline DEXA imaging as previously described in 5.3.4 Production Performance 
provided starting bone mineral content (BMC; g) and bone mineral density (BMD; g/cm2). 
BMC was measured to evaluate total mineral content within bone and BMD was measured to 
evaluate the distribution of mineral in an aerial plane. At the end of the 7 d inflammatory 
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challenge, 1 broiler/EU (120 = 40 broiler/diet) was euthanized and imaged to obtain end 
BMC and BMD values. The difference between the end and baseline values equated to BMC 
accretion and BMD change for the 7 d inflammatory challenge period (35 to 42 d of age). 
 
5.3.8 Statistical Analysis 
Data were analyzed using the UNIVARIATE procedure in SAS 9.4 (SAS Institute 
Inc., Cary, NC) to test for normality by plotting the predicted residuals and the quantile-
quantile values. The experiment was a randomized complete block design consisting of 3 
experimental diets (palm oil control, flaxseed oil, and fish oil) and 20 EU replicates for each 
diet (n = 120 broilers). Each half of the poultry house was a block with experimental diets 
equally assigned to each block. For the repeated inflammatory challenge, broilers from 10 
EU replicates for each diet were injected with LPS and the broilers from the remaining 10 
EU replicates for each diet were injected with equal volume of sterile saline. Performance 
(BW, FI, FCR, and ADG), fatty acid, qRT-PCR, and DEXA data (fat accretion, total fat, lean 
accretion, total lean, mass accretion, total mass, BMC, and BMD) were analyzed using the 
MIXED procedure in SAS. The statistical model included inflammatory challenge injection 
(saline vs. LPS) and experimental diet (palm oil control vs. flaxseed oil vs. fish oil) as fixed 
effects in a factorial arrangement (diet*challenge) with baseline 35 d of age starting BW and 
starting BMD as covariates. The random effect of pen nested within treatment was included 
in the model. The PDIFF option was used to identify significant differences. Tukey’s 
Honestly Significant Difference (HSD) Test was used to separate means. A P-value ≤ 0.05 
was considered to be significant. 
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5.4 Results 
5.4.1 Production Performance 
 No diet*challenge interactions occurred for performance measured during the 
repeated inflammatory challenge period from 35 to 42 d of age (P ≥ 0.26); therefore, the 
main effects of inflammatory challenge (LPS and saline injection) and diet (palm oil control, 
flaxseed oil, and fish oil diet) were reported. 
Lipopolysaccharide injection administered to broilers resulted in decreased end BW 
by 0.133 ± 0.0183 kg/bird compared to saline injection administered to broilers during the 7 
d inflammatory challenge (P ≤ 0.01). Lipopolysaccharide injection given to broilers, 
regardless of experimental diet during the 7 d challenge period, resulted in reduced FI by 
0.102 ± 0.0198 kg and ADG by 0.019 ± 0.0024 kg/d compared to broilers that were injected 
with saline (P ≤ 0.01). Broilers that were injected with LPS resulted in increased FCR by 
0.189 ± 0.0404 compared to broilers that were administered saline injections (P = 0.03; Table 
5.3).  
Feeding the fish oil diet to broilers, regardless of challenge, resulted in increased lean 
accretion by 0.229 ± 0.0498 kg compared to broilers fed the flaxseed oil diet (P = 0.04). 
Feeding the fish oil diet to broilers resulted in increased total lean tissue composition by > 
4% at 42 d of age compared to broilers fed either the palm oil control or flaxseed oil diets (P 
≤ 0.01; Table 5.4). The effect of diet did not affect the remaining performance parameters 
during the inflammatory challenge (P ≥ 0.11; Table 5.4), other than 35 d of age starting BW 
used a statistical covariate in the model (P ≤ 0.01; Table 5.3). 
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5.4.2 Fatty Acid Analysis 
 Flaxseed oil and fish oil complete diets both consisted of 4.48% total dietary omega-3 
fatty acids when calculated using analyzed ALA, EPA, DHA, and dietary crude fat values 
(Table 5.5). The control diet contained 2 times more palmitic acid and ≥ 1.4 times more oleic 
acid than the treatment diets, which corresponded with the increased dietary composition of 
palm oil (Table 5.1). The flaxseed oil diet contained 14 times more ALA content compared 
to palm oil control and fish oil diets, while the fish oil diet contained 19 times more EPA and 
10 times more DHA than the palm oil control and flaxseed oil diets. Neither the palm oil 
control nor flaxseed oil diets contained detectable amounts of DHA (Table 5.5).  
 Neither the inflammatory challenge nor the interaction of experimental diet by 
inflammatory challenge altered the fatty acid composition of broiler muscle tissue (P ≥ 0.11). 
Feeding the fish oil diet to broilers resulted in increased myristic, palmitoleic, margaric, 
EPA, and DHA content in muscle tissue compared to muscle tissue from broilers fed the 
palm oil control or flaxseed oil diets (P ≥ 0.01). Feeding the flaxseed oil diet to broilers 
resulted in the greatest concentration of ALA in muscle tissue compared to muscle tissue 
from broilers fed the palm oil control or fish oil diets (P ≥ 0.01). Muscular total fat content 
was not different among broilers fed experimental diets (P = 0.66; Table 5.6). 
 
5.4.3 Quantitative Real-Time PCR 
 An interaction was observed when investigating the inflammatory responses of 
broiler liver to the experimental diet and inflammatory challenge. It was found that feeding 
the flaxseed oil diet and administering LPS to broilers resulted in reduced liver IL-6 gene 
expression by 0.09-fold compared to broilers fed the palm oil control diet and injected with 
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saline (P = 0.02). A similar response was observed for broilers fed the fish oil diet and 
injected with saline, which resulted in reduced liver IL-6 gene expression by 0.04-fold 
compared to broilers fed the palm oil control diet and injected with saline (P = 0.02; Figure 
5.1A). Lipopolysaccharide administration resulted in increased relative mRNA gene 
expression of liver pro-inflammatory cytokines IL-1β by 4.90 and IL-18 by 1.65-fold 
compared to broilers injected with saline (P ≤ 0.01; Figure 5.1B). Feeding the fish oil diet to 
broilers resulted in reduced liver pro-inflammatory cytokines IL-1β, IL-6, IL-18, and IFNγ 
and anti-inflammatory IL-10 relative gene expression by 0.38, 0.21, 0.62, 0.62 and 0.41-fold, 
respectively, compared to broilers fed the palm oil control diet (P ≤ 0.05; Figure 5.1C).  
 An interaction was observed when investigating the metabolic responses of broiler 
muscle tissue to the experimental diet and inflammatory challenge. It was discovered that 
feeding the palm oil control diet to broilers and administering a LPS injection resulted in 
reduced relative expression of muscle catabolic protein PSMC2 by 0.8-fold compared to 
muscle tissue from broilers fed the palm oil control diet and injected with saline (P = 0.04; 
Figure 5.2A). No differences were observed in broiler pectoralis muscle relative mRNA gene 
expression due to the inflammatory challenge (Saline vs. LPS) or from feeding experimental 
diets (P ≥ 0.06; Figures 5.2B and 5.2C, respectively). However, feeding the flaxseed oil diet 
to broilers resulted in a trending reduction in pro-inflammatory cytokine IL-6 (P = 0.06) and 
acute phase protein SAA (P = 0.09) gene expression in muscle tissue compared to broilers 
fed the palm oil control diet (Figure 5.2C).  
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5.4.4 Bone Mineral Absorptiometry 
 Inflammatory challenge and interaction of inflammatory challenge by experimental 
diet did not affect broiler BMC or BMD (P ≥ 0.24). Broilers fed the flaxseed oil and fish oil 
diets resulted in increased BMC accretion during the 7 d challenge period by an average of 
10.217 ± 0.9263 g compared to broilers fed the palm oil control diet (P ≤ 0.01). Feeding the 
flaxseed oil and fish oil diets to broilers resulted in increased total BMC by ≥ 0.2% and BMD 
by ≥ 0.020 g/cm2 at 42 d of age compared to broilers fed the palm oil control diet (P ≤ 0.01). 
Feeding the fish oil diet to broilers resulted in a 0.023 ± 0.0041 g/cm2 increase in BMD 
compared to broilers fed the flaxseed oil diet, while feeding the palm oil control diet to 
broilers resulted in a loss in BMD g/cm2 by -0.010 during the 7 d challenge period (P ≤ 0.01; 
Table 5.7).  
 
5.5 Discussion 
The growth performance data from this experiment support that repeated LPS 
injections at 20% increasing dosage was effective at inducing inflammation in broilers 
through the 7 d inflammatory challenge. As expected, LPS injections regardless of diet 
resulted in depressed FI, reduced BW, and increased FCR. These phenotypic performance 
losses were in agreement with previous broiler LPS studies, which reported that LPS 
administration resulted in reduced FI and BW (Korver et al., 1998; Gonzalez et al., 2011; 
Morris et al., 2014). Although BW and total mass accretion were negatively affected by LPS 
administration, the tissue composition and amount accrued was directly influenced by the 
experimental diets fed. 
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During the repeated LPS inflammatory challenge from 35 to 42 d of age, EPA and 
DHA supplied by dietary fish oil supported anabolic activity in broiler muscle tissue. Feeding 
the fish oil diet to broilers resulted in significantly increased lean tissue by > 4% based on 
total body composition, regardless of LPS or saline injection. This agreed with previous work 
reported by Newman et al. (2002b) that dietary fish oil supplementation increased broiler 
breast muscle:fat pad ratio. However, neither dietary ALA or EPA and DHA was able to 
mitigate the overall loss of 0.133 ± 0.0183 kg BW due to LPS administration. Gene 
expression in muscle from the current experiment did not provide supportive evidence that 
anabolic activity was up regulated or catabolic activity was down regulated, as measured by 
4EBP1, RPS6K1, ubiquitin, CAPN2, and PSMC2. The current experimental data suggests 
that dietary fish oil supplementation may not alleviate broiler performance losses during 
periods of stress, where the expectation is to produce lean meat efficiently. 
Previous studies demonstrated that LPS administration to rats generated increased 
ubiquitin and proteasome subunit synthesis from tissue samples, although measured 24 h 
after a single LPS injection (Rossi et al., 2015). In the current experiment, repeated LPS 
administration and feeding experimental diets did not result in inflammatory or anabolic gene 
expression differences in broiler muscle tissue. However, feeding the palm oil control diet to 
broilers and administering LPS injections resulted in reduced gene expression of catabolic 
protein PSMC2 compared to their palm oil control-fed counterparts that were injected with 
saline. The protein PSMC2 is part of the proteasome complex which is responsible for 
degrading intracellular proteins marked for removal (Nakashima et al., 2009). Reduced 
PSMC2 gene expression with LPS administration suggests that protein degradation was 
suppressed during the repeated inflammatory challenge while dietary ALA or EPA and DHA 
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supplementation assisted in maintaining myocellular catabolic capabilities. Measuring 
additional metabolic genes would assist in describing how broiler muscle tissue responds to 
inflammatory stress. 
Protective anti-inflammatory effects were observed in broilers due to EPA and DHA 
from dietary fish oil supplementation; however, feeding flaxseed oil to broilers and injecting 
them with LPS resulted in suppressed expression of IL-6, a pro-inflammatory cytokine 
responsible for inducing the acute phase inflammatory response and T lymphocyte activation 
(Staeheli et al., 2001). In all other instances, flaxseed oil supplementation had no detectable 
effect at this age. The lack of anti-inflammatory effect may be due to inefficient enzymatic 
synthesis, as seen in other species at this young age, which would impair ALA conversion to 
EPA and DHA (Burdge and Calder, 2006; Guilloteau et al., 2010).  
Overall, feeding the fish oil diets to broilers resulted in consistent suppression of 
inflammatory genes IL-1β, IL-6, IL-18, and IFNγ in the liver throughout the repeated LPS 
inflammatory challenge. These results supported previous in vitro work suggesting that EPA 
and DHA interfered with inflammatory signaling and activation, most likely through cell 
membrane incorporation and receptor interference (Rockett et al., 2011; Hou et al., 2015; 
Shoda et al., 2015). The inflammatory cytokine IL-1β is an endogenous pyrogen responsible 
for stimulating acute phase protein production in the liver and IL-18 stimulates natural killer 
cells and TH1 lymphocytes to produce IFNγ for pathogen clearance (Duque and Descoteaux, 
2014; Wawrocki et al., 2016). Another study reported that feeding mice fish oil diets 
supplying EPA and DHA resulted in suppressed IFNγ signaling during a Listeria 
monocytogenes infection and mice were not able to clear the pathogen from infected cells 
(Irons and Fritsche, 2005). Muted pro-inflammatory responses or gene expression, as 
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reported in the current experiment, are beneficial for managing chronic inflammatory 
conditions or autoimmune disorders (Lofvenborg et al., 2014; Shoda et al., 2015). However, 
immunosuppression may allow for or prevent clearance of opportunistic infections and may 
not be ideal in all situations, specifically for commercial producers that are dealing with 
influenza, Gram-positive, and mycobacterial disease challenges (Irons and Fritsche, 2005; 
McMurray et al., 2011).  
The repeated LPS inflammatory challenge was effective at inducing inflammation in 
broilers. All broilers administered the LPS injection experienced increased gene expression 
of IL-1β and IL-18 in the liver, confirming that the immune system was under stress (Duque 
and Descoteaux, 2014; Wawrocki et al., 2016). During periods of acute inflammation PPARγ 
becomes elevated, which acts as an agonist for IL-10 release (Ferreira et al., 2014). However, 
in the current experiment feeding the fish oil diets to broilers resulted in reduced liver 
expression of the anti-inflammatory gene IL-10 due to EPA and DHA. These results suggest 
that inflammatory resolution occurred and finished for fish oil supplemented broilers during 
the repeated inflammatory challenge. If inflammation resolved, IL-10 would no longer be 
needed, therefore, expression levels would be reduced. 
 Throughout the repeated inflammatory challenge, broilers fed flaxseed oil and fish oil 
diets resulted in increased total BMC and BMD compared to the control. These results agree 
with previous reports that dietary fish oil supplementation fed in swine and rats models 
increased BMC and BMD compared to their respective controls (Lukas et al., 2011; 
Andersen et al., 2013). The current experiment, using both ALA or EPA and DHA, also 
supported work done by Zhong et al. (2014) who demonstrated that dietary ALA was able to 
increase final BMD in growing broilers, although LPS was not used. Under stressful 
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conditions, dietary flaxseed oil and fish oil supplementation provided protective effects on 
broiler bone metabolism allowing for improved mineral deposition.  
 The results of this study demonstrated that fish oil supplementation in broiler diets 
provided anti-inflammatory protection and both flaxseed and fish oils improved bone 
characteristics, demonstrating a secondary benefit for producers that supplement their broiler 
rations. However, the experimentally high oil level of 14% used in the current experiment to 
attain the therapeutic omega-3 fatty acid concentrations in the broiler diets may not be easily 
applied in commercial feed mills due to infrastructural limitations. Further investigation is 
recommended to determine the minimum level of oil needed to produce beneficial health 
effects during inflammation.   
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TABLES 
Table 5.1. Composition of experimental starter diets1 fed to Ross 308 broilers for a 28 
consecutive d dietary supplementation period followed by a repeated inflammatory 
challenge.2 
 Experimental diet (%) 
Ingredients Palm oil control Flaxseed oil Fish oil 
Corn 26.60 26.61 26.61 
Soybean meal 48% crude protein 50.00 50.00 50.00 
Wheat middlings 5.00 5.00 5.00 
Palm oil 14.00 6.53 0.33 
Flaxseed oil 0.00 7.48 0.00 
Fish oil 0.00 0.00 13.68 
Dicalcium phosphate 1.76 1.76 1.76 
Calcium carbonate3 1.06 1.07 1.07 
Sodium chloride 0.50 0.50 0.50 
Methionine hydroxy analogue 0.32 0.30 0.30 
Choline chloride 0.10 0.10 0.10 
L-threonine 0.03 0.03 0.03 
V and M premix4 0.63 0.63 0.63 
Calculated values    
Calcium 1.00 1.00 1.00 
Available phosphorus 0.45 0.45 0.45 
Analyzed values    
Crude fat 13.61 15.15 13.21 
1Palm oil control, flaxseed oil, and fish oil experimental diets used a common basal diet 
combined with 14% palm oil, 7.48% flaxseed oil, or 13.68% fish oil. Calculated ME for each 
diet was 3,400 kcal/kg. 
2Broilers were injected intraperitoneally 4 times with LPS solution (1 mg/kg) or equal 
volume sterile saline every 48 h (35, 37, 39, 41 d of age) administering 20% increased 
dosage with each successive injection (1.0 to 1.7 mg/kg). An experimental unit (EU) 
consisted of 2 broilers sharing a pen with 20 EU for each experimental diet. 
3Calcium carbonate added was a 50/50 mixture of small (< 2 mm) and large (≥ 2 mm) 
particle. 
4Vitamin and mineral premix provided per kg of diet: selenium 250 µg; vitamin A 8,250 IU; 
vitamin D3 2,750 IU; vitamin E 17.9 IU; menadione 1.1 mg; vitamin B12 12 µg; biotin 41 µg; 
choline 447 mg; folic acid 1.4 mg; niacin 41.3 mg; pantothenic acid 11 mg; pyridoxine 1.1 
mg; riboflavin 5.5 mg; thiamine 1.4 mg; iron 282 mg; magnesium 125 mg; manganese 275 
mg; zinc 275 mg; copper 27.5 mg; iodine 844 µg. 
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Table 5.2. Forward (F) and reverse (R) primer sequences1 for quantitative real-time PCR 
mRNA gene expression. 
1Primers were designed using the corresponding accession number or listed reference. 
2Gene expression analyzed for interleukin-1 β (IL-1β), interleukin-6 (IL-6), interleukin-18 
(IL-18), interferon γ (IFNγ), serum amyloid A (SAA), interleukin-10 (IL-10), peroxisome 
proliferator-activated receptor (PPARγ), eukaryotic translation initiation factor 4E binding 
protein 1 (4EBP1), ribosomal protein S6 kinase 1 (RPS6K1), ubiquitin, calpain-2 (CAPN2), 
proteasome 26S subunit ATPase 2 (PSMC2), glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) reference gene, and ribosomal 28S subunit (28S) reference gene. 
 
  
Gene2 Primer Sequence Accession number or referenced source 
IL-1β 
F 5'-GCTCTACATGTCGTGTGTGATGAG-3' 
AJ245728 
R 5'-TGTCGATGTCCCGCATGA-3' 
IL-6 
F 5'-GCTCGCCGGCTTCGA-3' 
AJ250838 
R 5'-GGTAGGTCTGAAAGGCGAACAG-3' 
IL-18 
F 5'-AGGTGAAATCTGGCAGTGGAAT-3' 
AJ276026 
R 5'-ACCTGGACGCTGAATGCAA-3' 
IFNγ 
F 5'-GTGAAGAAGGTGAAAGATATCATGGA-3' 
Y07922 
R 5'-GCTTTGCGCTGGATTCTCA-3' 
SAA 
F 5'-TTCTGTGGGCTAGGTTCCTG-3' 
Q9PSM7 
R 5'-GCAAGTCAGCAACAACCAGA-3' 
IL-10 
F 5'-CATGCTGCTGGGCCTGAA-3' 
AJ621614 
R 5'-CGTCTCCTTGATCTGCTTGATG-3' 
PPARγ F 5'-GGGCGATCTTGACAGGAA-3' Sun et al., 2014 R 5'-GCCTCCACAGAGCGAAAC-3' 
4EBP1 F 5' -GCGAATGTAGGTGAAGAAGAG-3' Deng et al., 2014 R 5' -AACAGGAAGGCACTCAAGG-3' 
RPS6K1 F 5'-CAATTTGCCTCCCTACCTCA-3' Deng et al., 2014 R 5'-AAGGAGGTTCCACCTTTCGT-3' 
Ubiquitin F 5'-CGCACCCTGTCTGACTACAA-3' Nakashima et al., 2009 R 5'-GCCTTCACGTTCTCAATGGT-3' 
CAPN2 F 5'-ACATCATCGTGCCCTCTACC-3' Nakashima et al., 2009 R 5'-GAGATCTCTGCATCGCTTCC-3' 
PSMC2 F 5'-AACACACGCTGTTCTGGTTG-3' Nakashima et al., 2009 R 5'-CTGCGTTGGTATCTGGGTTT-3' 
GAPDH F 5'-GTGCTGGCATTGCACTGAA-3' NM_204305.1 R 5'CACAACACGGTTGCTGTATCC-3' 
28S 
F 5'-GGCGAAGCCAGAGGAAACT-3' 
X59733 
R 5'-GACGACCGATTTGCACGTC-3' 
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Table 5.3. Ross 308 broiler performance1 when fed palm oil control, flaxseed oil, or fish oil 
experimental diets2 followed by a repeated inflammatory challenge.3 
 Inflammatory challenge
 P-value4 
Measure  Saline LPS SEM Diet Challenge Diet*Challenge 
SBW (kg) 2.420 2.426 0.0289 ≤ 0.01 0.89 0.27 
EBW (kg) 3.298 3.165 0.0183 0.95 ≤ 0.01 0.26 
FI (kg) 1.631 1.529 0.0198 0.46 ≤ 0.01 0.62 
FCR 1.909 2.098 0.0404 0.78 0.03 0.50 
ADG (kg/d) 0.125 0.106 0.0024 0.89 ≤ 0.01 0.37 
1Performance measurements included starting body weight at 35 d of age (SBW), ending 
body weight at 42 d of age (EBW), feed intake (FI), feed conversion ratio (FCR), and 
average daily gain (ADG). 
2Experimental diets were applied for a 28 consecutive d dietary supplementation period (6 to 
34 d of age). Broiler chicks were fed a palm oil control diet (basal diet + no supplemental 
omega-3 fatty acids), flaxseed oil (basal + 4.1% alpha-linolenic acid), or fish oil (basal + 
4.1% eicosapentaenoic acid and docosahexaenoic acid). 
3Broilers were injected intraperitoneally 4 times with LPS solution (1 mg/kg) or equal 
volume sterile saline every 48 h (35, 37, 39, 41 d of age) administering 20% increased 
dosage with each successive injection (1.0 to 1.7 mg/kg). An experimental unit (EU) 
consisted of 2 broilers sharing a pen with 30 EU injected with LPS and the remaining 30 EU 
injected with sterile saline. 
4Challenge = inflammatory challenge with 10 EU per experimental diet injected with LPS 
and the remaining 10 EU injected with sterile saline. 
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Table 5.5. Dietary fatty acid profile for palm oil control, flaxseed oil, and fish oil 
experimental starter diets1 fed to Ross 308 broiler chickens for a 28 consecutive d dietary 
supplementation period followed by a repeated inflammatory challenge.2 
 Experimental diet (%) 
Fatty acid (C:double bond) Palm oil control Flaxseed oil Fish oil 
Myristic acid (14:0) 1.04 0.67 7.99 
Palmitic acid (16:0) 39.34 21.46 19.96 
Palmitoleic acid (16:1) 0.00 0.33 8.63 
Margaric acid (17:0) 0.00 0.00 0.42 
Stearic acid (18:0) 3.82 3.48 3.56 
Oleic acid (18:1) 35.49 25.49 11.61 
Linoleic acid (18:2) 18.06 18.81 11.74 
Alpha-linolenic acid (18:3) 1.91 28.39 2.32 
Arachidic acid (20:0) 0.33 0.22 0.24 
Arachidonic acid (20:4) 0.00 0.00 1.07 
Eicosapentaenoic acid (20:5) 0.00 1.16 19.55 
Docosapentaenoic acid (22:5) 0.00 0.00 2.04 
Docosahexaenoic acid (22:6) 0.00 0.00 10.87 
Crude fat3 13.61 15.15 13.21 
Saturated fat 44.53 25.83 32.17 
Unsaturated fat 55.47 74.17 67.83 
Total omega-3 fatty acid4 1.91 29.55 32.73 
Total omega-6 fatty acid5 18.06 18.81 12.82 
Omega-6:omega-3 ratio 9.46 0.64 0.39 
1Palm oil control, flaxseed oil, and fish oil experimental diets used a basal diet containing 
14% palm oil, 7.48% flaxseed oil, or 13.68% fish oil. 
2Broilers were injected intraperitoneally 4 times with LPS solution (1 mg/kg) or equal 
volume sterile saline every 48 h (35, 37, 39, 41 d of age) administering 20% increased 
dosage with each successive injection (1.0 to 1.7 mg/kg). An experimental unit (EU) 
consisted of 2 broilers sharing a pen with 20 EU per experimental diet. 
3Crude fat was the analyzed fat content of pooled feed samples. The fatty acid values 
represent the percent composition of the crude fat for each diet. 
4Total omega-3 fatty acid was the sum of alpha-linolenic acid, eicosapentaenoic acid, and 
docosahexaenoic acid.  
5Total omega-6 fatty acid was the sum of linoleic acid and arachidonic acid.  
 
T
ab
le
 5
.6
. P
ec
to
ra
lis
 m
aj
or
 fa
tty
 a
ci
d 
an
al
ys
is
 fo
r R
os
s 
30
8 
br
oi
le
rs
 fe
d 
pa
lm
 o
il 
co
nt
ro
l, 
fla
xs
ee
d 
oi
l, 
or
 fi
sh
 o
il 
ex
pe
rim
en
ta
l d
ie
ts
1  
fo
r a
 2
8 
co
ns
ec
ut
iv
e 
d 
di
et
ar
y 
su
pp
le
m
en
ta
tio
n 
pe
rio
d 
fo
llo
w
ed
 b
y 
a 
re
pe
at
ed
 in
fla
m
m
at
or
y 
ch
al
le
ng
e.
2  
 
E
xp
er
im
en
ta
l d
ie
t (
%
) 
 
P-
va
lu
e3
 
Fa
tty
 a
ci
d 
(C
:d
ou
bl
e 
bo
nd
) 
Pa
lm
 o
il 
co
nt
ro
l 
Fl
ax
se
ed
 o
il 
Fi
sh
 o
il 
SE
M
 
D
ie
t 
C
ha
lle
ng
e 
D
ie
t*
C
ha
lle
ng
e 
M
yr
is
tic
 a
ci
d 
(1
4:
0)
 
0.
93
b 
0.
62
b 
4.
63
a 
0.
25
0 
≤ 
0.
01
 
0.
50
 
0.
26
 
Pa
lm
iti
c 
ac
id
 (1
6:
0)
 
29
.0
3a
 
20
.5
7b
 
22
.8
1b
 
0.
59
0 
≤ 
0.
01
 
0.
20
 
0.
26
 
Pa
lm
ito
le
ic
 a
ci
d 
(1
6:
1)
 
2.
57
b 
1.
63
b 
6.
88
a 
0.
27
7 
≤ 
0.
01
 
0.
43
 
0.
23
 
M
ar
ga
ric
 a
ci
d 
(1
7:
0)
 
0.
11
b 
0.
10
b 
0.
56
a 
0.
03
3 
≤ 
0.
01
 
0.
96
 
0.
60
 
St
ea
ric
 a
ci
d 
(1
8:
0)
 
7.
06
 
7.
00
 
8.
75
 
0.
44
7 
0.
31
 
0.
77
 
0.
56
 
O
le
ic
 a
ci
d 
(1
8:
1)
 
38
.9
3a
 
27
.5
4b
 
16
.1
8b
 
1.
57
6 
≤ 
0.
01
 
0.
76
 
0.
36
 
Li
no
le
ic
 a
ci
d 
(1
8:
2)
 
15
.3
2a
 
16
.8
7a
 
8.
88
b 
0.
45
9 
≤ 
0.
01
 
0.
61
 
0.
15
 
A
lp
ha
-li
no
le
ni
c 
ac
id
 (1
8:
3)
 
0.
23
b 
19
.0
7a
 
1.
89
b 
0.
53
4 
≤ 
0.
01
 
0.
65
 
0.
89
 
A
ra
ch
id
ic
 a
ci
d 
(2
0:
0)
 
0.
12
 
0.
10
 
0.
07
 
0.
03
0 
0.
50
 
0.
54
 
0.
43
 
A
ra
ch
id
on
ic
 a
ci
d 
(2
0:
4)
 
4.
30
a 
1.
59
b 
2.
17
b 
0.
24
0 
≤ 
0.
01
 
0.
60
 
0.
11
 
Ei
co
sa
pe
nt
ae
no
ic
 a
ci
d 
(2
0:
5)
 
0.
29
b 
1.
49
b 
11
.5
5a
 
0.
58
9 
≤ 
0.
01
 
0.
49
 
0.
52
 
D
oc
os
ap
en
ta
en
oi
c 
ac
id
 (2
2:
5)
 
0.
55
b 
1.
99
a 
2.
86
a 
0.
24
7 
≤ 
0.
01
 
0.
63
 
0.
60
 
D
oc
os
ah
ex
ae
no
ic
 a
ci
d 
(2
2:
6)
 
0.
56
b 
1.
43
b 
12
.7
7a
 
0.
87
6 
≤ 
0.
01
 
0.
85
 
0.
18
 
M
us
cu
la
r c
ru
de
 fa
t4  
2.
80
 
2.
62
 
2.
11
 
0.
39
2 
0.
66
 
0.
70
 
0.
86
 
C
al
cu
la
te
d 
va
lu
es
 
 
 
 
 
Sa
tu
ra
te
d 
fa
t 
37
.2
5 
28
.3
9 
36
.8
1 
- 
- 
- 
- 
U
ns
at
ur
at
ed
 fa
t 
62
.7
5 
71
.6
1 
63
.1
9 
- 
- 
- 
- 
To
ta
l o
m
eg
a-
3 
fa
tty
 a
ci
d5
 
1.
08
 
21
.9
9 
26
.2
2 
- 
- 
- 
- 
To
ta
l o
m
eg
a-
6 
fa
tty
 a
ci
d6
 
19
.6
2 
18
.4
6 
11
.0
5 
- 
- 
- 
- 
O
m
eg
a-
6:
om
eg
a-
3 
ra
tio
 
18
.1
0 
0.
84
 
0.
42
 
- 
- 
- 
- 
1 M
us
cl
e 
tis
su
e 
w
as
 s
am
pl
ed
 f
ro
m
 3
 e
xp
er
im
en
ta
l 
un
its
 p
er
 f
ac
to
ria
l 
ar
ra
ng
em
en
t 
(D
ie
t*
C
ha
lle
ng
e)
. 
A
n 
ex
pe
rim
en
ta
l 
un
it 
(E
U
) 
co
ns
is
te
d 
of
 2
 b
ro
ile
rs
 s
ha
rin
g 
a 
pe
n 
w
ith
 2
0 
EU
 p
er
 e
xp
er
im
en
ta
l d
ie
t. 
Ex
pe
rim
en
ta
l d
ie
ts
 w
er
e 
ap
pl
ie
d 
fo
r a
 2
8 
co
ns
ec
ut
iv
e 
d 
di
et
ar
y 
su
pp
le
m
en
ta
tio
n 
pe
rio
d 
(6
 to
 3
4 
d 
of
 a
ge
). 
B
ro
ile
r 
bi
rd
s 
w
er
e 
fe
d 
a 
pa
lm
 o
il 
co
nt
ro
l (
ba
sa
l +
 n
o 
su
pp
le
m
en
ta
l o
m
eg
a-
3 
fa
tty
 a
ci
ds
), 
fla
xs
ee
d 
oi
l (
ba
sa
l +
 4
.1
%
 a
lp
ha
-li
no
le
ni
c 
ac
id
), 
or
 fi
sh
 o
il 
(b
as
al
 +
 4
.1
%
 e
ic
os
ap
en
ta
en
oi
c 
ac
id
 a
nd
 d
oc
os
ah
ex
ae
no
ic
 a
ci
d)
 d
ie
t. 
 
178 
T
ab
le
 5
.6
 c
on
tin
ue
d.
 
2 B
ro
ile
rs
 w
er
e 
in
je
ct
ed
 in
tra
pe
rit
on
ea
lly
 4
 ti
m
es
 w
ith
 L
PS
 s
ol
ut
io
n 
(1
 m
g/
kg
) o
r e
qu
al
 v
ol
um
e 
st
er
ile
 s
al
in
e 
ev
er
y 
48
 h
 (3
5,
 3
7,
 3
9,
 4
1 
d 
of
 a
ge
) a
dm
in
is
te
rin
g 
20
%
 in
cr
ea
se
d 
do
sa
ge
 w
ith
 e
ac
h 
su
cc
es
si
ve
 in
je
ct
io
n 
(1
.0
 to
 1
.7
 m
g/
kg
). 
3 C
ha
lle
ng
e 
= 
in
fla
m
m
at
or
y 
ch
al
le
ng
e 
w
ith
 1
0 
EU
 p
er
 e
xp
er
im
en
ta
l d
ie
t i
nj
ec
te
d 
w
ith
 L
PS
 a
nd
 th
e 
re
m
ai
ni
ng
 1
0 
EU
 in
je
ct
ed
 w
ith
 
st
er
ile
 sa
lin
e.
 
4 C
ru
de
 fa
t w
as
 th
e 
an
al
yz
ed
 fa
t c
on
te
nt
 o
f m
us
cl
e 
sa
m
pl
es
. T
he
 fa
tty
 a
ci
d 
va
lu
es
 re
pr
es
en
t t
he
 p
er
ce
nt
 c
om
po
si
tio
n 
of
 th
e 
cr
ud
e 
fa
t f
or
 
ea
ch
 tr
ea
tm
en
t. 
5 T
ot
al
 o
m
eg
a-
3 
fa
tty
 a
ci
d 
w
as
 th
e 
su
m
 o
f a
lp
ha
-li
no
le
ni
c 
ac
id
, e
ic
os
ap
en
ta
en
oi
c 
ac
id
, a
nd
 d
oc
os
ah
ex
ae
no
ic
 a
ci
d.
  
6 T
ot
al
 o
m
eg
a-
6 
fa
tty
 a
ci
d 
w
as
 th
e 
su
m
 o
f l
in
ol
ei
c 
ac
id
 a
nd
 a
ra
ch
id
on
ic
 a
ci
d.
 
a-
b L
ea
st
 sq
ua
re
 m
ea
ns
 w
ith
ou
t a
 c
om
m
on
 su
pe
rs
cr
ip
t d
iff
er
 si
gn
ifi
ca
nt
ly
 w
ith
in
 a
 ro
w
 (P
 ≤
 0
.0
5)
. 
 
 
 
179 
T
ab
le
 5
.7
. C
ha
ng
es
 in
 b
on
e 
ab
so
rp
tio
m
et
ry
1  
fo
r 
R
os
s 
30
8 
br
oi
le
rs
 f
ed
 p
al
m
 o
il 
co
nt
ro
l, 
fla
xs
ee
d 
oi
l, 
or
 f
is
h 
oi
l e
xp
er
im
en
ta
l d
ie
ts
2  
fo
llo
w
ed
 b
y 
a 
re
pe
at
ed
 in
fla
m
m
at
or
y 
ch
al
le
ng
e.
3  
 
E
xp
er
im
en
ta
l d
ie
t 
P-
va
lu
e4
 
M
ea
su
re
 
Pa
lm
 o
il 
co
nt
ro
l 
Fl
ax
se
ed
 o
il 
Fi
sh
 o
il 
SE
M
 
D
ie
t 
C
ha
lle
ng
e 
D
ie
t*
C
ha
lle
ng
e 
B
M
C
 a
cc
re
tio
n 
(g
) 
6.
12
7b
 
9.
75
2a
 
10
.6
82
a  
0.
92
63
 
≤ 
0.
01
 
0.
24
 
0.
63
 
To
ta
l B
M
C
 (%
) 
1.
0b
 
1.
2a
 
1.
3a
 
0.
03
 
≤ 
0.
01
 
0.
96
 
0.
28
 
B
M
D
 c
ha
ng
e 
(g
/c
m
2 )
 
-0
.0
10
b  
0.
00
0b
 
0.
02
3a
 
0.
00
41
 
≤ 
0.
01
 
0.
69
 
0.
74
 
B
M
D
 (g
/c
m
2 )
 
0.
14
5b
 
0.
16
5a
 
0.
17
4a
 
0.
00
40
 
≤ 
0.
01
 
0.
83
 
0.
58
 
1 A
bs
or
pt
io
m
et
ry
 m
ea
su
re
m
en
ts
 in
cl
ud
ed
 b
on
e 
m
in
er
al
 c
on
te
nt
 (B
M
C
) a
cc
re
tio
n 
an
d 
ch
an
ge
s i
n 
bo
ne
 m
in
er
al
 d
en
si
ty
 (B
M
D
). 
2 E
xp
er
im
en
ta
l d
ie
ts
 w
er
e 
ap
pl
ie
d 
fo
r a
 2
8 
co
ns
ec
ut
iv
e 
d 
di
et
ar
y 
su
pp
le
m
en
ta
tio
n 
pe
rio
d 
(6
 to
 3
4 
d 
of
 a
ge
). 
B
ro
ile
rs
 w
er
e 
fe
d 
a 
pa
lm
 o
il 
co
nt
ro
l 
(b
as
al
 +
 n
o 
su
pp
le
m
en
ta
l 
om
eg
a-
3 
fa
tty
 a
ci
ds
), 
fla
xs
ee
d 
oi
l 
(b
as
al
 +
 4
.1
%
 a
lp
ha
-li
no
le
ni
c 
ac
id
), 
or
 f
is
h 
oi
l 
(b
as
al
 +
 4
.1
%
 
ei
co
sa
pe
nt
ae
no
ic
 a
ci
d 
an
d 
do
co
sa
he
xa
en
oi
c 
ac
id
) d
ie
t. 
A
n 
ex
pe
rim
en
ta
l u
ni
t (
EU
) c
on
si
st
ed
 o
f 2
 b
ro
ile
rs
 sh
ar
in
g 
a 
pe
n 
w
ith
 2
0 
EU
 p
er
 
ex
pe
rim
en
ta
l d
ie
t. 
3 B
ro
ile
rs
 w
er
e 
in
je
ct
ed
 in
tra
pe
rit
on
ea
lly
 4
 ti
m
es
 w
ith
 L
PS
 s
ol
ut
io
n 
(1
 m
g/
kg
) o
r e
qu
al
 v
ol
um
e 
st
er
ile
 s
al
in
e 
ev
er
y 
48
 h
 (3
5,
 3
7,
 3
9,
 4
1 
d 
of
 a
ge
) a
dm
in
is
te
rin
g 
20
%
 in
cr
ea
se
d 
do
sa
ge
 w
ith
 e
ac
h 
su
cc
es
si
ve
 in
je
ct
io
n 
(1
.0
 to
 1
.7
 m
g/
kg
). 
4 C
ha
lle
ng
e 
= 
in
fla
m
m
at
or
y 
ch
al
le
ng
e 
w
ith
 1
0 
EU
 p
er
 e
xp
er
im
en
ta
l d
ie
t i
nj
ec
te
d 
w
ith
 L
PS
 a
nd
 th
e 
re
m
ai
ni
ng
 1
0 
EU
 in
je
ct
ed
 w
ith
 
st
er
ile
 sa
lin
e.
 
a-
b L
ea
st
 sq
ua
re
 m
ea
ns
 w
ith
ou
t a
 c
om
m
on
 su
pe
rs
cr
ip
t d
iff
er
 si
gn
ifi
ca
nt
ly
 w
ith
in
 a
 ro
w
 (P
 ≤
 0
.0
5)
. 
  
 
 
180 
FI
G
U
R
E
S 
 
 
Fi
gu
re
 5
.1
. L
iv
er
 r
el
at
iv
e 
m
R
N
A
 g
en
e 
ex
pr
es
si
on
 in
 L
og
2 
tra
ns
fo
rm
ed
 f
ol
d 
ch
an
ge
 f
or
 b
ro
ile
rs
 f
ed
 a
 p
al
m
 o
il 
co
nt
ro
l (
ba
sa
l +
 n
o 
su
pp
le
m
en
ta
l o
m
eg
a-
3 
fa
tty
 a
ci
ds
), 
fla
xs
ee
d 
oi
l (
ba
sa
l +
 4
.1
%
 a
lp
ha
-li
no
le
ni
c 
ac
id
), 
or
 f
is
h 
oi
l (
ba
sa
l +
 4
.1
%
 e
ic
os
ap
en
ta
en
oi
c 
ac
id
 
an
d 
do
co
sa
he
xa
en
oi
c 
ac
id
) 
di
et
 f
ro
m
 6
 to
 3
4 
d 
of
 a
ge
 f
ol
lo
w
ed
 b
y 
a 
re
pe
at
ed
 in
fla
m
m
at
or
y 
ch
al
le
ng
e 
fr
om
 3
5 
to
 4
2 
d 
of
 a
ge
. F
ol
d 
ch
an
ge
 d
is
pl
ay
ed
 a
s 
A
) 
di
et
*c
ha
lle
ng
e 
in
te
ra
ct
io
n 
fo
r 
cy
to
ki
ne
s 
in
te
rle
uk
in
-1
 β
 (
IL
-1
β)
, 
IL
-6
, 
IL
-1
8,
 i
nt
er
fe
ro
n 
γ 
(I
FN
γ)
, 
se
ru
m
 
am
yl
oi
d 
A
 (S
A
A
), 
IL
-1
0,
 a
nd
 p
er
ox
is
om
e 
pr
ol
ife
ra
to
r-
ac
tiv
at
ed
 re
ce
pt
or
 γ
 (P
PA
R
γ)
 u
si
ng
 g
ly
ce
ra
ld
eh
yd
e 
3-
ph
os
ph
at
e 
de
hy
dr
og
en
as
e 
re
fe
re
nc
e 
ge
ne
, B
) i
nf
la
m
m
at
or
y 
ch
al
le
ng
e 
in
je
ct
io
n 
(L
PS
 v
s. 
Sa
lin
e)
, a
nd
 C
) d
ie
t (
Pa
lm
 o
il 
co
nt
ro
l v
s. 
Fl
ax
se
ed
 o
il 
vs
. F
is
h 
oi
l).
 
* P
 ≤
 0
.0
5 
an
d 
**
P 
≤ 
0.
01
 in
 re
fe
re
nc
e 
to
 b
as
el
in
e 
1-
fo
ld
 c
ha
ng
e,
 u
nl
es
s 
ot
he
rw
is
e 
no
te
d.
 A
) B
as
el
in
e 
1-
fo
ld
 c
ha
ng
e 
= 
C
on
tro
l*
Sa
lin
e,
 
B
) b
as
el
in
e 
1-
fo
ld
 c
ha
ng
e 
= 
Sa
lin
e,
 a
nd
 C
) b
as
el
in
e 
1-
fo
ld
 c
ha
ng
e 
= 
C
on
tro
l. 
IL
-1β
IL
-6
IL
-18
IF
Nγ
SA
A
IL
-10
PP
AR
γ
0.
12
5
0.
251248 0.
5
Fold change
LP
S
**
**
Sa
lin
e
IL
-1β
IL
-6
IL
-18
IF
Nγ
SA
A
IL
-10
PP
AR
γ
0.
03
12
5
0.
06
25
0.
12
5
0.
2512481632 0.
5
Fold change
C
on
tr
ol
*L
PS
Fl
ax
*S
al
in
e
Fl
ax
*L
PS
Fi
sh
*S
al
in
e
Fi
sh
*L
PS
 
*
C
on
tr
ol
*S
al
in
e
*
IL
-1β
IL
-6
IL
-18
IF
Nγ
SA
A
IL
-10
PP
AR
γ
0.
12
5
0.
251248 0.
5
Fold change
Fl
ax
se
ed
 o
il
Fi
sh
 o
il
**
*
**
C
on
tr
ol
*
*
IL
-1β
IL
-6
IL
-18
IF
Nγ
SA
A
IL
-10
PP
AR
γ
0.
12
5
0.
251248 0.
5
Fold change
LP
S
**
**
Sa
lin
e
IL
-1β
IL
-6
IL
-18
IF
Nγ
SA
A
IL
-10
PP
AR
γ
0.
03
12
5
0.
06
25
0.
12
5
0.
2512481632 0.
5
Fold change
C
on
tr
ol
*L
PS
Fl
ax
*S
al
in
e
Fl
ax
*L
PS
Fi
sh
*S
al
in
e
Fi
sh
*L
PS
 
*
C
on
tr
ol
*S
al
in
e
*
IL
-1β
IL
-6
IL
-18
IF
Nγ
SA
A
IL
-10
PP
AR
γ
0.
12
5
0.
251248 0.
5
Fold change
Fl
ax
se
ed
 o
il
Fi
sh
 o
il
**
*
**
C
on
tr
ol
*
*
A
)
B)
C
)
A
)
B)
C
)
 
181 
 
 
Fi
gu
re
 5
.2
. P
ec
to
ra
lis
 m
aj
or
 m
us
cl
e 
re
la
tiv
e 
m
R
N
A
 g
en
e 
ex
pr
es
si
on
 i
n 
Lo
g2
 t
ra
ns
fo
rm
ed
 f
ol
d 
ch
an
ge
 f
or
 b
ro
ile
rs
 f
ed
 a
 p
al
m
 o
il 
co
nt
ro
l 
(b
as
al
 +
 n
o 
su
pp
le
m
en
ta
l 
om
eg
a-
3 
fa
tty
 a
ci
ds
), 
fla
xs
ee
d 
oi
l 
(b
as
al
 +
 4
.1
%
 a
lp
ha
-li
no
le
ni
c 
ac
id
), 
or
 f
is
h 
oi
l 
(b
as
al
 +
 4
.1
%
 
ei
co
sa
pe
nt
ae
no
ic
 a
ci
d 
an
d 
do
co
sa
he
xa
en
oi
c 
ac
id
) d
ie
t f
ro
m
 6
 to
 3
4 
d 
of
 a
ge
 fo
llo
w
ed
 b
y 
a 
re
pe
at
ed
 in
fla
m
m
at
or
y 
ch
al
le
ng
e 
fr
om
 3
5 
to
 
42
 d
 o
f 
ag
e.
 F
ol
d 
ch
an
ge
 d
is
pl
ay
ed
 a
s 
A
) 
di
et
*c
ha
lle
ng
e 
in
te
ra
ct
io
n 
fo
r 
cy
to
ki
ne
s 
in
te
rle
uk
in
-6
 (
IL
-6
), 
se
ru
m
 a
m
yl
oi
d 
A
 (
SA
A
), 
eu
ka
ry
ot
ic
 tr
an
sl
at
io
n 
in
iti
at
io
n 
fa
ct
or
 4
E 
bi
nd
in
g 
pr
ot
ei
n 
1 
(4
EB
P1
), 
rib
os
om
al
 p
ro
te
in
 S
6 
ki
na
se
 1
 (
R
PS
6K
1)
, u
bi
qu
iti
n,
 c
al
pa
in
-2
 
(C
A
PN
2)
, a
nd
 p
ro
te
as
om
e 
26
S 
su
bu
ni
t A
TP
as
e 
2 
(P
SM
C
2)
 u
si
ng
 ri
bo
so
m
al
 2
8S
 s
ub
un
it 
re
fe
re
nc
e 
ge
ne
, B
) i
nf
la
m
m
at
or
y 
ch
al
le
ng
e 
in
je
ct
io
n 
(L
PS
 v
s. 
Sa
lin
e)
, a
nd
 C
) d
ie
t (
Pa
lm
 o
il 
co
nt
ro
l v
s. 
Fl
ax
se
ed
 o
il 
vs
. F
is
h 
oi
l).
 
* P
 ≤
 0
.0
5 
in
 re
fe
re
nc
e 
to
 b
as
el
in
e 
1-
fo
ld
 c
ha
ng
e,
 u
nl
es
s 
ot
he
rw
is
e 
no
te
d.
 A
) B
as
el
in
e 
1-
fo
ld
 c
ha
ng
e 
= 
C
on
tro
l*
Sa
lin
e,
 B
) b
as
el
in
e 
1-
fo
ld
 c
ha
ng
e 
= 
Sa
lin
e,
 a
nd
 C
) b
as
el
in
e 
1-
fo
ld
 c
ha
ng
e 
= 
C
on
tro
l. 
 
IL
 6
SA
A
4E
BP
1 R
PS
6K
1 Ub
iqu
itin
CA
PN
2 P
SM
C2
0.
12
5
0.
251248 0.
5
Fold change
LP
S
Sa
lin
e
In
fla
m
m
at
or
y
A
na
bo
lic
C
at
ab
ol
ic
IL
 6
SA
A
4E
BP
1 R
PS
6K
1 Ub
iqu
itin
CA
PN
2
PS
M
C2
0.
03
12
5
0.
06
25
0.
12
5
0.
2512481632 0.
5
Fold change
C
on
tr
ol
*L
PS
Fl
ax
*S
al
in
e
Fl
ax
*L
PS
Fi
sh
*S
al
in
e
Fi
sh
*L
PS
 
C
on
tr
ol
*S
al
in
e I
nf
la
m
m
at
or
y
A
na
bo
lic
C
at
ab
ol
ic
*
IL
 6
SA
A
4E
BP
1 R
PS
6K
1 U
biq
uit
in
CA
PN
2
PS
M
C2
0.
12
5
0.
251248 0.
5
Fold change
Fl
ax
se
ed
 o
il
Fi
sh
 o
il
C
on
tr
ol
In
fla
m
m
at
or
y
A
na
bo
lic
C
at
ab
ol
ic
IL
 6
SA
A
4E
BP
1 R
PS
6K
1 Ub
iqu
itin
CA
PN
2 P
SM
C2
0.
12
5
0.
251248 0.
5
Fold change
LP
S
Sa
lin
e
In
fla
m
m
at
or
y
A
na
bo
lic
C
at
ab
ol
ic
IL
 6
SA
A
4E
BP
1 R
PS
6K
1 Ub
iqu
itin
CA
PN
2
PS
M
C2
0.
03
12
5
0.
06
25
0.
12
5
0.
2512481632 0.
5
Fold change
C
on
tr
ol
*L
PS
Fl
ax
*S
al
in
e
Fl
ax
*L
PS
Fi
sh
*S
al
in
e
Fi
sh
*L
PS
 
C
on
tr
ol
*S
al
in
e I
nf
la
m
m
at
or
y
A
na
bo
lic
C
at
ab
ol
ic
*
IL
 6
SA
A
4E
BP
1 R
PS
6K
1 U
biq
uit
in
CA
PN
2
PS
M
C2
0.
12
5
0.
251248 0.
5
Fold change
Fl
ax
se
ed
 o
il
Fi
sh
 o
il
C
on
tr
ol
In
fla
m
m
at
or
y
A
na
bo
lic
C
at
ab
ol
ic
A
)
B)
C
)
A
)
B)
C
)
 
182 
	 183 
CHAPTER 6. GENERAL CONCLUSIONS AND RECOMMENDATIONS FOR 
FUTURE RESEARCH 
 
Poultry diets are supplemented with omega-3 fatty acids to generate value-added eggs 
and meats. There is a gap in research regarding how ALA or EPA and DHA supplementation 
in poultry diets affect bird health and performance. The overarching goal of this dissertation 
was to determine the effects of omega-3 fatty acid supplementation on poultry health and 
performance with the hypothesis that dietary omega-3 fatty acid supplementation would 
provide a health benefit to the bird leading to a secondary benefit for the producer. In order to 
investigate the potential health benefits provided to poultry consuming omega-3 fatty acid 
supplemented diets, four experiments were performed addressing specific objectives.  
The objective of Experiment 1 was to evaluate how dietary ALA sources affect the 
fatty acid transfer rate from laying hen diet to the egg yolk near peak production. The data 
gathered from the experiment allowed for the creation of omega-3 fatty acid transfer 
equations, which can be used by producers to accurately formulate flaxseed oil supplemented 
diets for generating value-added omega-3 fatty acid enriched eggs with specific label claims. 
The results demonstrated that flaxseed oil was a more efficient and cost effective functional 
ingredient for producing value-added ALA enriched eggs compared to ground flaxseed, 
therefore it was applied to the future experiments. It took the hens up to 6 wk to acclimate to 
the supplemented diets and reach a transfer plateau, therefore a minimum of 6 wk was used 
in the following laying hen experiment.  
 The objective of Experiment 2 was to determine if dietary supplementation of ALA 
or EPA and DHA improves performance and bone health of aged laying hens with mature 
	 184 
immune systems, at risk for osteoporosis, and whether protective anti-inflammatory effects 
would be exerted during acute inflammation. Contrary to the hypothesis, dietary ALA or 
EPA and DHA did not improve aged laying hen performance or bone strength 
prophylactically. The lack of bone health response may have been due to the older age of the 
laying hens. Supplementation at this stage may have been too late to generate a bone health 
response whereas supplementation at an earlier age may have been beneficial. Under stress, 
dietary ALA or EPA and DHA fed to the laying hens provided anti-inflammatory protection, 
which is advantageous with a healthy flock of birds in a clean environment. However, 
immune suppression may not be advantageous in disease challenged commercial settings, 
such as with Mycoplasma spp. infected populations. This experiment demonstrated that 
omega-3 fatty acid supplementation in laying hen diets yielded value-added eggs and 
provided anti-inflammatory protection, but the protection may not be a practical benefit for 
producers faced with endemic disease challenges. Due to the age of the laying hens and lack 
of bone health response, a broiler model with growing bones was used in the following 
experiment and administered a therapeutic oil inclusion level (14% oil; 4% total omega-3 
fatty acid).  
The objective of Experiment 3 was to investigate if dietary supplementation of ALA 
or EPA and DHA impact bone health and performance in growing broilers, at risk for 
lameness and leg bone pathology. Dietary ALA or EPA and DHA at therapeutic levels did 
not improve broiler bone characteristics when provided prophylactically. It is possible that 
broilers require a full 6 wk to respond to the effects of ALA or EPA and DHA from their 
growing bones, similar to the time needed for dietary acclimation and transfer rate plateau of 
laying hens from Experiment 1. Fish oil supplementation negatively affected broiler 
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performance while the flaxseed oil diet containing 6.53% palm oil did not. Fatty acid 
utilization may have been affected by oxidative stability, where the fish oil may have been 
less stable than flaxseed oil. These results suggested that palm oil, providing saturated fatty 
acids, might be required in combination with ALA or EPA and DHA to maintain broiler 
performance. No secondary benefit of improving bone health or performance was 
demonstrated in this experiment when broilers were supplemented with flaxseed oil or fish 
oil; producers should consider the stability of the oil ingredient when selecting an omega-3 
fatty acid supplement for their poultry diet to prevent potential performance losses. In a 
continuation of this experiment, these broilers were used for Experiment 4 in a repeated 
inflammatory challenge. 
 The objective of Experiment 4 was to examine the protective anti-inflammatory and 
bone modulating effects of ALA or EPA and DHA on performance and health of growing 
broilers with naïve immune systems at risk for lameness during a period of repeated 
inflammation, in contrast to Experiment 2 where aged laying hens with a developed immune 
system were challenged to a single acute inflammatory challenge. As hypothesized, broilers	subjected	to	repeated	inflammatory	stress	and	fed	therapeutic	levels	of	dietary	ALA	or	EPA	 and	 DHA	 improved	 bone	 health,	 providing	 a	 secondary	 benefit.	 Dietary	 fish	 oil	supplementation	 provided	 anti-inflammatory	 protection,	 as	 discussed	 previously	immune	 suppression	 may	 not	 be	 a	 benefit	 in	 certain	 disease	 challenge	 scenarios.	Dietary	ALA	or	EPA	and	DHA	did	not	result	in	performance	differences	due	to	repeated	inflammation.	Producers	should	be	aware	that	the	beneficial	effects	in	this	experiment	were	attained	using	therapeutic	levels	of	dietary	oil	(14%)	in	the	feed,	which	may	not	be	possible	to	manufacture	in	a	commercial	feed	mill.	
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 Overall, dietary ALA or EPA and DHA supplementation in poultry diets provided 
secondary benefits related to animal health, but these experiments did not demonstrate as 
many as hypothesized. Further investigation is needed in order to understand how immune 
suppression via ALA or EPA and DHA affects pathogen clearance in a living biological 
system (in vivo infectious model using laying hens and broilers) compared to published cell 
culture and in vitro research to determine the level of secondary benefit that the 
supplementation is providing.   
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APPENDIX. EFFECTS OF PEROXIDIZED CORN OIL ON PERFORMANCE, 
AMEN, AND ABDOMINAL FAT PAD WEIGHT IN BROILER CHICKS1 
 
A research note published in Poultry Science 
 
I. J. Ehr2,3,
 
B. J. Kerr4,5, and M. E. Persia
3,6
 
 
Abstract 
There is a trend to use more alternative lipids in poultry diets, either through animal-
vegetable blends, distillers corn oil, or yellow grease. This has resulted in the use of lipids in 
poultry diets with a higher concentration of unsaturated fatty acids, which have a greater 
potential for peroxidation. The objective of this experiment was to determine the effects of 
peroxidized corn oil on broiler performance, dietary AMEn, and abdominal fat pad weight. 
The same refined corn oil sample was divided into 3 subsamples, 2 of which were exposed to 
different peroxidative processes. The 3 diets contained the unperoxidized corn oil (UO), a 
slowly peroxidized corn oil (SO; heated for 72 h at 95°C with compressed air flow rate of 12																																																									
1This research was financially supported in part by the Iowa State University Ag Experiment 
Station. Mention of a trade name, proprietary product, or specific equipment does not 
constitute a guarantee or warranty by Iowa State University or the USDA, and does not imply 
approval to the exclusion of other products that may be suitable. The authors gratefully 
acknowledge the assistance of J. Cook (USDA-ARS, Ames) with laboratory analysis, and M. 
Hansen, A. Gareis, and N. Nachtrieb (ISU, Ames) for animal care assistance. The USDA is 
an equal opportunity provider and employer. 
2Primary author and researcher.  
3Graduate student and Collaborator Assistant Professor, respectively, Department of Animal 
Science, Iowa State University. 
4Collaborator Associate Professor, United States USDA-ARS-National Laboratory for 
Agriculture and the Environment. 
5Corresponding author. 
6Assistant Professor, Department of Animal and Poultry Sciences, Virginia Tech.		
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L/min), or a rapidly peroxidized corn oil (RO; heated for 12 h at 185°C with compressed air 
flow rate of 12 L/min). Diets were fed from 0 to 14 d of age with each lipid fed at a 5% 
inclusion rate, continuing on from 15 to 27 d of age with each lipid fed at a 10% inclusion 
rate. There were 6 Ross 708 broiler chicks per cage with 10 replicates for each of the 3 
dietary treatments. Abdominal fat pad and excreta collection was performed on d 27. Body 
weight gain, feed intake and feed efficiency were measured for the 0 to 14 and 0 to 27 d 
periods. The increased level of peroxidation reduced AMEn in broiler diets (UO = 3,490 
kcal/kg; SO = 3,402 kcal/kg; RO = 3,344 kcal/kg on an as-is basis; SEM = 12.9, P ≤ 0.01). 
No significant treatment differences were observed among oil supplemented birds for BW 
gain, feed intake, feed efficiency, or abdominal fat pad weight. In conclusion, corn oil 
peroxidation status resulted in a decrease in dietary AMEn, but had minimal effects on 
broiler performance or fat pad weights.  
Key words: broiler, energy, lipid peroxidation, performance  
 
Introduction 
Dietary energy is a major cost component in feed formulation with lipids added to 
diets due to of their energy density. Sources of lipids include refined oils, rendered animal 
fats, acidulated soap stocks, and yellow grease to name a few. In addition, improved 
extraction technologies in the ethanol industry has allowed for the increased removal of corn 
oil from dried distiller’s grains with solubles resulting in increased availability of distillers 
corn oil (Singh and Cheryan, 1998; Winkler-Moser and Breyer, 2011; Kim et al., 2013). 
However, lipids high in polyunsaturated fatty acids such as corn oil are sensitive to 
peroxidation (Holman, 1954; Liu et al., 2014) where it has been shown that consumption of 
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peroxidized lipids have the potential to adversely affect broiler performance (Cabel et al., 
1988; Engberg et al., 1996), physiological oxidative status (Dibner et al., 1996; Zhang et al., 
2011), and lipid deposition (Lin et al., 1989; Sheehe et al., 1994; Pesti et al., 2002). In a 
review of the literature Hanson (2014) reported that overall responses for pigs and broilers 
fed diets with peroxidized lipids had an 11% reduction in daily gain, 7% reduction in daily 
feed intake, and a 4% reduction in feed efficiency relative to animals fed diets with 
unperoxidized lipids. Dietary peroxide value (PV) was negatively correlated with gain in 
broilers, but other measures of lipid peroxidation were not measured making correlations to 
other measures of lipid peroxidation impossible.  
The objective of this experiment was to determine the effects of slowly (SO) and 
rapidly peroxidized (RO) corn oil versus unperoxidized (UO) corn oil in diets fed to broilers 
on bird performance, dietary AMEn, and abdominal fat pad deposition.  
 
Materials and Methods 
Animals and Housing 
The Institutional Animal Care and Use Committee at Iowa State University (Ames, 
IA) approved the experimental protocol. Commercial Ross × Ross 708 hatching-day male 
broiler chicks (Aviagen Group, Huntsville, AL) were procured from a local commercial 
hatchery. The experimental unit consisted of a cage of 6 broiler chicks with 10 replicates for 
each of the 3 treatments. On arrival, chicks were individually wing banded, weighed and 
sorted for placement into battery cages (Petersime Incubator Co., Gettysburg, OH) with an 
equal BW (treatment initial body weight was between 41.8 and 42.8 g/chick: P = 0.31) at a 
density of 567 cm/bird. Birds were supplied with continuous light and supplemental heat was 
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provided from brooders in the battery cages. The initial house temperature was set at 29°C, 
reduced by 2.5°C weekly until 21°C was attained. Birds had ad libitum access to 
experimental diets and water for the duration of the 27 d experimental period. Treatments 
were applied to cages in completely randomized design.  
 
Diets 
Formulation of the basal diet met or exceeded breeder recommendations (Ross 
Nutritional Supplement, 2012; Aviagen Group, Huntsville, AL) of the broiler chicks with the 
caloric energy formulation based on UO refined corn oil values. Titanium dioxide marker 
was included at 0.25% for AMEn calculation (Leone, 1973). Diets were formulated to 
contain an UO, SO, or RO corn oil treatment (Table 1). The SO treatment was generated by 
heating refined corn oil at 95°C for 72 h while the RO treatment was generated by heating 
refined corn oil at 185°C for 12 hr, with both heating process accompanied by bubbling air 
into the heating vessel at a flow rate of 12 L/min (Table 2). To acclimate the birds to the 
higher than normal level of corn oil in the experimental diets, birds were fed at a 5% 
inclusion rate from 0 to 14 d of age and 10% from 15 to 27 d of age (Table 1). The increased 
oil inclusion rates used were higher than typical commercial oil additions for broiler 
chickens, but were used to maximize the opportunity to detect differences in dietary AMEn 
among the oil treatments. The heat treatment of the corn oil (UO, SO, and RO) was the only 
difference between the treatment diets. 
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Data Collection 
Broiler chicks were monitored twice daily over the duration of the experiment. The 
birds were individually weighed on d 0, 14, and 27 and BW gain was calculated over the 0 to 
14 and 0 to 27 d periods. Feed disappearance was measured on d 14 and 27 to calculate d 0 to 
14 and d 0 to 27 period feed intakes. Feed efficiency was corrected for mortality and reported 
as g BW gain per kg feed intake. Excreta collection pans located under the raised-wire cages 
were cleaned of all excreta, feed, and feathers on d 26 and fresh excreta were collected on d 
26 and 27 for AMEn determination. At the end of the experiment, d 27, all remaining broilers 
were euthanized via carbon dioxide asphyxiation. An incision was made into the abdominal 
cavity of each bird to allow access to the abdominal fat pad for removal and immediate wet 
weight determination. The removal of the abdominal fat pad was completed by a single 
individual to reduce variation in the collection process.  
 
Chemical Analysis 
Corn oil samples were analyzed for fatty acid profile (methods Ce 2–66; AOCS, 2009 
and 996.06; AOAC, 2010), free fatty acids (method Ca 5a–40; AOCS, 2009), moisture 
(method Ca 2c–25; AOCS, 2009), impurities (method Ca 3a–46; AOCS, 2009), 
unsaponifiables (method Ca 6a–40; AOCS, 2009), peroxide value (method Cd 8–53; AOCS, 
2009), thiobarbituric acid reactive substances, (TBARS, modified method Cd 19– 90; AOCS, 
2009; using malonaldehyde as a standard as described by Pegg, 2001), and hexanal (Elisia 
and Kitts, 2011) at the University of Missouri Agricultural Experiment Station Chemistry 
Laboratory (AESCL, Columbia, MO). The p-ansidine value (method Cd 18– 90; AOCS, 
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2009) and oxidative stability index at 110°C (method Cd 12b–92; AOCS, 2009) were 
determined at Barrow-Agee Laboratories (Memphis, TN).  
Feed samples were ground through a 0.5-mm screen and subsequently dried for 24 h 
at 100°C for DM determination. Pooled excreta samples were dried at 75°C in a convection 
oven for 3 d and subsequently ground through a 1.0-mm screen. Ether extract content of the 
feed samples was determined by Soxhlet extraction using diethyl ether at the University of 
Missouri Agricultural Experiment Station Chemistry Laboratory (method 920.39; AOAC, 
2010; AESCL, Columbia, MO). For the feed and excreta samples, N concentration was 
determined by thermocombustion (TruMac N Analyzer, LECO Corp., St. Joseph, MI), GE 
determined using an adiabatic oxygen bomb calorimeter (Parr Instrument Co., Moline, IL), 
and Ti concentration were determined using the method outlined by Leone (1973). All 
samples of excreta and feed were analyzed in duplicate. The diet AMEn determination was 
calculated as: AMEn = GEDiet − (GEExcreta × TiDiet ÷ TiExcreta) − 8.22 × (NDiet − 
NExcreta × TiDiet ÷ TiExcreta).  
 
Statistics 
The experimental unit was defined as a cage of 6 birds and data were analyzed using 
the GLM procedure of SAS (SAS Institute Inc., Cary, NC) with means reported as LSMeans. 
Fisher’s LSD test was used to separate treatment means if significance was detected (P ≤ 
0.05). In addition, the overall effect heating (SO and RO) was compared to the unheated 
lipid, UO, using a contrast statement.  
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Results and Discussion 
Lipid peroxidation is a complex process that is affected by several factors including 
the degree of lipid saturation, temperature, presence of oxygen, and contamination with 
transition metals, undissociated salts, or water (Frankel, 2005; Schaich, 2005). The process of 
lipid peroxidation is classically broken down into 3 phases, which include initiation, 
propagation, and termination, with each step “consuming” and “producing” primary, 
secondary, and tertiary compounds, respectively (Belitz et al., 2009). Because there is no 
single method accepted by the livestock community that adequately characterizes or predicts 
the peroxidation status of a lipid, we chose to analyze several compounds that represent a 
compound from each of these peroxidation phases and the remaining peroxidation potential. 
Peroxide value represented the initiation phase, TBARS and p-anisidine value representing 
the propagation phase, hexanal representing the termination phase, and oil stability index 
representing the remaining peroxidation potential. As shown in Table 2, there was a slight 
reduction in the relative concentration of C18:2 and C18:3; and slight increase in the relative 
concentration of C18:0 due to heating of the corn oil (SO and RO) relative to the unheated 
corn oil. This is not surprising given that the susceptibility of a lipid to peroxidation is 
directly related to the number of double bonds (Holman, 1954) and can subsequently affect 
fatty acid composition (Choe and Min, 2007). The SO and RO heating processes had a large 
impact on the peroxidation status of the corn oil as indicated by their elevated PV, TBARS, 
p-anisidine, and hexanal values, and the reduction in their oxygen stability index. This was 
expected and similar to other recent research on corn oil (Liu et al., 2014).  
Regardless of the increased peroxidation of corn oil by either the SO or RO heating 
process, there were no significant differences observed for BW gain, feed intake, or feed 
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efficiency for the 0 to 14 or 0 to 27 d period (Table 3). Averaged across both heating 
processes, lipid peroxidation reduced BW gain by 4.0% (P = 0.05), feed intake by 1.8% (P = 
0.34), and feed efficiency by 2.4% (P = 0.11) compared to birds fed the unheated corn oil 
control from d 0 to 14. From d 0 to 27, lipid peroxidation reduced BW gain by 3.4% (P = 
0.11), feed intake by 1.2% (P = 0.49), and feed efficiency by 2.2% (P = 0.05) compared to 
birds fed the unheated corn oil control. In a review of the literature on experiments that 
measured growth performance in broilers, Hanson (2014) indicated that the magnitude of 
reduction from feeding diets with peroxidized lipids relative to diets with unperoxidized 
lipids was 11.1% for BW gain and 6.6% for feed intake. Our results were less than these 
values, but reflect the same directional impact on bird performance.  
Supplementation of 10% peroxidized corn oil reduced the dietary AMEn (P < 0.01) 
compared to birds fed the UO corn oil (Figure 1). Birds fed the diet containing UO corn oil 
resulted in a dietary AMEn of 3,490 kcal/kg, with birds fed the diet containing the RO corn 
oil resulting in a dietary AMEn of 3,344 kcal/kg, with birds fed the SO corn oil resulting in 
an intermediate AMEn of 3,402 kcal/kg. On average, the heating of corn oil by the SO or RO 
process reduced dietary AMEn by 3.4% (P < 0.01). The slight change in corn oil composition 
(Table 2) may be partially responsible for the reduced ability of the broilers to metabolize 
and utilize energy from the peroxidized oils to the same capacity as the unheated oil as 
reflected in the lower C18:2 and C18:3, or total PUFA, content compared to the UO corn oil. 
In addition, both SO and RO corn oil had greater primary, secondary, and tertiary oxidation 
values that would increase the oxidative stress on the animal, which may impact the dietary 
AMEn values (Engberg et al., 1996). The fact that the reduction in AMEn did not affect 
performance was not unexpected as it has been shown that small differences in lipid energy 
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values can be difficult to demonstrate an impact on bird performance (Pesti et al., 2002; 
Firman et al., 2008).  
Differences in AMEn should affect the ability of birds to utilize and store the energy 
from their feed (Pesti et al., 2002), and this was indeed the case, albeit differences in 
abdominal fat pad weights were not significantly different among treatments (Figure 2). On 
average, birds fed the peroxidized corn oil treatments had abdominal fat pads that were 9.7% 
lighter than that of birds fed the UO corn oil treatment (P = 0.08), suggesting an impact on 
lipid digestion or utilization in the body. Due to excreta collection, birds were housed in 
grower batteries that prohibited determination of performance and abdominal fat pad weight 
at older ages where cumulative effects may have become significant. However, it is worthy 
to note that Engberg et al. (1996) showed that intake of peroxidized vegetable oil caused a 
reduction in whole body lipid and energy retention when birds were fed for 28 d.  
It is worthy to note that in the review by Hanson (2014), that dietary PV had the 
highest negative correlation to BW gain. Pesti et al. (2002) also reported correlations 
between various measures of lipid quality (active oxygen method, iodine value, initial PV, 
moisture plus insolubles plus unsaponifiables, and free fatty acids) and bird performance, but 
measures of lipid peroxidation are not independent of the fatty acid composition of the lipid 
(Liu et al., 2014), and therefore lipid peroxidation correlations to animal performance when 
evaluated across lipids with differing fatty acid composition, must be viewed with caution. In 
the current experiment, the lowest dietary AMEn was noted with the RO corn oil was which 
had a lower PV compared to the SO corn oil. We have no explanation for this apparent 
discrepancy, but this supports the concept that the numerous lipid peroxidation compounds 
generated during the peroxidation process may have differing effects on lipid metabolism 
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(Liu et al., 2014). This implies that a single peroxidation variable may be inadequate in 
determining the “true” peroxidation status of a lipid relative to animal performance and their 
oxidative status (Liu et al., 2014). Consequently, a multivariate analysis, such as TOTOX, 
which encompasses both primary and secondary products of lipid peroxidation (TOTOX = [2 
× PV] + p-anisidine), may be more predictive of the peroxidation status of a lipid (List et al., 
1974; Shahidi and Wanasundara, 2008). It is important to note, however, that even this 
calculated value does not include tertiary lipid peroxidation compounds such as 2, 4-
decadienal or 4-hydroxynonenal, both of which are known to damage DNA (Seppanen and 
Csallany, 2002; Wu et al., 2001; Zarkovic, 2003).  
Overall, the data indicate that corn oil with oxidative damage results in a lower 
dietary AMEn value when included at 10% in the diet. This lower caloric availability should 
be taken into account for commercial broiler ration formulations as it may affect bird 
performance and lipid deposition as well. A larger more encompassing study is deemed 
necessary to solidify the impact of lipid peroxidation on bird performance, whole body lean 
and lipid accretion rates, and measures of oxidative status. In addition, a comprehensive list 
of lipid peroxidation measures are also necessary to determine which measure or measures 
should be put into a model, independent of the FA composition of the lipid, to accurately 
characterize and quantify the “true” peroxidation status of a lipid to growing broilers.  
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TABLES 
 
Table 1. Composition of basal broiler diets containing unheated, slowly heated, or rapidly 
heated 5% (0 to 14 d) and 10% (15 to 27 d) corn oil.  
 
1Refined corn oil was unheated, slowly heated at 95°C for 72 hr, or rapidly heated at 185°C 
for 12 hr; each heat treatment accompanied with 12 L/m air flow.  
2Provided per kg of diet: vitamin A, 8,250 IU; vitamin D3, 2,750 IU; vitamin E, 17.9 IU; 
menadione, 1.1 mg; vitamin B12, 12 µg; biotin, 41 µg; choline, 447 mg; folic acid, 1.4 mg; 
niacin, 41.3 mg; pantothenic acid, 11 mg; pyridoxine, 1.1 mg; riboflavin, 5.5 mg; thiamine, 
1.4 mg; Cu, 27.5 mg; Fe, 282 mg; I, 844 µg; Mg, 125 mg; Mn, 275 mg; Se, 250 µg; Zn, 275 
mg.  
3Crude protein analyzed 21.2, 21.1, and 21.5% for the unheated, slowly heated, and rapidly 
heated treatments, respectively, for the 0 to 14 d diets and 19.5, 19.6, and 19.5% for the 
unheated, slowly heated, and rapidly heated treatments, respectively, for the 15 to 27 d diets.  
4Ether extract analyzed 6.8, 4.4, and 5.5% for the unheated, slowly heated, and rapidly heated 
treatments, respectively, for the 0 to 14 d diets; and 10.2, 8.5, and 8.3% for the unheated, 
slowly heated, and rapidly heated treatments, respectively, for the 15 to 27 d diets.  
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Table 2. Characterization of corn oil. 
 
1Refined corn oil was unheated, slowly heated at 95°C for 72 hr, or rapidly heated at 185◦C 
for 12 hr; each heat treatment accompanied with 12 L/m air flow.  
2Thiobarbituric acid reactive substances.  
3There is no unit of measure for anisidine value.  
 
 
 
 
Table 3. Performance of broiler chickens fed diets containing unheated, slowly heated, or 
rapidly heated 5% (0 to 14 d) and 10% (15 to 27 d) corn oil.  
 
1Gain and feed intake reported on a g/bird basis. Gain:feed reported as g of BW gain per kg 
of feed consumed.  
2Refined corn oil was unheated, slowly heated at 95°C for 72 hr, or rapidly heated at 185°C 
for 12 hr; each heat treatment accompanied with 12 L/m air flow.  
3Contrast of unheated, UO, versus heated, SO and RO, corn oil. For each treatment there 
were 10 pens per treatment with 6 birds per pen.   
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FIGURES 
 
 
Figure 1. Broiler AMEn (kcal/kg) of diets (as-is basis) containing 10% (15 to 27 d) refined 
unheated (UO), slowly heated at 95°C for 72 hr (SO), or rapidly heated at 185°C for 12 hr 
(RO) corn oil, with each heat treatment accompanied with 12 L/m air flow. Excreta samples 
collected on d 26 to 27 of the experiment to determine AMEn. Columns are mean values of 
10 pens per treatment with 6 birds per pen and bars are defined as the overall pooled SEM 
(12.9).  
a-cSuperscript values without common letters are significantly different (P ≤ 0.05). Contrast 
of unheated, UO, versus heated, SO and RO, corn oil; P < 0.01.  
 
 
 
 
 
 
Figure 2. Abdominal fat pad (AFP) weight (g/bird) of broilers, collected on d 27, feed diets 
containing 5% (0 to 14 d) and 10% (15 to 27 d) refined unheated (UO), slowly heated at 
95°C for 72 hr (SO), or rapidly heated at 185°C for 12 hr (RO) corn oil, with each heat 
treatment accompanied with 12 L/m air flow. Columns are mean values of 10 pens per 
treatment with 6 birds per pen and bars are defined as the overall pooled SEM (0.68) for AFP 
weight. Overall treatment P-value was 0.15. Contrast of unheated, UO, versus heated, SO 
and RO, corn oil; P = 0.08.  
 
